NOTICE OF ELECTRONIC FILING - AIG-Caremark …...CASE NO. CV-2003-006630-PJB CITY OF BIRMINGHAM...
Transcript of NOTICE OF ELECTRONIC FILING - AIG-Caremark …...CASE NO. CV-2003-006630-PJB CITY OF BIRMINGHAM...
AlaFile E-Notice
To: SCOTT A. POWELL ESQ.
01-CV-2003-006630.00
Judge: PAT BALLARD
NOTICE OF ELECTRONIC FILING
IN THE CIRCUIT COURT OF JEFFERSON COUNTY, ALABAMA
The following matter was FILED on 7/5/2018 2:46:18 PM
JOHN LAURIELLO VS CAREMARK RX LLC
01-CV-2003-006630.00
MOTION FOR COURT TO DIRECT CLAIMS ADMINISTRATOR
Notice Date: 7/5/2018 2:46:18 PM
[Filer: POWELL SCOTT ASHLEY]
ANNE-MARIE ADAMS
CIRCUIT COURT CLERK
JEFFERSON COUNTY, ALABAMA
716 N. RICHARD ARRINGTON BLVD.
BIRMINGHAM, AL, 35203
205-325-5355
JEFFERSON COUNTY, ALABAMA
C004 CITY OF BIRMINGHAM RETIREMENT AND RELIEF SYSTEM
Motion to Intervene ($297.00)
Oral Arguments Requested
Pendente Lite
CV200300663000
7/5/2018 2:42:49 PM
0
C004 - CITY OF BIRMINGHAM RETIREMENTAND RELIEF SYSTEM
Local Court Costs $
*Motion fees are enumerated in §12-19-71(a). Feespursuant to Local Act are not included. Please contact theClerk of the Court regarding applicable local fees.
*This Cover Sheet must be completed and submitted to the Clerk of Court upon the filing of any motion. Each motion should contain a separate Cover Sheet.
($50.00)pursuant to Rule
(Subject to Filing Fee).pursuant to Rule
Motion for Court to Direct ClaimsAdministrator
Other
Withdraw
Vacate or Modify
Supplement to Pending Motion
Strike
Stay
Special Practice in Alabama
Sever
Sanctions
Release from Stay of Execution
Quash
Protective Order
Preliminary Injunction
Plaintiff's Motion to Dismiss
Objection of Exemptions Claimed
New Trial
Motion to Dismiss pursuant to Rule 12(b)
More Definite Statement
Joinder
In Limine
Extension of Time
Disburse Funds
Judgment as a Matter of Law (during Trial)
Designate a Mediator
Deposition
Continue
Consolidation
Compel
Change of Venue/Transfer
Amend
Add Party
Other
Motion to Dismiss, or in the AlternativeSummaryJudgment($50.00)
Judgment on the Pleadings ($50.00)
Renewed Dispositive Motion(SummaryJudgment,Judgment on the Pleadings, or otherDispositiveMotion not pursuant to Rule 12(b)) ($50.00)
Summary Judgment pursuant to Rule 56($50.00)
Joinder in Other Party's Dispositive Motion(i.e.Summary Judgment, Judgment on the Pleadings,orother Dispositive Motion not pursuant to Rule 12(b))($50.00)
Default Judgment ($50.00)
Motions Not Requiring FeeMotions Requiring Fee
TYPE OF MOTION
POW005
BIRMINGHAM, AL 35203
2025 3RD AVENUE NORTH, SUITE 800
SCOTT A. POWELL ESQ.
Attorney Bar No.:
Name, Address, and Telephone No. of Attorney or Party. If Not Represented.
Name of Filing Party:
CIVIL MOTION COVER SHEETJOHN LAURIELLO VS CAREMARK RX LLC
Revised 3/5/08
Circuit CourtDistrict Court01-JEFFERSON
Unified Judicial System
STATE OF ALABAMA Case No.
Check here if you have filed or are filing contemoraneouslywith this motion an Affidavit of Substantial Hardship or if youare filing on behalf of an agency or department of the State,county, or municipal government. (Pursuant to §6-5-1 Codeof Alabama (1975), governmental entities are exempt fromprepayment of filing fees)
Date: Signature of Attorney or Party
/s/ SCOTT A. POWELL ESQ.
ELECTRONICALLY FILED7/5/2018 2:45 PM
01-CV-2003-006630.00CIRCUIT COURT OF
JEFFERSON COUNTY, ALABAMAANNE-MARIE ADAMS, CLERK
DOCUMENT 3727
**Motions titled 'Motion to Dismiss' that are not pursuant to Rule 12(b) and are in fact Motions for Summary Judgments are subject to filing fee.
DOCUMENT 3727
IN THE CIRCUIT COURT OF JEFFERSON COUNTY, ALABAMA
CASE NO. CV-2003-006630-PJB
CITY OF BIRMINGHAM RETIREMENT AND RELIEF SYSTEM, for itself, individually, and on behalf of a class of all others who are similarly situated,
Plaintiff,
v.
CAREMARK Rx, L.L.C.; AMERICAN INTERNATIONAL GROUP, INC.; NATIONAL UNION FIRE INSURANCE COMPANY OF PITTSBURGH, PA.; AIG TECHNICAL SERVICES, INC.; And AMERICAN INTERNATIONAL SPECIALTY LINES INSURANCE COMPANY,
Defendants.
PLAINTIFF'S MOTION FOR THE COURT TO DIRECT THE CLAIMS ADMINISTRATOR TO TRANSMIT ITS PRELIMINARY APPROVAL/REJECTION
LETTERS TO THE CLAIMANTS
Comes now the plaintiff and seeks an order that directs the claims administrator, Gilardi
and Co. LLC, to mail or transmit letters to each claimant stating that their claim is recommended
by the claims administrator either to be rejected (and on what ground) or to be approved (and in
what amount). The letters will explain that the claimants have 28 days to request further review
by Gilardi if they believe the recommended disposition of their claim is in error. When Gilardi
has processed all such requests, Gilardi will file with the Court its final recommendations and the
1
V
IN THE CIRCUIT COURT OF JEFFERSON COLTNTY, ALABAMA
CASE NO. CV-2003 -00663 O.PJB
CITY OF BIRMINGHAM RETIREMENTAND RELIEF SYSTEM, for itself,individually, and on behalf of a class ofall others who are similarly situated,
Plaintiff,
CAREMARK RX, L.L.C.; AMERICANINTERNATIONAL GROUP, INC.;NATIONAL LTNION FIRE INSURANCECOMPANY OF PITTSBURGH, PA.;AIG TECHNICAL SERVICES, INC.;And AMERICAN INTERNATIONALSPECIALTY LINES INSURANCECOMPANY,
Defendants
PLAINTIFF'S MOTION FOR THE COURT TO DIRECT THE CLAIMSADMINISTRATOR TO TRANSMIT ITS PRT,LIMINARY APPROVAL/REJECTION
LETTERS TO THE CLAIMANTS
Comes now the plaintiff and seeks an order that directs the claims administrator, Gilardi
and Co. LLC, to mail or transmit letters to each claimant stating that their claim is recommended
by the claims administrator either to be rejected (and on what ground) or to be approved (and in
what amount). The letters will explain that the claimants have28 days to request further review
by Gilardi if they believe the recommended disposition of their claim is in error. When Gilardi
has processed all such requests, Gilardi will file with the Court its final recommendations and the
ELECTRONICALLY FILED7/5/2018 2:45 PM
01-CV-2003-006630.00CIRCUIT COURT OF
JEFFERSON COUNTY, ALABAMAANNE-MARIE ADAMS, CLERK
DOCUMENT 3728
Court can hold a hearing on the request for final Court approval for the disposition of claims.'
Attached hereto as Exhibit 1 is the July 3, 2018, declaration of Gilardi's Marc Wall.
There are, in turn, several exhibits (A-H) to Mr. Wall's declaration.2 Except for three groups of
claims (explained below), Gilardi has proposed a recommended disposition for each of the
approximately 9500 claims. This motion and all non-sealed exhibits will be posted to the class
website: www.aig-caremarkclassaction.com.
There are three groups of claims for which Gilardi has no recommendation. Gilardi,
plaintiff, and class counsel seek a judicial resolution of these three groups of claims. These three
groups are explained at Section VII., TT 50-57, of Mr. Wall's declaration. The first group is one
individual's claim: Virginia Hoffman Greene.' The second group consists of competing
claimants to the claims originally belonging to the General Motors Corporation and its related
entities.' The third group consists of four individuals who were a part of the InPhyNet Medical
Management entity that was acquired by MedPartners during the class period.' Plaintiff proposes
that these three groups be discussed and decided at the Court's final hearing on Gilardi's final
' That final hearing can also address all of the other items of relief requested in the concluding paragraph 67 of Mr. Wall's declaration.
2 The exhibits (C and E) that include the claims forms and documents from individual claimants are filed under seal because they contain personal financial information.
3 Ms. Greene's name and identity is already public record in this case, as she is the intervenor.
GM is a public corporation, so its identity and the fact that competing GM entities have filed claims are not private facts.
5 The identities of these four individual claimants are not being disclosed in publicly-filed documents. Their claim forms, which identify them, are being filed under seal.
2
Court can hold a hearing on the request for final Court approval for the disposition of claims.r
Attached hereto as Exhibit 1 is the July 3, 2018, declaration of Gilardi's Marc Wall.
There areo in tum, several exhibits (A-H) to Mr. Wall's declaration.2 Except for three groups of
claims (explained below), Gilardi has proposed a recommended disposition for each of the
approximately 9500 claims. This motion and all non-sealed exhibits will be posted to the class
website : www.aig-caremarkclassaction.com.
There are three groups of claims for which Gilardi has no recommendation. Gilardi,
plaintiff, and class counsel seek a judicial resolution of these three groups of claims. These three
groups are explained at Section Vtr., lTfl 50-57, of Mr. Wall's declaration. The first group is one
individual's claim: Virginia Hoffman Greene.3 The second group consists of competing
claimants to the claims originally belonging to the General Motors Corporation and its related
entities.a The third group consists of four individuals who were apart of the InPhyNet Medical
Management entity that was acquired by MedPartners during the class period.s Plaintiff proposes
that these three groups be discussed and decided at the Court's final hearing on Gilardi's final
t That final hearing can also address all of the other items of relief requested in theconcluding paragraph 67 of Mr. Wall's declaration.
2 The exhibits (C and E) that include the claims forms and documents from individualclaimants are filed under seal because they contain personal financial information.
' Ms. Greeneos name and identity is already public record in this case, as she is theintervenor.
o GM is a public corporation, so its identity and the fact that competing GM entities havefiled claims are not private facts.
5 The identities of these four individual claimants are not being disclosed in publicly-fileddocuments. Their claim forms, which identifu themo are being filed under seal.
2
DOCUMENT 3728
recommendations.
As part of this motion, plaintiff moves the Court to direct class counsel to immediately
transmit notices to these three groups of claimants, substantially, as follows:
(A) Greene.
NOTICE OF RIGHT TO FILE ADDITIONAL MATERIALS OR WRITTEN ARGUMENTS
This Notice is being sent by class counsel at the Court's direction to Ms. Virginia Hoffman Greene, who filed Claim No. 300287-0 in the above-styled action, via her attorney, Mr. Lanny S. Vines, at 2142 Highland Avenue South, Birmingham, Alabama 35205.
The claims administrator for this class-action settlement, Gilardi & Co. LLC, is unable to formulate a recommendation to the Court as to whether your claim should be approved or rejected. Thus, it has asked the Court to adjudicate the validity or invalidity of your claim. For more detail, see Section VII of Marc Wall's declaration of July 2018, which can be viewed in the "Case Documents" section of www.aig-caremarkclassaction.com as Exhibit 1 to "Plaintiffs Motion for the Court to Direct the Claims Administrator to Transmit its Preliminary Approval/rejection Letters to the Claimants."
The Court has a copy of your claim form and every other written document you provided to Gilardi. Within 30 days of today's date, you may file any additional documentation in support of your claim, and you or your attorney may file written arguments in support of your claim. Any additional documentation or argument must be received by class counsel no later than [state the date of the thirtieth day]. Such materials must be emailed to Scott Powell at [email protected] or you or your attorney may file such materials in person or by mail (to be received prior to the 30-day deadline) with Scott Powell, Hare, Wynn, Newell & Newton, LLP, 2025 Third Avenue North, Suite 800, Birmingham, AL 35203. Class counsel will then file all such materials with the Court, and shall request filing under seal if such documents contain personal financial information.
The Court will rule on your claim and you will be notified of the Court's ruling.
(B) The General Motors Claimants.
NOTICE OF RIGHT TO FILE ADDITIONAL MATERIALS OR WRITTEN ARGUMENTS
This Notice is being sent by class counsel at the Court's direction to [NAME], who filed Claim No. [NUMBER] in the above-styled action.
The claims administrator for this class-action settlement, Gilardi & Co.
3
recommendations.
As part of this motion, plaintiff moves the Court to direct class counsel to immediately
transmit notices to these three groups of claimants, substantially, as follows:
(A) Greene.
NOTICE OF RIGHT TO FILE ADDITIONAL MATERIALS OR WRITTEN ARGUMENTS
This Notice is being sent by class counsel at the Court's direction to Ms.Virginia Hoffman Greene, who filed Claim No' 300287-0 in the above-styledaction, via her attorney, Mr. Lanny S. Vines, at2142 Highland Avenue South,Birmingham, Alabama 35205.
The claims administrator for this class-action settlement, Gilardi & Co.LLC, is unable to formulate a recommendation to the Court as to whether yourclaim should be approved or rejected. Thus, it has asked the Court to adjudicatethe validity or invatiOity of your claim. For more detail, see Section VII of MarcWall,s declaration of July 2018, which can be viewed in the "Case Documents"section of www.aig-caremarkclassaction.com as Exhibit I to "Plaintiffs Motionfor the Court to Direct the Claims Administrator to Transmit its PreliminaryApproval/rejection Letters to the Claimants'"
The Court has a copy of your claim form and every other written documentyou provided to Gilardi. Within 30 days of today's date, you may file anyadditional documentation in support of your claim, and you or your attorney mayfile written arguments in support of your claim. Any additional documentation orargument rn,rtt b. received by class counsel no later than [state the date of thettri"rtiettr day]. Such materials must be emailed to Scott Powell at [email protected] you or your attomey may file such materials in person or by mail (to bereceived prior to the 30-day deadline) with Scott Powell, Hare, wynn, Newell &Newton, LLP,2025 Third Avenue North, suite 800, Birmingham, AL35203.Class counsel will then file all such materials with the Court, and shall requestfiling under seal if such documents contain personal financial information.
The Court will rule on your claim and you will be notified of the Court'sruling.
(B) The General Motors Claimants.
NOTICE OF RIGHT TO FILE ADDITIONAL MATERIALS OR WRITTEN ARGUMENTS
This Notice is being sent by class counsel at the Court's direction to
[NAME], who filed claim No. INUMBER] in the above-styled action.The claims administrator for this class-action settlement, Gilardi & Co.
-t
DOCUMENT 3728
LLC, is unable to formulate a recommendation to the Court as to which claimant/claimants is/are entitled to receive the settlement proceeds deriving from the claims belonging to the General Motors Corporation, General Motors Foundation, and other General Motors affiliated claimants. Competing claims have been filed in relation to the General Motors-related claims. Thus, Gilardi has asked the Court to adjudicate the validity or invalidity of your claims (or parts thereof). For more detail, see Section VII of Marc Wall's declaration of July 2018, which can be viewed in the "Case Documents" section of www.aig-caremarkclassaction.com as Exhibit 1 to "Plaintiffs Motion for the Court to Direct the Claims Administrator to Transmit its Preliminary Approval/rejection Letters to the Claimants."
The Court has a copy of your claim form(s) and every other written document you provided to Gilardi. Within 30 days of today's date, you may file any additional documentation in support of your claim(s), and you or your attorney may file written arguments in support of your claim(s). Any additional documentation or argument must be received by class counsel no later than [state the date of the thirtieth day]. Such materials must be emailed to Scott Powell at [email protected] or you or your attorney may file such materials in person or by mail (to be received prior to the 30-day deadline) with Scott Powell, Hare, Wynn, Newell & Newton, LLP, 2025 Third Avenue North, Suite 800, Birmingham, AL 35203. Class counsel will then file all such materials with the Court.
The Court will rule on your claim(s) and you will be notified of the Court's ruling.
(C) The Four Individuals Associated With lnPhyNet.
NOTICE OF RIGHT TO FILE ADDITIONAL MATERIALS OR WRITTEN ARGUMENTS
This Notice is being sent by class counsel at the Court's direction to [NAME], who filed Claim No. [NUMBER] in the above-styled action.
The claims administrator for this class-action settlement, Gilardi & Co. LLC, is unable to formulate a recommendation to the Court as to whether your claim should be approved or rejected (in whole or in part). Thus, it has asked the Court to adjudicate the validity or invalidity of your claim (or parts thereof). For more detail, see Section VII of Marc Wall's declaration of July 2018, which can be viewed in the "Case Documents" section of www.aig-caremarkclassaction.com as Exhibit 1 to "Plaintiffs Motion for the Court to Direct the Claims Administrator to Transmit its Preliminary Approval/rejection Letters to the Claimants."
The Court has a copy of your claim form and every other written document you provided to Gilardi. Within 30 days of today's date, you may file any additional documentation in support of your claim, and you or your attorney may file written arguments in support of your claim. Any additional documentation or
4
LLC, is unable to formulate a recommendation to the Court as to whichclaimant/claimants is/are entitled to receive the settlement proceeds deriving fromthe claims belonging to the General Motors Corporation, General MotorsFoundation, and other General Motors affiliated claimants. Competing claimshave been filed in relation to the General Motors-related claims. Thus, Gilardi has
asked the Court to adjudicate the validity or invalidity of your claims (or partsthereof). For more detail, see Section VII of Marc Wall's declaration of July 2018,which can be viewed in the "Case Documents" section ofwww.aig-caremarkclassaction.com as Exhibit 1 to "Plaintiffs Motion for theCourt to Direct the Claims Administrator to Transmit its PreliminaryApproval/rejection Letters to the Claimants."
The Court has a copy of your claim form(s) and every other writtendocument you provided to Gilardi. Within 30 days of today's date, you may fileany additional documentation in support of your claim(s), and you or yourattomey may file written arguments in support of your claim(s). Any additionaldocumentation or argument must be received by class counsel no later than [statethe date of the thirtieth dayl. Such materials must be emailed to Scott Powell [email protected] or you or your attorney may file such materials in person or bymail (to be received prior to the 30-day deadline) with Scott Powell, Hare, Wynn,Newell & Newton, LLP,2025 Third Avenue North, Suite 800, Birmingham, AL35203. Class counsel will then file all such materials with the Court.
The Court will rule on your claim(s) and you will be notified of the Court'sruling.
(C) The Four lndivi .
NOTICE OF RIGHT TO FILE ADDITIONAL MATERIALS OR WRITTEN ARGUMENTS
This Notice is being sent by class counsel at the Court's direction to
[NAME], who filed Claim No. [NUMBER] in the above-styled action.The claims administrator for this class-action settlement, Gilardi & Co.
LLC, is unable to formulate a recommendation to the Court as to whether yourclaim should be approved or rejected (in whole or in part). Thus, it has asked the
Court to adjudicate the validity or invalidity of your claim (or parts thereof). Formore detail, see Section VII of Marc Wall's declaration of July 2018, which can
be viewed in the "Case Documents" section of www.aig-caremarkclassaction.comas Exhibit 1 to "Plaintiff s Motion for the Court to Direct the ClaimsAdministrator to Transmit its Preliminary Approval/rejection Letters to theClaimants."
The Court has a copy of your claim form and every other written documentyou provided to Gilardi. Within 30 days of today's date, you may file any
additional documentation in support of your claim, and you or your attorney mayfile written arguments in support of your claim. Any additional documentation or
4
DOCUMENT 3728
argument must be received by class counsel no later than [state the date of the thirtieth day]. Such materials must be emai led to Scott Powell at [email protected] or you or your attorney may file such materials in person or by mail (to be received prior to the 30-day deadline) with Scott Powell, Hare, Wynn, Newell & Newton, LLP, 2025 Third Avenue North, Suite 800, Birmingham, AL 35203. Class counsel will then file all such materials with the Court, and shall request filing under seal if such documents contain personal financial information.
The Court will rule on your claim and you will be notified of the Court's ruling.
WHEREFORE, plaintiff seeks: (1) a Court order that directs the claims administrator,
Gilardi and Co. LLC, to mail or transmit letters to each claimant stating that their claim is
recommended by the claims administrator either to be rejected (and on what ground) or to be
approved (and in what amount); and (2) the Court's direction to class counsel to transmit the
above-noted "Notice of Right to File Additional Materials or Written Arguments" to the three
groups of claimants noted above.
Respectfully submitted this the 5' day of July, 2018.
s/ Scott A. Powell Scott A. Powell One of the Attorneys for the Plaintiff Class
OF COUNSEL:
John W. Haley Scott A. Powell Bruce J. McKee Brian M. Vines Ralph D. Cook Tempe D. Smith Hare, Wynn, Newell & Newton, LLP 2025 3rd Avenue N., Suite 800 Birmingham, Alabama 35203 (205) 328-5330 fax: (205) 324-2165 [email protected]
5
argument must be received by class counsel no later than [state the date of thethirtieth dayl. Such materials must be emailed to Scoff Powell at scott@hwnn'comoryouoryourattorneymayfilesuchmaterialsinpersonorbymail(tobereceived prior to the 3b-dai deadline) with Scott Pg*_.ll,Hare, wynn, Newell &Newton, LLP,2025 Third Avenue North' Suite 800, Birmingham, AL35203.Class counsel will then file all such materials with the Court, and shall requestfiling under seal if such documents contain personal financial information'
The court will rule on your claim and you will be notified of the court'sruling.
WHEREFORE, plaintiff seeks: (1) a Court order that directs the claims administrator,
Gilardi and co. LLC, to mail or transmit letters to each claimant stating that their claim is
recommended by the claims administrator either to be rejected (and on what ground) or to be
approved (and in what amount); and (2) the court's direction to class counsel to transmit the
above_noted..Notice of Right to File Additional Materials or written Arguments" to the three
groups of claimants noted above'
Respectfully submitted this the 5'h day of July' 2018'
s/ Scott A. PowellScott A. PowellOne of the Attomeys for the Plaintiff Class
OF COUNSEL:
John W. HaleYScott A. PowellBruce J. McKeeBrian M. VinesRalph D. CookTempe D. Smith'Hare, Wynn, Newell & Newton, LLP2025 3rd Avenue N., Suite 800Birmingham, Alabama 3 5203(205) 328-5330fax: (205) [email protected]
5
DOCUMENT 3728
J. Timothy Francis Francis Law, LLC 300 N. Richard Arrington Jr. Blvd. 700 Title Building Birmingham, Alabama 35203 (205) 251-0252 [email protected]
John Q. Somerville Somerville, LLC 300 N. Richard Arrington Jr. Blvd. Suite 710 Title Building Birmingham, Alabama 35203 (205) 871-2183 [email protected]
Counsel for the Plaintiff and Plaintiff Class
CERTIFICATE OF SERVICE
I hereby certify that I have on this 5' day of July, 2018, served a copy of the foregoing on counsel of record by notice of electronic mail on those who are registered participants in the electronic-filing system and upon counsel of record who are not participants in the electronic-filing system by placing a copy of same in the United States Mail, first class postage prepaid, and addressed, as follows:
Randall D. Quarles Frances P. Quarles QUARLES LAW FIRM, LLC 300 Office Park Drive, Suite 100 Birmingham, AL 35223 Telephone: (205) 874-7000 Telecopier: (205) 874-7002 [email protected]
Matthew J. Evans Michael J. King Paine Bickers LLP 900 South Gay Street, Suite 2200 Knoxville, Tennessee 37902-1821 Phone: 865.525.0880 Fax: 865.521.7441 Email: [email protected]
6
J. Timothy FrancisFrancis Law, LLC300 N. Richard Arrington Jr. Blvd.700 Title BuildingBirmingham, Alabama 3 5203
John Q. SomervilleSomerville, LLC300 N. Richard Anington Jr. Blvd.Suite 710 Title BuildingBirmingham, Alabama 3 5203(205) [email protected]
Counsel for the Plaintiff and Plaintiff Class
CERTIFICA OF SERVICE
I hereby certiff that I have on this 5'h day of July, 2018, served a copy of the foregoing oncounsel of record by notice of electronic mail on those who are registered participants in theelectronic-filing system and upon counsel of record who are not participants in theelectronic-filing system by placing a copy of same in the United States Mail, first class postageprepaid, and addressed, as follows:
Randall D. QuarlesFrances P. QuarlesQUARLES LAW FIRM, LLC300 Qffice Park Drive, Suite 100
Birmingham, AL35223Telephone: (205) 87 4-7 000Telecopier: (205) 87 4-7 002rquarles @quarleslawfi rm. com
Matthew J. EvansMichael J. KingPaine Bickers LLP900 South Gay Street, Suite 2200Knoxville, Tennessee 37 902-1 821Phone: 865.525.0880Fax: 865.521.7441Email : [email protected]
6
DOCUMENT 3728
Attorneys for Clete Walker & Georgia Urology Group
and
William Brower W. Scott Brower Brower Law Firm P.O. Box 130249 Birmingham, AL 35213 (205) 458-9889 [email protected] [email protected]
Attorneys for Stanley D. Lawler
and
Lanny S. Vines LANNY VINES & ASSOCIATES, LLC 2142 Highland Avenue South Birmingham, Alabama 35205 (205) 933-1277 [email protected] Attorney for Former Intervenor
s/ Scott A. Powell Scott A. Powell One of the Attorneys for the Plaintiff Class
7
and
Attorneys for Clete Walker & Georgia Urology Group
William BrowerW. Scott BrowerBrower Law FirmP.O. Box 130249Birmingham, AL35213(20s) 4s8-9889williambrower@bell [email protected]
Attorneys for Stanley D. Lawler
and
Lanny S. VinesLANNY VINES & ASSOCIATES, LLC21 42 Highland Avenue SouthBirmingham, Alabama 35205
Q0s)[email protected] for Former Intervenor
s/ Scoff A. PowellScott A. PowellOne of the Attorneys for the Plaintiff Class
7
DOCUMENT 3728
EXHIBIT 1
July 3, 2018, Declaration of Marc Wall
EXHIBIT 1
July 3, 201 8, Declaration of Marc Wall
DOCUMENT 3728
IN THE CIRCUIT COURT OF JEFFERSON COUNTY, ALABAMA CASE NO. CV-2003-006630-PJB
CITY OF BIRMINGHAM RETIREMENT AND RELIEF SYSTEM, for itself, individually, and on behalf of a class of all others who are similarly situated,
Plaintiff,
vs.
CAREMARK RX, LLC; AMERICAN INTERNATIONAL GROUP, INC.; NATIONAL UNION FIRE INSURANCE COMPANY OF PITTSBURGH, PA.; AIG TECHNICAL SERVICES, INC.; and AMERICAN INTERNATIONAL SPECIALTY LINES INSURANCE COMPANY,
Defendants,
DECLARATION OF MARC WALL REGARDING STATUS OF CLAIMS ADMINISTRATION AND PROPOSED DISTRIBUTION PLAN OF NET
SETTLEMENT FUND
Page 1 of 29
iN THE CIRCUIT COURT OF JEFFERSON COIINTY, ALABAMACASE NO. CV-2003-OO663O-PJB
CITY OF BIRMINGHAM RETIREMENTAND RELIEF SYSTEM, for itself, individually,and on behalfofa class ofallothers who are similarlY situated,
Plaintiff,
VS
CAREMARK RX, LLC; AMERICAN INTERNATIONALGROUP, INC.; NATIONAL IINION FIREINSURANCE COMPANY OF PITTSBURGH, PA.;AIG TECHNICAL SERVICES, INC'; ANd AMEzuCANINTERNATIONAL SPECiALTY LINES INSURANCECOMPANY,
Defendants,
DECLARATION OF MARC WALL REGARDING STATUS OFclanns numntstn luoN lNu pRoposnn ulsrrunutloN pl,lN or nnr
SETTLEMENT F'UND
Page I of29
DOCUMENT 3728
I, MARC WALL, declare:
1. 1 am employed as a Senior Project Manager by Gilardi & Co. LLC ("Gilardi"),
the Claims Administrator in the above-captioned matter. Gilardi's office is located at 3301
Kerner Blvd., in San Rafael, California. I am over 21 years of age and am not a party to this
action. As part of my role as Senior Project Manager, I oversee the administration of the
Settlement in this class action. I have personal knowledge of the facts set forth herein and, if
called as a witness, could and would testify competently thereto.
2. I submit this declaration in order to provide the Court and the Parties to this action
with information regarding the administration of the settlement of the above-captioned matter
(the "Settlement"), the processing of the Proofs of Claim and Release forms ("Claims")
submitted in connection with the Settlement, and the calculation of recognized Claims pursuant
to the Plan of Allocation of the Net Settlement Fund (the "Plan of Allocation") contained in the
Notice of Proposed Settlement of Class Action disseminated to the Settlement Class.'
I. DISSEMINATION OF THE NOTICE
A. NOTICE MAILING
3. On June 1, 2016, this Court entered its Order Approving Settlement and
Providing for Notices to the Class and authorized the retention of Gilardi as the Claims
Administrator. Gilardi had previously been retained in 2015 as the Notice Administrator for the
The Settlement Class is defined as "All Persons who (a) purchased MedPartners common stock, including through open-market transactions, mergers or acquisitions in which MedPartners issued common stock, acquisition through the Company's Employee Stock Purchase Plan ("ESPP"), and any other type of transaction in which a Person acquired one or more shares of MedPartners stock in return for consideration during the period from October 30, 1996, through January 7, 1998, inclusive; (b) purchased call option contracts on MedPartners common stock during the period October 30, 1996, through January 7, 1998, inclusive; (c) sold put option contracts on MedPartners common stock during the period October 30, 1996, through January 7, 1998, inclusive; (d) purchased MedPartners Threshold Appreciation Price Securities ("TAPS") in the September 15, 1997 offering or thereafter through January 7, 1998; or (c) tendered shares of Talbert Medical Management Holdings Corporation to MedPartners between August 20, 1997, and September 19, 1997, but excluding (i) all those Persons who submitted valid requests for exclusion in connection with the MedPartners Securities Litigation Settlement and (ii) all those Persons who submitted valid requests for exclusions in the response to the Class Notice (collectively, the "Class," comprised of "Class Members"),"
Page 2 of 29
I, MARC WALL, declat'e:
l. l am employed as a Senior Ploject Managet'by Gilardi & Co. LI-C ("Gilardi"),
the Claims Aclninistrator in the above-captioned maller. Gilardi's office is located at 3301
I(et.ner. Blvd., in San Rafael, Califolnia. I am over 21 years of age and am not a party to this
action. As part of my role as senior Project Manager, I oversee the administtation of the
Settlement in this class aetion. I have personai knowleclge of the facts set forth herein and' if
called as a witness, couicl and would testifr competently thereto'
Z. I sub'rit this declaration in orcier to provide the Court and the Parties to this action
with infbrrnation regarding tlie aclministration of the settlement of the above-captioned matter
(the ,.Settlement,,), the processing of the Proofs of clairn and Release forms ("claims")
subrnitted in comrection with the Settlernent, and the calculation of recognized Claims pursuant
to the pla' of Allocation of the Net Seltlernent Fund (the "Plan of Allocation") contained in the
Notice of proposed Settlement of Class Action disseminated to the Settlement Class'r
I. DISSEMINATION OIi THB NOTICE
A. NOTICE MAILING
3. On June 1, 2016, this courl entered its order Apploving settlement and
providing for Notices to the Ciass and authorized the retention of Gilardi as the Claims
Administrator. Gilardi had previously been retained in 2015 as the Notice Administrator for the
, The settle'rent class is definecl as ,,All persons who (a) pulchased MedPafine|s conlnlon stock, including th|ough
open-mar.ket transactions, r;il;;; ol acquisitions in *ftilft MedPaltnels issued common stock, acquisition throughrhe Company,s Enployee Sto;k Purchase Plan ("ESPP"), and any other type of h'ansaction in which a Person
acquir.ed one or mor.e shar.es of Me6Partners stock in l'eturn for consideration duling the period fi'om octobet 30,1996, through January 't ,lggS,inclusive; (b) purchased call option colltl'acts on MedPartners cornmon sfocl< duringift" pi,ri",f drtob",, ZO, igS'A,inrouglt Jartuar:y'7 , 1998, inclusive; (c) sold put option contracts on MedPat'tnersc.rrmon stock dur.ing gr" r*.i",r oitou". 30', 1996,through January 7, 1998, inclusive; (d) purchased MedPa'he'sTln.eshold Appreciation p,iir. s".urlti"s i"f iPS") in the bepternber 15, 199"1 offeling or thet'eafter through January./, l99g;or {ej tencleLed shares of Talbert Medical Managemetrt Holdings Corporation to MedPartnels betweenAugust 20, lggl ,ancl September. 19, 1997,but exclucline (i) all those Pet'sons who subrnitled valid requests forexclusion in conneciion with the Meclpartrier.s s-cur-iles t-itigation Settlenrerrt and (ii) all those Persons rvhosubmitted valid requests for exclusions in the r.esponse to the Class Notice (collectively, the "Class," comprised oi"Class Members")."
Page2 of29
DOCUMENT 3728
limited purpose of a postcard mailing advising potential Class Members of the class certification.
That mailing took place in June 2015.
4. On June 17, 2016, Gilardi mailed 94,005 single page, self-mailer Notices by first
class mail to potential Class Members. Two different Notices, previously referred to in other
declarations submitted with this Court as "Self-Mailer A" and "Self-Mailer B," were used in this
mailing. To the 17,903 Class Members who had submitted a valid claim in the earlier class
action (the "MedPartners class action") and received a distribution, Gilardi mailed Self-Mailer A.
Self-Mailer A included both a claim identification and personal identification number ("PIN").
These numbers would permit Gilardi to trace the Class Member's claim back to the MedPartners
class action should the Class Member choose to file a claim online based on the previously-
submitted information. All other potential Class Members received Self-Mailer B. Because
those potential Class Members could not be directly traced to a valid claim in the MedPartners
class action, Self-Mailer B did not contain a claim identification number or PIN.
5. On June 17, 2016, as part of its normal mailing procedures, Gilardi mailed
Notices and cover letters to 251 brokerages, custodial banks, and other institutions ("Nominal
Holders") that hold securities in "street name" as nominees for the benefit of their customers
who are the beneficial owners of the securities. The Nominal Holders also included a group of
filers/institutions who have requested notification of every securities case. These Nominal
Holders are included in a proprietary database created and maintained by Gilardi. In response to
this mailing, Nominal Holders provided names and addresses. An additional 5,037 Self-Mailer B
notices were sent to potential class members since the original mailing date.
6. For more information regarding the specific details of the Notice campaign, see
the Declaration of Ross Murray Regarding Mailing of the Notice of Class Action and List of
Objections filed with this Court on July 29, 2016.
Page 3 of 29
lirnitecl purpose of a postcard mailing advising potential Class Mernbers of the class certification'
That mailing toolc place in June 2015.
4. On June 17,2016, Gilardi mailed 94,005 single page, self-mailer Notices by first
class mail to potential Class Members. Two different Notices, previously refered to in other
cleclarations submitted with this Coufi as "Self-Mailer A" and "Self-Mailer B," were used in this
mailing. To the 17,903 Class Members who had submitted a valid claim in the earlier class
action (the "MedPartners class action") and received a distribution, Gilardi mailed Self-Mailer A'
Self.-Mailer A included both a claim identification and personal identification number ("PfN").
These numbers would permit Gilardi to trace the Class Member's claim back to the MedPartnets
class action should the Class Member choose to file a claim online based on the previously-
submitted infomation. All other potentiai Class Members received Self-Maiier B. Because
those potential Class Members could not be directly traced to a valid clairn in the MedPaltners
class action, SeliMailer B did not contain a claim identificatiott number or PIN'
5. On June 17,2016, as part of its normal mailing ptocedures, Gilardi mailed
Notices ancl cover letters to 251brokerages, custodiai banks, and other institutions ("Nominal
Flolders") that hold securities in "street name" as nominees for the benefit of their customers
who are the beneficial owners of the securities. The Nominal Holders also included a group of
filers/institutions who have requested notification of every securities case. These Norninal
Holders are included in a proprietary database created and maintained by Gilatdi' In response to
this mailing, Nominal Holders provided names and addresses, An additional 5,037 Self-Mailer B
notices were sent lo potential class members since the original mailing date.
6. For more information regarding the specific details of the Notice campaign, see
the Declaration of Ross Murray Regarding Mailing of the Notice of Class Action and List of
Objections filed with this Court on July 29,2016.
Page3 of29
DOCUMENT 3728
B. SETTLEMENT WEBSITE AND TOLL-FREE TELEPHONE HELPLINE
7. Gilardi established and continues to maintain a case settlement website (www.aig-
caremarkclassaction.com) and a toll-free telephone helpline (1-888-564-1149) dedicated to
assisting Class Members. On June 17, 2016, the same date as the Notices were initially mailed,
the toll-free telephone helpline was activated and the website went live. Both the case settlement
website and telephone helpline have enabled Class Members to obtain information about the
Settlement, including the exclusion, objection and claim filing deadlines, and have provided
access to important documents relevant to the Settlement, including the Notices. In connection
with establishing and maintaining the case settlement website and telephone helpline, Gilardi,
among other things, formulated a system to assure that proper responses were provided to all
telephone and electronic inquiries. That work included training telephone agents to respond to
inquiries specific to the Settlement; developing a series of common questions and the answers
thereto, known as Frequently Asked Questions, or "FAQs;" loading key documents onto the
Settlement Website; and programming the website to permit the viewing and downloading of
those documents.
C. PUBLICATION NOTICE
8. On June 17, 2016, Gilardi also caused the short-form Notice to be published in
both the paper and online versions of The Wall Street Journal. Among other things, the
Summary Notice directed potential Class Members to the case settlement website which contains
various relevant documents, and also advised potential Class Members of how they could obtain
Notice Packets as well as the deadline for the submission of Claims.
II. PROCEDURES FOLLOWED IN PROCESSING CLAIMS
9. There were three possible ways in which a claimant could submit a Claim in this
matter. Claimants could mail in a paper claim form, complete the online claim form on the case
settlement website (www.aig-caremarkclassaction.com) (also known as a "web" claim) or a third
Page 4 of 29
B.SETTLEMITNTWEBSITEANDTOLL-FREETELEPHONEHELPLINE7. Gilardi established and continues to maintain a case settlement website (www'aig-
caremarkclassaction.com) and a toll-free telephone helpline (1-888-564-1149) dedicated to
assisting class Members. on .Tune 17, 2016, the same date as the Notices were initially mailed,
the toll-fi.ee telephone helpline was activated and the website went live, Both the case settlement
website and telephone helpline have enabled class Members to obtain information about the
settlement, including the exclusion, objection and clairn filing deadlines, and have provided
access to impofiant documents relevant to the Settlement, including the Notices. In connection
with establishing and maintaining the case settlement website and telephone helpline' Gilardi,
among other things, formulated a system to assure that proper l€sponses were provided to all
telephone and electronic inquiries. That work included training telephone agents to respond to
inquiries specific to the Settlement; developing a series of common questions and the answers
thereto, known as FreqUently Asked Questions, or "FAQs;" loading lcey documents onto the
settlement website; and programming the website to perrnit the viewing and downloading of
those documents.
C. PUBLICATION NOTICE
g. On June 17,2016, Gilardi also caused the shorl-fonn Notice to be published in
both the paper and online versions of The Wall Street Jotn'nal' Among other things, the
summary Notice directed potential class Members to the case settlement website which contains
various relevant documents, and also advised potential Class Members of how they could obtain
Notice Packets as well as the deadline for the submission of claims'
II. PROCEDURES FOLLOWED IN PROCESSING CLAIMS
g. There were thlee possible ways in which a claimant could submit a Claim in this
matter. Claimants could mail in a paper claim form, complete the online claim form on the case
settlement website fwww.aig-caremarkclas (also known as a "web" claim) or a third
Page 4 of29
DOCUMENT 3728
party filer could electronically submit a Claim on the claimant's behalf (also known as an
"Electronic" claim). As of the date of this declaration, Gilardi has received 9,533 Claims, of
which 792 were paper Claims, 1,326 were web Claims and 7,415 were Electronic Claims.
10. Unlike in most securities class actions where Class Members are required to
submit transactional information and supporting documentation to verify their claim, this
Settlement permitted Class Members to rely on the information and documentation submitted in
the MedPartners class action, where appropriate. The MedPartners class action is the 1998
MedPartners Securities Litigation Settlement which serves as the basis for the Class' causes of
action in this case. As a result, two different paper claim forms and two different online paths
were available to the Claimants to submit their Claims. Class Members who wanted to rely on
the information they submitted in the MedPartners class action were directed down one path
while those who wanted to submit a Claim based on new or additional information were directed
down another path.
11. With respect to paper Claims, Claimants' filing a paper claim form known as
Form A indicated an intention to rely solely on the information they submitted in the
MedPartners class action. The release language stated as such and dispensed with the need to
provide the transactional information. Filing a paper claim form known as Form B required
providing the transactional information for transactions that occurred during the Class Period
along with the supporting documentation. Form B is similar to the claim form used in most
securities litigation class actions handled by Gilardi.
12. Similarly, for online Claims, if Claimants wanted to rely on the previously-
submitted MedPartners class action Claim, they only needed to supply their claim identification
number and personal identification number listed on Self-Mailer A and, upon verification,
provide current contact information and accept the terms of the release. Online filers who
received Self-Mailer B were required to submit the transactional information down the online
path that mirrored the format found in Form B and upload the supporting documentation.
Page 5 of 29
party filer could electronically submit a Clairn on 1he claimant's behalf (also l<nown as an
,,lllectronic,, clairn). As of the date of this declaration, Gilaldi has received 9,533 Claims, o1'
whiclr 792 wet^epaper claims, 1,326 were web clairns andT ,475 were Electronic clairns'
10. Unlike in most securities class actions where Class Members are lequired to
subrnit transactional information and stlpporting documentation to verify tireir claim, this
Settlement per.mitted Class Members to rely on the information and docrtmentation subrnitted in
the MedPar.tners ciass action, where appropliate. The MedPartners class action is the 1998
Medparlners Securities Litigation Settlement which serves as the basis for the Class' causes of
action in this case. As a result, two different paper ciaim forms and two different online paths
were availabie to the Clairnants to submit their Claims. Class Members who wanted to rely on
the information they submitted in the MedPartners class action were directed down one path
while tirose who wanted to submit a claim based on new or additional information were directed
down another Path.
11. With respect to paper Claims, Claimants' tiling a papet claim lbrm l<nown as
Form A indicated an intention to rely soiely on the information they submitted in the
MedPartners class action. Tire release language stated as such and dispensed with the need to
provide the transactional information' Filing a papel olaim forrn known as Form B required
providing the transactional infomration for transactions that occurred dnring the Class Period
along with the supporting documentation. Form B is sirnilar to the claim form used in most
secut'ities litigation ciass actions handled by Gilardi'
lZ. Sirlilarly, for online Claims, if Claimants wanted to rely on the previously-
s*bmitted Medparlners class action clairn, they only needed to supply tl,eir claim identification
number and personal identification number listed on Self-Mailer A and, upon verification,
provide culrent contact information and accept the terms of the release. online filers who
received Self-Mailer B were lequired to subrnit the transactional information down the online
path that mirrored the format found in Fofm B and upload the supporting documentation'
Page 5 of29
DOCUMENT 3728
A. PROCESSING PAPER CLAIMS
13. Once received, paper Claims were opened and prepared for scanning. This
process included unfolding documents, removing staples, copying non-conforming sized
documents, sorting documents, and, where Claimant identification information was not provided
on the Claim, copying and attaching the envelope with the return address to the file. Once
prepared, the paper Claims were scanned into a database together with all submitted
documentation. Subsequently, each Claim was assigned a unique claim number. Once scanned,
the information from each Claim, including the name, address, and the claimant's
purchase/acquisition transactions, sale transactions, and holdings listed on the Claim, was
entered into a database developed by Gilardi to process Claims submitted for the Settlement.
Next, the information provided by each Claimant in support of the Claim was reviewed to
determine whether each Claimant purchased or otherwise acquired the eligible MedPartners'
common stock, TAPS or Talbert stock during the Class Period.
14. In order to process the transactions detailed in each Claim, Gilardi used internal
codes to classify Claims and any deficiency or ineligibility conditions that existed within those
Claims. The appropriate codes were prograrrunatically assigned to the Claims as they were
processed, based on certain existing conditions. For example, where a Claim was submitted by a
Claimant who did not have any eligible purchases or acquisitions of MedPartners' stock, that
Claim received a code denoting ineligibility. These codes indicated to Gilardi that the Claimant
is not eligible to receive any payment from the Net Settlement Fund with respect to that Claim
unless the deficiency is cured.2
B. PROCESSING WEB CLAIMS
15. For those web Claims where Class Members filed with a claim identification
number and PIN, those Claims were matched with the transactional information provided by that
2 The deficiency process is discussed in more detail in Section III.
Page 6 of 29
A. PROCESSING PAPER CLAIMS
13. once received, paper clairns were opened and prepaled for scanning' This
process included unfolclirrg documents, r'emoving staples, copying non-conforming sized
documents, sorting documents, and, where Clairnant identification information was not provided
on the claim, copying and attaching the envelope with the return address to the file' once
prepared, the paper claims wefe scanned into a database together with all submitted
documentation. Subsequently, each Claim was assigned a unique claim number' Once scanned'
the infon'ation from each Claim, including the name' address, and the claimant's
purchase/acquisition transactions, sale ttansactions, and holdings listed on the Claim' was
entered into a database developed by Gilardi to process clairhs submitted for the settlernent'
Next, the infonnation provided by each Claimant in support of the Claim was reviewed to
detennine whether each Claimant purchased or otherwise acquired the eligible MedPartners'
colnmon stock, TAPS or Talbert stock during the Class Period'
14. In order to process the transactions detailed in each Claim, Gilardi used internal
codes to ctassify Claims ancl any deficiency or ineligibility conditions that existed within those
claims. The appropriate codes wele plogramrnatically assigned to the claims as they were
processed, based on ceftain existing conditions. For example, where a claim was submitted by a
clairnant who clid not have any eligible purchases or acquisitions of MedPartners' stock' that
claim received a cocle denoting ineligibility. These codes indicated to Gilardi that the claimant
is not eligible to receive any payment fi'orn the Net Settlernent Fund with respect to that Clairn
unless the deficiencY is cured.2
B. PROCESSING WEB CLAIMS
15.ForthosewebClaimswhereClassMernbersfiledwithaclaimidentificationnumber and pIN, those claims were matchecl with the transactional information provided by tliat
, The deficiency process is discussed in more detail in section III
Page 6 of29
DOCUMENT 3728
Class Member in the MedPartners class action and the relevant data was uploaded into the
database. Web Claims where the Claimants supplied the transactional information and
documentation were processed using the same internal codes used to identify and classify
deficient or ineligible paper Claims. Information submitted by the Claimants was also verified
by the claims analysts and compared to the supporting documentation.
C. PROCESSING ELECTRONICALLY FILED CLAIMS
16. Electronic Claims are typically submitted by institutional investors who may have
hundreds or thousands of transactions across multiple Claims during the relevant period. Rather
than provide reams of paper requiring data entry, the institutional investors filing Electronic
Claims either mail a computer disc or email a file to Gilardi, so that Gilardi may electronically
upload all Claims and transactions to its proprietary database developed for the Settlement.
17. Gilardi maintains an electronic filing operations team (the "Electronic Filing
Team") to coordinate and supervise the receipt and handling of all Electronic Claims. In this
case, as in all other claims administrations, the Electronic Filing Team reviewed and analyzed
each electronic file to ensure that it was formatted in accordance with Gilardi's required format,
and to identify any potential data issues or inconsistencies within the file. If any issues or
inconsistencies arose, Gilardi notified the sender. If the electronic file was deemed to be in an
acceptable format, it was then forwarded to Gilardi's data team with detailed loading instructions
including the number of Claims and transaction totals that the institution provided when it sent
the electronic file.
18. Once the electronic file was loaded, Gilardi's Quality Assurance personnel
reviewed the electronic file to confirm that the number of Claims and transactions matched the
information provided by the filer.
19. Once the above criteria were confirmed, the Electronic Claims were coded to
identify and classify Electronic Claims and any deficiency or ineligibility conditions that existed
within them. These codes are the same as those applied to the paper and web Claims. The
Page 7 of 29
class Member in the MedParlners class action and the televant data was uploaded into the
clatabase. web claims where the Claimants s'pplied the transactionar inrb'mation and
documentation were processed using the same internal oodes used to identify and classify
def.icient or ineligibre paper claims. Information s*brnitted by the clairnants was also verified
by the claims analysts and compated to the supporting documentation'
C. PROCESSING ELECTRONICALLY FILI'D CLAIMS
ld. Electronic Claims are typically submitted by institutional investors who may have
hunclrecls or thousands of transactions across multiple claims cluring the relevant pe|iod' Rather
than pr.ovide rearns of paper requiring data entry, the institutional investo|s filing Electfonic
claims either mail a computer disc or email a file to Gilardi, so that Gilardi may electronically
upload all Claims and transactions to its proprietary database developed for the Settlement'
lT.Gilardirraintainsanelectroniclilingoperationslearn(the"ElectronicFilingTeam") to cootdinate ancl supervise the receipt and hanctling of all Electronic claims' In this
case, as in all other claims administrations, the Electronic Filing Team reviewed and analyzed
each electronic file to ensure that it was formatted in accordance with Gila|di's required format'
and to identity any poterilial data issues or inconsistencies within the file' If any issues or
inconsistencies arose, Gilardi notified the sender. If the electronic file was deemed to be in an
acceptable fbrmat, it was then tbrwarded to Gilardi's data team with detailed loading instructions
includi'g the number of craims ancr transaction totars that the institution provided when it sent
the elech'onic tile'
18. Once the electronic file was loacled, Gilardi's Quality Assurance personnel
reviewed the electronic file to confirm that the uumber of claims and transactions rnatched the
infomation provided bY the filer'
19. Once the above criteria were confirmed, the Electronic Claims wele coded to
identify and classif, Electronic claims and any deficiency ol ineligibility conditions that existed
within thern. These cocles are the same as those appliecl to the paper and web Clairns' The
PageT of29
DOCUMENT 3728
Electronic Filing Team performed programmatic reviews on Electronic Claims to identify
deficient and ineligible conditions (such as, but not limited to, price-per-share validation issues,
out-of-balance conditions, and transactions outside the relevant period) and the appropriate codes
were then assigned programmatically once the output of the reviews was thoroughly analyzed
and confirmed as accurate.
D. EXCLUDED PERSONS AND ENTITIES
20. Under the terms of the MedPartners Securities Litigation Settlement, neither the
Defendants nor their counsel could participate in the Settlement. This included MedPartners,
TalMed Merger Corporation, individuals Larry M. House, Mark L. Wagar, Harold 0. Knight,
Jr., Charles W. Newhall, III, Ted H. McCourtney, Walter T. Mullikin, M.D., Richard M.
Scrushy, Larry D. Striplin, Jr., John S. McDonald, Lance Piccolo, Roger L. Headrick, Harry M.
Jansen Kraemer, Jr., Michael D. Martin, and Ed Hardin as well as underwriters Smith Barney,
Inc., Merrill Lynch & Co., Credit Suisse First Boston, Montgomery Securities, Morgan Stanley
Dean Witter and Piper Jaffray, Inc. The Defendants' names were checked against all Claims
received to date. A thorough search of the Claims has been conducted and, as of the date of this
declaration, no paper, web or Electronic Claim has been submitted on behalf of these
Defendants.
21. Also excluded from this Settlement were Class Members who had excluded
themselves from the MedPartners class action and the June 2015 notice mailing. Gilardi has
confirmed that none of the four people who opted out of the Settlement after receiving the June
2015 notice filed a Claim in the current action. The names of those Class Members who opted
out in the MedPartners class action were checked against all of the Claims in the current action
and nine Claims were excluded on this basis. These nine Claims are included in the list of
Claims to be rejected which is attached to this declaration as Exhibit B-3.
Page 8 of 29
Electronic Filing Team perlbrmed programmatic reviews on Electronic claims to identify
cleficient a'd ineligible conditio's (s'ch as, but not li'ritecl to, price-per'-share validatio' issues,
out-of-balance conditions, ancl transactions outside the relevant period) and the appropriate codes
were then assigned progfammatically once the outptrt of the reviews was thotoughly analyzed
and confinled as accurate'
D. EXCLUDND PERSONS AND ENTITIES
20. U'der the te'ms of the MedPartners Securities Litigation Settlement, neither the
Defendants nor their counsel could participate in the Settlement. This included MedPafiners'
TalMed Merger corpo|ation, individuals Lauy M. House, Mark L' wagar, Harold o' Ifuiglrt'
Jr., charles w. Newhall, iII, Ted H. McCourtney, walter T. Mullikin, M'D" fuchard M'
scrushy, Larry D. Striplin, Jr., John s. McDonald, Lance Piccolo, Roger L' Headrick' Harry M'
.Iansen Kraemer, Jr., Michael D. Mafiin, and Ed Hardin as well as underwriters smith Batney'
Inc., Mepill Lynch & Co., Credit Suisse First Boston, Montgomery Securities' Morgan Stanley
Dean witter and Piper Jaffi'ay, Inc. The Defendants' names were checked against all claims
received to date. A thorough search of the claims has been conducted and, as of the date of this
declaration, no papel, web or Electronic Claim has been submitted on behalf of these
Defendants.
Zl. Also excluded from this Settlement were Class Members who had excluded
themselves from the MedParlners class action and the June 2015 notice mailing' Gilardi has
confir.med that none of the foul people who opted out of the Settlement after receiving the June
2015 notice filed a claim in the curreut action, The names of those class Members who opted
out in the MedParlners class action were checked against all of the claims in the cuffent action
and nine claims were excluded on this basis. These nine clairns are included in the list of
claims to be rejected which is attached to this declaration as Exhibit B-3'
Page 8 of29
DOCUMENT 3728
E. THE UNIQUE NATURE OF THIS PARTICULAR ADMINISTRATION AND ITS RESULTING COMPLEXITIES
22. The complexities of this administration start with the unique nature of this case.
This lawsuit is a hybrid case where the damages for the "fraud upon the class" case are
calculated as if it was a securities litigation matter. For purposes of determining damages, it is,
in essence, a continuation of the MedPartners class action and involves the application of the
same Plan of Allocation. Just as the underlying litigation has been described as a "one-off' type
of case in other pleadings filed with this Court, the same description could apply to this
administration. Extensive customization across every aspect of the administration was required
to meet the particular needs of this administration. To overcome some of the challenges of this
particular litigation, in particular, the impact of the passage of time between settlements, where
there was an indication the Class Member filed in the MedPartners class action every effort was
made to match back to the earlier claim.
23. Typically, a securities litigation settlement does not involve a group of known
Class Members or multiple claim forms. Here, before the standard review process even began,
every claim required the additional preliminary steps of determining: (1) whether the Claimant
filed in the earlier action; (2) whether the Claimant submitted the proper form in the current
action and (3) the actual number of Claims being made by the filer. These preliminary and
procedural determinations had to be resolved before a proper and accurate review of the
underlying substantive merits of the Claim could take place.
24. The fact that there had already been a complete claims administration in the
MedPartners class action significantly complicated the claims review process. As explained in
greater detail below, after the claims deadline, it became clear that the first step in the process
would be a baseline, systemic comparison of all Claims (paper, web and Electronic) to the
Claims filed in 1999. This was necessary in order to try to match Claims filed in this case with
those filed in the MedPartners class action. Using Gilardi's proprietary database, potential
matches were initially proposed by the software program for the administration of securities
Page 9 of 29
E.THEUNIQUENATUREoFTHISPARTICULARADMINISTRATIONANDITS RESULTING COMPLEXITIES
22. The complexities of this administration stafi with the unique nature of this case'
This lawsuit is a hybrid case where the damages for the "fraud upon the class" case ate
calcuiated as if it was a secul.ities litigation matter. For purposes of determining damages, it is,
in essence, a continuation of the Medpartners class action and involves the application of the
same plan of Allocation. Just as rhe underlying litigation has been described as a "one-off' type
of case in other pleadings filed with this Court, the same description could apply to this
administration. Extensive customization across every aspect of the administration was required
to meet the particular needs of this administration' To ovel'come some of the chalienges of this
parlicular litigation, in pafiicular, the impact of the passage of tirne between settlements' where
ther.e was an indication the class Mernber filed in the Medpartners class action every effoft was
made to match baclc to the earlier claim'
23'Typically,asecuritieslitigationsettleruentdoesnotinvolveagfoupofknownclass Members or multiple claim forms. Here, befote the standard review pl'ocess even began'
ever.y claim required the additional preliminary steps of determining: (l) whether the claimant
filed in the earlier action; (2) whether the Claimant submitted the proper form in the cunent
action and (3) the actual number of claims being made by the filer' These preliminary and
procedural deteminations had to be resolved before a propel'and accurate |eview of the
underlying substantive met'its of the Claim could take place'
24. The fact that there had already been a complete claims administration in the
MedPartners class action significantly cornplicated the claims review process' As expiained in
greater detail below, after the claims deadline, it became clear that the first step in the process
would be a baseline, systemic compalison of all Clairns (paper, web and Electronic) to the
ciairns filed in 1999. 'fhis was necessary in ordel to try to match claims filed in this case with
those filed in the MedPartnel's class action' Using Gilardi's proprietary database' potential
matches were initiaily ploposed by the software plogfam for the administration of securities
Page9 of 29
DOCUMENT 3728
litigation class action settlements. Potential matches were then reviewed for name, amount,
account number and tax identification number similarity and a match determination was made as
to each one of those fields. The matches were further broken down by comparing the underlying
transactions of the matched Claims. However, for a variety of reasons, including but not limited
to changes in industry practices or the information provided, many matches were not direct "one
to one" matches. The matching process is more fully explained below in Section E. Although
most of the matching process was performed at the onset of the claims review process, the
matching process was used throughout the entire Claims review phase as warranted.
25. Another complexity to the claims review process was the need for two different
claims processes — one for those relying upon the information submitted in the MedPartners class
action (Form A) and one for those submitting the transactional information to support their
Claim (Form B). During the claims filing period, it became apparent that many paper claim
filers were confused with the purpose behind the two forms. Some Claimants submitted both
forms. Some Claimants used Form A but included the Form B transaction pages. Form A filers'
names had to be matched to the MedPartners Authorized Claimant list. A match was treated as
the claimant confirming that he/she intended to rely upon their MedPartners class action Claim.
An unmatched Form A indicated that the claimant submitted the wrong form. If the Form B
filers' names matched to a name on the earlier class action, then the claim was reviewed to
determine whether it was a new Claim or whether the match could cure any deficiency
associated with the current Claim. If the Form B filer did not match to the MedPartners list, then
it was treated like any claim filed in any securities class action. In short, if transactional
information was provided and the Claim did not match, the Claim was treated as an unknown
filer. The two different online paths appeared to create a similar confusion among the online
filers as well.
26. The use of an additional, case-specific form also added a layer of complexity to
processing these Claims. The Declaration of Representative form was created for this
administration primarily to limit disputes between Claimants in situations where a Class Member
Page 10 of 29
litigation class action settlements, Potential matches were then reviewed fot name' amount'
account number and tax identification number similarity and a match determination was made as
to each one of those fields. The matches were fuither broken down by comparing the underlying
transactions of the matched clairns. However, for a valiety of l'easons, including but not limited
to changes in industty practices or the infonnation provided, many matches were not direct "one
to one,,matches. The matching process is more fully explained below in section E' Although
most of the malching process was performed at the onset of the claims review process' the
matching process was used throughout the entire claims review phase as waranted'
25. Another complexity to the claims review process was the need for two different
claims processes - one for those relying upon the inforrnation submitted in the MedPafiners class
action (Form A) and one for those submitting the transactional information to suppofi their
claim (Form B). Duling the clairns filing period' it became apparent that many paper claim
filer.s were confused with the pulpose behind the two fotms. some claimants submitted both
founs. sorne claimants used Form A but included the Form B transaction pages' Form A filers'
names hacl to be matched to the MedPadners Authorized Claimant iist' A match was treated as
the claimant confirming that helshe intended to rely upon theif MedPartners class action claim'
An unmatched Form A indicated that the claimant subrnitted the wrong form. If the Form B
filers, names matched to a name on the earlier class action, then the claim was reviewed to
determine whether it was a new claim or whether the match could cure any deficiency
associated with the curent clairn. if the Form B filer did not match to the MedPa$ners list' then
it was trcated like any claim filed in any secutities class action. In shott, if transactional
information was ptovided and the Claim dicl not match, the Claim was treated as an unlcnown
filer, The two different online paths appeared to create a similar confusion among the online
filers as well.
26. The use of an additional, case-specific form also added a iayer of complexity to
processing these Clairus. The Declaration of Representative form was created for this
administration primarily to limit disputes between Claimants in situations where a Class Member
Page 10 of29
DOCUMENT 3728
was deceased, incompetent or a minor. Although the need to submit the Declaration of
Representative form was limited to those three situations, many of the filers who were acting in
other representative capacities were unsure about the need to file the form and submitted the
form. Others who should have filed the form did not and a significant amount of follow-up with
the Claimants was required.
27. Further complicating the submission and review of Claims was the nearly twenty
year passage of time between class action settlements. A common complaint relayed by
Claimants was the inability to provide documentation for transactions that occurred twenty years
prior. Major life events such as deaths, changes in residences, divorces, or dissolution of
businesses all impacted Class Members' abilities to submit and/or document their Claims. This
posed the biggest challenge to those Claimants who did not file a Claim in the MedPartners class
action and could not rely on what had been previously submitted.
28. Other common filing problems that added to the complexity of this administration
included:
• Claimants filling out both web and paper Claims — multiple times
• Claimants submitting multiple Claims for different entities on one form
• Claimants filling out one form in multiple capacities (ex: Class Member and
Representative)
• Business entities or fund Claimants now operating under completely different names
• Multi-claim filers who separated out Claims or filed down multiple paths.
The above list is not exhaustive and does not include the usual administration problems seen
such as Claims submitted with no transactional information, name change requests, incomplete
claim forms, etc.
29. In addition to the procedural claims review challenges described above, there
were several logistical hurdles that needed to be overcome in order to be consistent with the
original MedPartners Securities Litigation Settlement almost twenty years ago where losses were
calculated with software that is no longer in use. This required extensive research and
Page 11 of 29
78.
included:
was deceased, incompetent or a minor. Although the need to submit the Declaration of
Representative form was limited to those three situations, lnany of the filsrs who were acting in
other representative capacities were ullsul€ about the need to file the form and submitted the
fotm. others who should have filed the form clid not and a significant amount of follow-up with
the Claimants was required.
2T.FurthercomplicatingthesubmissionandreviewofClairnswasthenearlytwentyyearpassageoftimebetweenclassactionsettlements.AcommoncomplaintrelayedbyClaimants was the inability to provide documentation for transactions that occuned twenty years
prior. Major life events such as deaths, changes in residences, divorces, or dissolution of
businesses ail impacted crass Members' abilities to submit and/or document thei'claims. This
posed the biggest challenge to those clairnants who did not file a clairn in the MedPartners class
action and could not reiy on what had been previously submitted'
other common filing problems that added to the complexity of this administration
oClaimantsfillingoutbothwebandpaperClainrs_multipletimes
r claimants submitting multiple ciaims fof different entities on one fotm
r claimants filling out one form in multiple capacities (ex: class Membel and
RePresentative)
r Business e'tities or fund Claimants now operating under completely differerrt names
r Multi-claim filers who separated out Claims or filed down multiple paths'
The above list is not exhaustive and does not include the usual adrninistration problems seen
such as claims subffritted with no transactional information' name change requests' incomplete
claim fotms, etc'
29'Inadditiontotheproceduralclaimsrcviewchallengesdescr.ibedabove,therewel.e several logistical hurdles that needed to be overcome in ordef to be consistent with the
original MedPartners seculities Litigalion settlement almost twenty years ago where losses were
calculated with software that is no longer in use. This required extensive research and
Page I 1 of29
DOCUMENT 3728
investigation into the earlier MedPartners class action. Voluminous records had to be reviewed,
analyzed and converted into formats compatible with the current systems in use. This was done
to ensure that all Claims still calculated as they would have in the MedPartners class action.
30. Finally, on a broader scale, it should be noted that with each added complexity,
the claims administration process becomes one step further removed from the standard claims
review process employed by Gilardi. Efficiency in administration depends in large part on how
many of the claims can fall within the standard approach applied to all securities litigation
settlements. Each component that is outside the standard practice adds a layer to the
administration process that must be addressed. Even a seemingly minor change can require
coordination and input across several departments including the Operations Department, Print
Production Group, Web Development Team, Data Analysis Team, Document Development
Team, and Fund Accounting Department. Each change to the standard process can have a ripple
effect and consideration must be given to how those changes impacts the work performed by
these other departments at their respective stage of involvement.
F. IMPACT OF MATCHING PROCESS ON DISTRIBUTION
31. In many instances, Claimants submitted the same information in the current action
as they did in the MedPartners class action but, for whatever reason, they chose to file in a
manner that required them to prove their Claim rather than simply use their claim identification
and personal identification numbers. Using the matching methodology described above, if an
analyst was able to match by name, account number, and/or tax identification number and the
difference in recognized loss amounts was minimal, they were treated as a match and granted the
higher loss amount. Gilardi's analysts identified over 800 Claims that fell into this category.
32. As the Claims review process progressed, several patterns among the matched
Claims emerged and those matched Claims were placed into specific categories created to assist
in the review process. In short, these Claims would otherwise be considered a match to a claim
filed in the MedPartners class action but for one distinct difference. This difference could be
Page 12 of 29
investigation into the earlier MedPartnels class action' voluminous records had to be reviewed'
analyzed and converted into formats compatible with the cufrent systems in use' This was done
to ensure that all claims still calculated as they would have in the MedPartners class action'
30. Finally, on a broacler scale, it should be noted that with each added complexity'
the claims administration process becomes one step furlher removed fi'om the standard claims
review process employed by Gilardi. Efficiency in administration depends in large part on how
many of the claims can fall within the standard approach applied to all securities litigation
settiements, Each component that is outside the standard practice adds a layer to the
administration process that must be addressed. Even a seemingly minor change can require
coordination and input across several depafments including the operations Depattnent' Priut
production Group, Web Development Team, Data Analysis Team, Document Development
Team, and Fund Accounting Deparlment. Each change to the standard process can have a ripple
effect and consideration must be given to how those changes impacts the work performed by
these other depaftments at their respective stage of involvement'
F..IMPACToT.MATCHINGPROCESSoNDISTRIBUTION31. In many instances, Claimants submitted the same information in the current action
as they did in the Medpartners class action but, for whatever reason, they chose to file in a
lnarlner that requirecl them to prove their Claim rather than simply use their claim identification
and personal identification numbers. Using the matching methodology described above' if an
analyst was able to match by name, account number, and/or tax identification number and the
differelce in recognized loss amounts was minimal, they were treated as a match and glanted the
higher loss amount. Gilardi's analysts identified over 800 claims that fell into this categoly'
32. As the claims review process proglessed, several pattems among the matched
claims emerged and those matched clairns were placed into specific categories created to assist
in the review pl'ocess. In shorl, these Claims wouid otherwise be considered a match to a claim
filed in tlie MeclPartnefs class action but for one distinct ditference' This difference could be
Page 12 of29
DOCUMENT 3728
either: (1) the existence of additional transactions on one Claim but not the other (i.e., a partial
duplicate); (2) the same transactions but different dates listed; (3) a change in the description of a
previously identified purchase or sale in the MedPartners class action to a "transfer in" or
"transfer out;" or (4) the identification of a transaction involving TAPS or beginning holdings
where it had not been previously identified. The common characteristic shared by the Claims in
that particular category represented the principal reason for the difference in the recognized loss
amounts between the two Claims. The creation of these categories allowed for a single decision
to be made as to how to handle all of the Claims in that category. These special categories are
as follows:
Category Name Description
New Transactions Partial match to the MedPartners class action Claim where current class action claim has new or additional transactions
Partial Duplicate Partial match to the MedPartners action Claim where the MedPartners class action Claim had additional transactions
Different Dates Claim matches to a MedPartners action Claim but for the dates listed on the transactions
Different Transactions
Same claimant as in the MedPartners class action Claim but involves entirely different transactions
Duplicate Transfers
Same transactional information as in the MedPartners class action but some transactions previously identified as purchases or sales now identified as "Transfers In" or "Transfers Out"
TAPS Same claimant as in the MedPartners class action Claim but new or different transactions involve TAPS
Beginning Holdings
Claim matches to a claim in the MedPartners class action but the current Claim now includes beginning holdings at the beginning of the Class Period
33. Over 280 Claims fell within these seven categories. During the review process,
these patterns were discussed with counsel and it was agreed that, but for the Claims that fell
within the Different Transactions category, the Claim with the greater recognized loss would he
the accepted loss amount and the other one would be withdrawn or rejected as a duplicate. For
Page 13 of 29
eitl.rer: (1) the existence of additional transactions on one Claim but not the other'(i'e., a paltial
duplicate); (2) the same trausactions but different dates iisted; (3) a change in the descdption of a
previously identified purchase or sale in the MedPartners class action to a "ttansfeL ilt" or
,,transfer out;,, or (4) the identification of a transaction involving TAPS ol beginning holdings
where it had not been previously identified. The comrnon characteristic shared by the Clairns in
that particular category represented the principal reason for the difference in the recognized loss
amouuts between the two Claims. The cleation of these categories allowed for a single decision
to be made as to how to handle all of the ciaims in that category. These special categories are
as follows;
33. Over 2g0 Clairns fell within these seven categories. During the review process'
these patterns wero discussed with counsel and it was agreed that, but fof the claims that feli
within the Different'I'ransactions category, the claim with the greater recognized loss would be
the accepted loss amount ancl the other one would be withdrawn or lejected as a duplicate' For
DescriptionCategory Name
MedPaftners class action Ciaim where current classhas new or additional transactions
Padial match to theaction clairn
New Transactions
Claim where the MedPartners classClaim had additional tt'attsactions
Paftial match to the MedPadners actionaction
Parlial Duplicate
Claim matches to a MedPatluers but for the dates listed on thetransactions
action ClaimDifferent Dates
action Claim but involvesSame claimant as in the MedPafiuers classditferent transactions
DifferentTransactions
onacti sol'I1ebutclassedPartners1nas MthenformationtransactionalameS
ASedidentifisalesof nowASfieddenti purchasesactionstrans ouslyprevi"Transfers In" or "Ttansfers Out"
DuplicateT'ransfels
Same claimant as in the class action Clairn but new ot'
tlansactions involve TAPSMedParlners
differentTAPS
ciass action but the cllffentthe beginning of the Class
Period
arlnersMedPailnc1 the1natomatchesC laimatincludes holdingsnowC laim beginning
BeginningHoldings
Page 13 af29
DOCUMENT 3728
those Claims in the Different Transactions category, given that the only matching factor
connecting the Claim to the MedPartners class action was the fact that it was the same filer, they
were subject to the same scrutiny and review as any newly-filed Claim.
III. THE DEFICIENCY PROCESS
34. Many of the Claims submitted were, on their face, not valid, payable Claims as
defined under the terms of the Stipulation and Agreement of Settlement ("Stipulation") and/or
the previous orders issued by this Court. These Claims are recommended to be rejected and
contained in Exhibit B-3.
35. Some of the Claims submitted were incomplete, not properly documented, or
were otherwise deficient. These Claims were likely valid Claims, but for some procedural or
technical failing, such as a lack of signature or failure to provide supporting documentation for
some or all of the transactions listed. As to these Claims, Gilardi sent letters and emails and
responded to calls from Claimants. The process was intended to assist Claimants in properly
completing their otherwise deficient submissions so that they may be eligible to participate in the
Settlement.
36. As described above, Gilardi used internal codes to identify and classify Claims,
including, among other things, notations that identified deficient Claims. If a Claim was
determined to be deficient (for example, if the Claim was missing documentation for the entire
Claim, or if the Claimant did not provide enough information to calculate the claim, Gilardi
mailed a letter entitled "Notice Of Deficiency.") In October 2017, Gilardi mailed 128 "Notices
of Deficiency."
37. This "Notice of Deficiency" described to the Claimant the defect(s) with the
Claim which would otherwise be a reject and what was necessary to cure the Claim. The letter
advised the Claimant that submission of the appropriate information and/or documentary
evidence to complete the Claim within thirty days from the date of the letter was required, or the
Claim would be recommended for rejection.
Page 14 of 29
those clairns in the Different Transactions category, given that the only natching factor
connecting the claim to the MedPattnets class action was the fact that it was the same filer' they
were subject to the same scrutiny and review as any newly-filed Claim'
III. TIIE DEFICIENCY PROCESS
34. Many of the Claims subrnitted wers, on their face, not valid, payable Claims as
detined under the terms of the Stipulation and Agreement of Settlernent ('stipulation") and/or
the previous orders issued by this court. These clairns are recommended to be rejected and
contained in Exhibit B-3.
35. Some of the clairns submitted wele incomplete, not properly documented' or
were otherwise cleficient. These Claims were likely valid Claims, but for some ptocedural or
technical failing, such as a lack of signatufe or failure to provide suppolting documentation for
some ol. all of the transactions listed. As to these clairns, Gilardi sent letters and ernails and
responded to calls from claimants. The process was intended to assist claimants in properly
cornpleti'g their otherwise deficient submissions so that they may be eligible to parlicipate in the
Settlement.
36.Asdescribedabove,GilardiusedintemalcodestoidentifyandclassifyClaims,including, among other things, notations that identified deficient Claims' If a Claim was
determined to be deticient (for example, if the claim was rnissing documentation for the entire
Claim, or. if the Clairnant did not provide enough infotmation to calculate the claim' Gilardi
mailed a letter entitled ,Notice of Deficiency.") In october 2017, Gilardi mailed 128 "Notices
of DeficiencY."
3T. This "Notice of Deficiency" described to the claimant the defbct(s) with the
ClaimwlrichwouldotherwisebearejectandwhatwasnecessarytocuretheClaim.Theletteradvised the clairnant that submission of the appropriate information and/or documentary
evidence to complete the clairn within thirty days from the date of the letter was required' or the
Claim would be recommended for rejection'
Page 14 of29
DOCUMENT 3728
38. Attached hereto as Exhibit A are examples of the types of letters sent to notify
Claimants of the deficiencies in their Claims.3
39. Claimants' responses to these letters were uploaded into Gilardi's database and
associated with the related Claims. Those responses were then carefiilly reviewed and evaluated
by Gilardi's Claims analysts. If a Claimant's response corrected the defect(s), Gilardi updated
the database manually to reflect the changes in status of the claim. Some of the Claimants in this
group were able to cure the deficiencies and Gilardi is recommending their cured Claims be
approved for payment, If the Claimant failed to respond or the response failed to cure the
deficiency and the recognized loss was not minimal, the Claim was then rejected for failure to
cure the deficiency.
IV. LATE CLAIMS
40. Under the terms of the Stipulation, and subsequently clarified in prior orders from
this Court, only valid and timely Claims qualify to receive any distribution of funds.
Accordingly, Gilardi had been instructed to reject any late Claims. As a result, any Claim
postmarked or received (in the case of Electronic and web-based Claims) after the September 30,
2016 deadline was flagged as "late." As of the date of this declaration, Gilardi has received
1,374 late Claims. These Claims are contained among the Claims identified in Exhibit B-2.
V. QUALITY ASSURANCE, FRAUD PREVENTION, AND REGULATORY COMPLIANCE
41. An integral part of all of Gilardi's settlement administration process is our Quality
Assurance review. Gilardi's Quality Assurance personnel worked throughout the entire
administration process to ensure that Claims were processed properly; that deficiency and
3 Portions of Exhibit A have been redacted to protect certain potentially-confidential, personally-identifiable information.
Page 15 of 29
3g. Attacliecl hereto as Exhibit A are examples of the types of letters sent to noti0
Claimants of the deficiencies in theil Claims'3
39. Clainants' responses to these letters were uploaded into Gilardi's database and
associated with the related Clairns. Those responses were then cateftilly reviewed and evaluated
by Gilarcli's Claims analysts. If a Clairnant's response corected the defect(s), Gilardi updated
the database manually to reflect the changes in status of the claim. Some of the Claimants in this
group were able to cure the cleficiencies and Gilardi is recomtnenciing their cured Claims be
approvecl for payment. If the Claimarrt fbilecl to respond or the response failed to cute the
deticiency and the recognized loss was not minimal, the Claim was then rejected for f'ailure to
curc the deficiencY.
IV. LATE CLAIMS
40. Under the ter.ms of the Stipulation, and subsequently clarified in prior orders fiom
this Court, only valid and timely Claims qualify to receive any distlibution of funds.
Accordingly, Gilardi had been instructed to reject any late Claims' As a result, any Claim
postmar.kecl or received (in the case of Electronic and web-based Claims) after the September 30,
2016 deadline was flagged as o'late." As of the date of this declaration, Gilardi has received
I,374lateClaims. These Claims are contained among the Claims identified in Exhibit B-2.
V. QI]ALITY ASSURANCB, FRAUD PREVENTION,COMPLIANCE
41. An iltegral part of all of Gilardi's settlement administration process is our Quality
Assurance review. Gilardi's Quality Assurance personnel worked throughout the entire
administration process to ensure that claims were plocessed properly; that deficiency and
3 portions ofExhibit A have been redacted ro protect cefiain potentially-confidential, pefsonally-identifiable
AND REGULATORY
information.
Page 15 of29
DOCUMENT 3728
ineligibility codes were properly applied to Claims; that deficiency letters were mailed to the
appropriate Claimants; and that Gilardi's computer programs were operating properly.
42. Gilardi's Quality Assurance team performed a final project wrap-up once all of
the Claims were processed, deficiency letters were mailed, and deficiency responses were
reviewed and processed, to ensure the correctness and completeness of all of the Claims before
Gilardi prepared its final reports to Class Counsel and the Court. Here, in connection with this
Quality Assurance wrap-up, Gilardi (i) confirmed that valid Claims have no messages denoting
ineligibility; (ii) confirmed that Claims that are ineligible have messages denoting ineligibility;
(iii) confirmed that all Claims requiring "deficiency" letters were sent such letters; (iv)
performed a sample review of deficient Claims; (v) reviewed Claims with large dollar losses; (vi)
sampled Claims that had been determined to be ineligible, including those with no calculated
recognized loss under the Plan of Allocation, in order to verify that all transactions had been
captured correctly; and (vii) tested the accuracy of the calculation program.
43. In support of the work described above, Gilardi's computer staff designed and
implemented, and the Quality Assurance team tested, the following programs for this
administration: (i) data entry screens that store Claim information (including all transactional
data included on each Claim) and attach codes and, where necessary, text to denote conditions
existing within the Claim; (ii) programs to load and analyze transactional data submitted
electronically for all Electronic Claims; (iii) a program to compare the claimed transaction prices
against the reported market prices to confirm that the claimed transactions were within an
acceptable range of the reported market prices; (iv) a calculation program to analyze the
transactional data for all Claims, and calculate each Claimant's recognized loss based on the Plan
of Allocation; and (v) programs to generate various reports throughout and at the conclusion of
the administration, including lists of all eligible and ineligible Claims.
44. Gilardi also used a variety of fraud protection controls throughout the
administration process to identify potential fraudulent Claims. Searches for duplicate Claims,
Page 16 of 29
ineligibility codes were pfopefly appliecl to clairns; that cleficiency letters were mailed to the
appropriate claimants; ancl tlut Gilardi's computer progfalns were operating propelly'
42. Gilardi's Quality Assurance team performed a final project wrap-up once all of
the Clairns were processed, deficiency letters were mailed, and deficiency lesponses werc
reviewed and processed, to ensure the conectness and completeness of all of the Claims before
Gilarcli prepared its final rcpofis to Class Counsel and the Court' Here' in connection with this
Quality Assurance wrap-up, Gilardi (i) confirmed that valicl claims have no messages denoting
ineligibility; (ii) confir'med that claims that arc ineligible have messages denoting ineligibility;
(iii) confirmed that all clai'rs requiring "deticiency" letteLs were sent such letters; (iv)
perfomred a sample review of deficient Clairns; (v) reviewed Claitns with large dollar losses; (vi)
sampled clairns that had been determined to be ineligible, including those with no calculated
recognized loss under the Plan of Allocation, in order to verifu that all transactions had been
captured conectly; and (vii) tested the accuracy of the calculation program'
43. In supporl of the work described aboveo Gilaldi's computer staff designed and
implemented, and the Quality Assurance team tested, the iollowing programs for this
acl*rinistration: (i) data entry scl'eens that store claim information (including all transactional
data included on each Claim) and attach codes and, where rlecessary' text to denote conditions
existing within the claim; (ii) programs to load ancl analyze transactional data submitted
electronically fbr all Electronic claims; (iii) a program to compare the clairned transaction prices
against the reported market prices to confirm that the clairned transactions were within an
acceptable range of the lepofled market prices; (iv) a calculation pfogram to analyze the
transactional data lbr all claims, and calculate each claimant's recognized loss based on the Plan
of Allocation; and (v) programs to genefate various reports thloughout and at the conclusion of
the administration, including lists of all eligible and ineligible claims'
44. Gilardi also used a variety of fi'aud protection controls throughout the
administration process to identify potential fi'audr"rlent claims. searches for duplicate claims'
Page 16 of29
DOCUMENT 3728
high-value reviews, spot reviews, and other standard audit reports that examined the information
in a variety of ways, were used during the claims review process.
45. Gilardi reviewed and compared the entire database for this Settlement against our
proprietary "Watch List" of known potential fraudulent filers that Gilardi developed throughout
its more than thirty years of experience as a claims administrator. Gilardi works with law
enforcement to update the Watch List with the latest information available.
46. In accordance with the Office of Foreign Asset Control, known as OFAC, Gilardi
will perform searches on every check that it will issue to identify any potential payees whose
names appear on the federal government's restricted person's list or who reside in countries to
which payments are prohibited. Gilardi regularly monitors changes to OFAC regulations and
guidelines.
VI. DISPOSITION OF CLAIMS
47. Gilardi has completed the processing of the 9,533 Claims that were received to
date, and has determined that 2,470 are acceptable in whole or in part and 7,042 should be
wholly rejected because they are ineligible for recovery from the Net Settlement Fund. The
7,042 rejected Claims are ineligible for the following reasons: (1) the Claim did not result in a
recognized loss; (2) the Claim did not fall within the "Settlement Class" definition; (3) duplicate
Claim; (4) deficient Claim that were never cured; (4) late Claim; (5) Claim previously rejected
by the Court; (6) Claim that failed to identify the beneficial owner and (7) Claim where the
Claimant had opted out in the MedPartners class action or 2015 notice mailing.
48. A list of the Claims submitted and their ultimate disposition is contained in the
Administrator's Report, attached hereto as Exhibit B. Exhibit B-1, entitled "Timely Eligible
Claims," lists all timely-filed, provisionally-accepted Claims and states the amount of their
recognized loss and, if matched to a Claim filed in the MedPartners class action, the distribution
amount in that action. Exhibit B-2, entitled "Late Claims," lists all late-filed Claims. Exhibit B-
3, entitled "Rejected Claims," lists all wholly-rejected Claims and states the reason for
Page 17 of 29
high-value reviews, spot reviews, and other standard audit reports that examined the infoflnatiott
in a variety of ways, were used during the claims review process.
45. Gilardi reviewed and compared the entire database for this Settlement against our
proprietary .,Watch List" of known potential fraudulent filers that Gilardi developed tluoughout
its more than thirty years of experience as a claims adrninistt'ator. Gilardi works with law
enfotcement to update the Watch List with the latest information available'
46. In accordance with the Office of Foreign Asset Control, known as OFAC, Gilardi
will perfor.m searches on every check that it will issue to identifu any potential payees whose
names appear on the federal gover'runent's restricted person's list or who reside in countries to
which payments are prohibited. Gilardi regulally monitors changes to oFAC rcgulations and
guidelines.
VI. DISPOSITION OF CLAIMS
47. Gilardi has completed the processing of the 9,533 Claims that were received to
date, and has determined that 2,470 are acceptable in whole or in part and 7,042 should be
wholly rejected because they are ineligible for recovery from the Net Settlernent Fuud' The
7,042 rejectecl claims are ineligible for the following reasons: (1) the claim did not result in a
recognized loss; (2) the Claim did not fall within the "settlement Class" definition; (3) duplicate
claim; (4) deficient clairn that were never curcd; (4) late claim; (5) claim previously rejected
by the Court; (6) Claim that failed to identiff the beneficial owner and (7) Claim where the
claimant had opted out in the MedParlnets class action ot 2015 notice mailing,
4g. A list of the Claims subrnitted and theil ultimate disposition is contained in the
Administrator.,s Report, attached hereto as Exhibit B. Exhibit B-1, entitled "Timely Eligible
Clairns," lists all timely-filed, provisionally-accepted Claims and states the amount of their
recognized loss and, if matched to a Claim filect in the MedParlners class action, the distribution
amount in that action. Exhibit B-2, entitled "Late Claims," lists all late-filed Claims' Exhibit B-
3, entitled ..Rejected Claims," lists all wholly-rejected Claims and states the reason for
Page77 of29
DOCUMENT 3728
ineligibility. For privacy reasons, Exhibit B provides only the claimant's unique claim number
assigned by Gilardi, along with that claim's recognized loss or reason for ineligibility (no names,
addresses, or social security or other taxpayers identification numbers are disclosed).
49. The sum total recognized loss for all provisionally-accepted Claims calculated in
accordance with the Plan of Allocation is $ 548,018,892.68. According to the Plan of
Allocation, each Authorized Claimant shall be allocated a pro rata share of the Net Settlement
Fund based on his, her, or its recognized loss as compared to the total recognized loss of all
Authorized Claimants; however, as set forth in the Court-approved Plan of Allocation, if an
Authorized Claimant's prorated payment calculates to less than $10.00, it will not be included in
the calculation and the claimant will not receive any distribution. Upon approval by the Court,
Gilardi will prepare and mail checks to all Authorized Claimants for their pro rata share of the
Net Settlement Fund, subject to the $10.00 threshold for payment to be made.
VII. OUTSTANDING MATTERS FOR COURT APPROVAL
Prior to any final determination on the following Claims, Gilardi submits the following
Claims for further determination by this Court:4
A. VIRGINIA HOFFMAN GREENE (CLAIM NO. 300287-0)
50. Intervenor Virginia Hoffman Greene has submitted a Claim which Gilardi has
preliminarily rejected on the grounds that the Claim fails to show any transactions in the Class
Period upon which a Claim could be based. A true and correct copy of the Claim, including the
supplemental documentation provided by the Intervenor, is contained in Exhibit C which is being
4 To protect the privacy of the Class Members, identification of specific Claims will be done by claim number only unless the specific claim involves a named party (as in the case of Intervenor Virginia Hoffinan Greene) or is a publicly-traded company such as General Motors. Furthermore, because the Claims include certain personal financial information, Exhibits C and E are being submitted under seal by Class Counsel contemporaneously with this declaration.
Page 18 of 29
ineligibility. For privacy reasons, Exhibit B provides only the claimant's unique claim numbet'
assigned by Gilarcli, along with that claim's recognized loss or l'eason for ineligibility (no names'
addresses, or social security or other taxpayefs identification numbers are disclosed)'
49.Thesumtotalrecognizedlossforallprovisionally-acceptedClaimscalculatedirraccordance with the plan of Allocation is $ 548,018,892.68' According to the Plan of
Allocation, each Authorized Claimant shall be allocated a pro rata share of the Net Settlement
Fund based on his, her, or its recognized loss as compat'ed to the total fecognized loss of all
Authorized claimants; however, as set forlh in the court-approved Plan of Allocation' if an
Authorized Claimant's prorated payment calculates to less than $10'00' it will not be irrcluded in
the calculation and the claimant will not receive any distribution' Upon approval by the Coutl'
Gilardi will prepare and mail checks to all Authorized claimants for thelf pro rala sharc of the
Net Settlement Fund, subject to the $10.00 ttu'eshold fbr payment to be made'
VII. OUTSTANDING MATTERS FOR COURT APPROVAI'
Prior to any final determination on the following Claims, Gilardi submits the following
Claims for further determination by this Courl:4
A.VIRGINIAHOFFMANGREENE(CLAIMNo.300287-0)
50. lntervenor Virginia Hoffman Greene has subrnitted a Clairn which Gilardi has
preliminarily rejected on the grounds that the Claim fails to show any transactions in the Class
period upon which a claim could be based. A true and cofrect copy of the claim, including the
supplemental documentation provided by the Intervenor, is contained in Exhibit c which is being
a To protect the PrivacY of the Class Membels, identification of specific Claims will be done by claim number onlyunless the sPecific claim involves a named PartY (as in the case of lntervenor Virginia Hoffinan Greene) or is apublicly-tladed company such as Genel'al Motot's. Furthermore, because the Claims include certain personalfinancial information, submitted undet'seal bY Classthis declaration.
Exhibits C and E are being
Page 18 of29
Counsel contelnporaneouslY with
DOCUMENT 3728
filed under seal by Class Counsel contemporaneously with this declaration. The question
surrounding her Claim is whether the "Acquired Date" on her supporting documentation from
broker Raymond James represents a purchase date that permits this "purchase" to fall within the
Class Period. The Claim lists beginning holdings of 900 shares and does not list any
transactions. The supporting documents indicate that the Intervenor had received 900 shares of
"MedPartners Mullikin" stock (CUSIP 584968101) on or about January 3, 1996. (In 1995, more
than a year before the Class Period starts, MedPartners merged with Mullikin Medical
Enterprises to become MedPartners-Mullikin Inc.) The November 1997 Raymond James
statement identifies 900 shares of MedPartners stock being "Received" on November 6, 1997.
Additional statements indicate that Ms. Hoffman held the shares through the end of the Class
Period and beyond; however, no documentation indicates that these 900 shares are not the same
900 shares she held since before the Class Period. Under the definition of "Class Member" the
MedPartners stock must have been purchased "through open-market transactions, mergers or
acquisitions . . . and any other type of transaction in which a Person acquired one or more shares
of MedPartners stock in return for consideration during the period from October 30, 1996,
through January 7, 1998 ..."
51. The term "Received" is commonly used by financial institutions on statements to
reflect circumstances where there has been a transfer of securities from one institution or account
to another which is distinguishable from a purchase or sale transaction. Intervenor contends that
the November 6, 1997 "Received" date places her claim within the Class Period and has
submitted an affidavit from a paralegal in the Raymond James Legal Department. A true and
correct copy of the affidavit is included within Exhibit C. Of note, the affiant could not
definitively state whether the November 6, 1997 date was the purchase date any more than any
Page 19 of 29
filed under seal by class counsel contetnporaneously with this declaration' The question
suffounding her claim is whether the "Acquired Date" on her supporting documentation fi'om
broker Raymond James represents a purchase date that permits this "purchase" to fall within the
Class Period. The Claim lists beginning holdings of 900 shares and does not list any
transactions. The supporting documents indicate that the Intervenor had received 900 shares of
,,MedPafiners Mullilcin" stock (cuslP 584968101) on or about January 3,1996' (ln 1995' more
than a year before the class Period stafis, MedPattnets merged with Mullikin Medical
Enterprises to become MedPartners-Mullikin Inc.) The November 1997 Raymond James
statement identifies 900 shares of MedPartners stock being "Received" on November 6,1997 '
Additional statements indicate that Ms, Hoffman held the shares through the end of the class
Period and beyond; howevet, no documentation indicates that these 900 shares are not the same
900 shares she held since before the class Period. under the definition of "class Member" the
MedParlners stock must have been purchased "ttu'ough open-matket transactions' melge1s or
acquisitions ... and any other type of transaction in which a Person acquired one or more shares
of Medparlners stock in return for consideration during the period fi'om october 30, 7996'
tln'ough JanuatY 7,1998 ..."
51. The ter.m ,oReceived" is commonly used by financial institutions on statements to
reflect circumstances where there has been a transfer of securities fi'om one institution or account
to another which is distinguishable from a purchase or sale transaction' Intervenor contends that
the Novemb er 6,1997 "Received" date places her claim within the class Period and has
submitted an affidavit from a paralegal in the Raymond James Legal Department' A true and
conect copy of the affidavit is included within Exhibit c. of note, the affiant could not
definitively state whether the Novemb er 6,1997 date was the purchase date any more than any
?age19 of29
DOCUMENT 3728
other date was.
B. GENERAL MOTORS CORPORATION
52. There are several competing Claims in the current action that were submitted on
behalf of Class Member General Motors. The question relating to these Claims involves
determining the proper recipient of any distribution to General Motors. In the MedPartners class
action, General Motors filed six Claims on which a distribution was made. General Motors filed
for bankruptcy in 2009 (In re: Motors Liquidation Company, Bank., S.D.N.Y., Chapter 11 Case
No. 09-50026 (REG). In the current action, several parties have submitted Claims on behalf of
General Motors. In late September 2016, the Honorable Quentin Brown (Ret.) submitted six
Claims on behalf of General Motors in his capacity as a member of the General Motors
Unsecured Creditors Committee. According to the affidavit submitted with the Form A paper
claim forms, Judge Brown was aware of the pending claims filing deadline in this class action
and submitted the paper Claims for each of the Claims filed in the MedPartners class action to
preserve the Claims, even attaching a list of the earlier Claims as well as their loss and
distribution amounts. Judge Brown stated in his affidavit that he was unaware of the proper
recipient of the funds and requested the funds be held in trust pending a ruling by the bankruptcy
court. Claims were also filed on behalf of General Motors by third party Electronic Claims filer,
BNY Mellon for the same transactions covered by the Claims filed by Judge Brown.5 State
Street Bank & Trust Company, another Electronic Claims filer, also filed Claims that match the
Claims with the two largest loss amounts.6 For the convenience of the Court, a detailed
breakdown of these Claims showing the competing nature between these five sets of competing
5 Two of the six competing General Motors Claims fi led in both the MedPartners class action and the current matter are actually filed on behalf of the General Motors Foundation and not General Motors Corporation. 6 BNY Mellon and State Street Bank fi led six other additional Claims that did not match to any Claims filed in the MedPartners class action. These Claims were all rejected on various grounds.
Page 20 of 29
other date was.
B. GENERAL MOTORS CORPORATION
SZ. There are several competing Claims in the cutrent action that were submitted on
behalf of Class Member General Motors. The question lelating to these Claims involves
determining the proper recipient of any distribution to General Motors' In the MedPadners class
action, General Motors filed six Claims on which a distribution was made, General Motors filed
for banlauptcy in2009 (In re: Motors I'iqtridation Comltany,Bank', S'D'N'Y', Chapter 11 Case
No. 09-50026 (REG). In the current action, several parties have subrnitted Claims on behalf of
General Motors. In late September 2016,thel{onorable Quentin Brown (Ret.) submitted six
Claims on behalf of General Motors in his capacity as a membet of the General Motors
Unsecured Creditors Committee. According to the affidavit submitted with the Form A paper
claim forms, Judge Brown was aware of the pending claims filing deadline in this class action
and submittecl the paper Claims for each of the Claims filed in the MedPatlners class action to
preserve the Claims, even attaching a list of the earlier Claims as well as their loss and
distribution amounts. Judge Brown stated in his affidavit that he was unaware of the proper
recipient of the funds and requested the funds be held in trust pending a ruling by the bankruptcy
cour1. Claims were also filed on behalf of General Motors by third party Electronie Claims filer',
BNy Mellon for the same transactions covered by the Claims filed by Judge Brown.t Stat"
Street Bank & Trust Company, another Electronic Claims filer, also filed Claims that match the
Ciaims with the two largest loss amounts.6 For the convenience of the Court, a detailed
breakdown of these Claims showing the competing nature between these five sets of competing
5 Two of the six cornpeting General Motors claims filed in both the MedPartners class action and the cuffent matterare actually filed on behaliof the General Motors Foundation and not General Motors Corporation.t gNy M.lf on and State Street Bank filed six other additional Clairns that did not match to any Claims filed in theMedPaltners class action. These clairns were all rejected on various gt'ounds.
Page2} of79
DOCUMENT 3728
Claims is attached as Exhibit D.
53. During the course of the administration, Gilardi reached out to Judge
Brown/General Motors Unsecured Creditors Committee and the Electronic Claims filers for
further information in support of their status as a proper filer. Gilardi advised the filers that no
monies would be paid on these Claims until resolution of any dispute by either settlement or
court order. None of the responses clarified who might be the proper recipient of any
distribution. In addition, it was also learned during the administration of the existence of Motors
Liquidation Company General Unsecured Creditors Trust overseen by the Wilmington Trust
Company.
C. CLAIM NOS. 300087-7, 300376-0, 300550-0 and 400498-1
54. These Claims involve four principals of InPhyNet Medical Management, a
company acquired by MedPartners during the Class Period. True and correct copies of these
Claims are contained in Exhibit E which is being filed under seal by Class Counsel
contemporaneously with this declaration. The issue for these four Claimants is whether they can
claim losses resulting from shares indirectly held through a corporation and from restricted
shares held in escrow. In all four instances, the transactions at issue relate to the number of
shares acquired as result of the in-class merger in which these InPhyNet principals received 1.18
shares of MedPartners common stock for every share of InPhyNet common stock. As part of
their recognized loss, the Claimants sought to include shares held not only in their individual
names but also shares they held indirectly through their respective ownership interest in three
now-defunct S-corporations. None of the Claimants or the S-corporations had filed a Claim in
the MedPartners class action. The Claimants did produce third party documents in the form of
broker's statements to substantiate the numbers of shares acquired from the InPhyNet-
Page 21 of 29
Claims is attached as Exhibit D'
53. During the course of the administration, Gilardi reached out to Judge
Brown/General Motors unsecured creditots committee and the Electfonic claims filers for
fuilher information in support of their status as a proper filer' Gilardi advised the filers that no
monies would be paid on these claims until resolution of any dispute by either settlemenl or
cou* order. None of the r.esponses clarified who might be the proper recipient of any
distribution. In addition, it was also learned during the administration of the existence of Motors
Liquidation company General unsecured creditors Trust overseen by the wilmington Trust
Company.
c.CLAIMNos.300087.7,30a376-0,300550-0and400498-1
54. These claims involve four principals of InPhyNet MedicalManagement' a
company acquired by MedPartners during the Class Period' True and couect copies of these
claims are contained in Exhibit E which is being filed under seal by Class counsel
contemporaneously with this declatation. The issue for these four claimants is whether they can
claim losses rcsulting from shares indirectly held tht'ough a cotporation and from restricted
shares held in escr.ow. In all four instances, the transactions at issue relate to the number of
shares acquired as result of the in-class mergef in which these InPhyNet principals received f i I
shares of Medpartners cofirmon stock for every share of InPhyNet common stock' As patt of
their recognized loss, the claimants sought to include shares held not only in their individual
names but also shares they held indirectly through their respective ownership interest in tt['ee
now-defunct S-corporations. None of the claimants or the s-corpol'ations had filed a claim in
the Medpartners class action. The Claimants did p|oduce third party documents in the form of
broker's statements to substantiate the numbers of shares acquired fiom the InPhyNet-
Page?l of29
DOCUMENT 3728
MedPartners merger that were held in their individual names.
55. While there is some evidence in SEC filings that the S-corporations did own
InPhyNet stock, the ownership interest of these four Claimants in these companies at the time of
the merger is only supported by an internally prepared ledger from their accountant. Third party
documents evidencing the specific transactions in question such as a statement from a financial
institution represent the preferred form of documentary support. 7
56. The Claimants are also claiming InPhyNet shares held in escrow. Typically,
shares held in escrow are viewed as restricted shares and would not be included in determining
any loss amount. Furthermore, in filings with the SEC, the escrow shares for at least two of the
four Claimants were subject to a pledge and security agreement.
57. For these four Claimants, the recognized loss amount varies substantially
depending on whether one includes the shares held indirectly and/or includes the shares held in
escrow. Depending on the level of documentary support the Court is willing to accept and
whether it is willing to include the shares held in escrow, there are three possible ways to
determine the loss amount: (1) include the total number of shares claimed (both directly and
indirectly); (2) include the shares owned as individuals and through the S-corporations but
exclude those held in escrow; and (3) include only those shares held in these Claimants' names.
Exhibit F illustrates the impact of this decision on each of the four Claims in question.
D. INFORMAL "OBJECTIONS"
58. In this matter, the deadline to object to any part of the Settlement was July 22,
2016. There were two Claimants (Claim Nos. 300251-9 and 400586-4) who submitted Claims
after the objection deadline and appear to have "objected" to the Settlement but failed to object
While the accountant who prepared these Claims swears in his enclosing letter that the information contained in the Claims is true and accurate, the statement is not made under penalty of perjury.
Page 22 of 29
MedPartners mefger that were held in their individual names.
55. Wriie there is some evidence in SEC filings that the S-corporations did own
inphyNet stock, the ownership intercst of these four clairnants in these companies at the time of
the merger is only supported by an internally prepared ledger from their accountant' Third party
documents evidencing the specific transactions in question such as a statement from a financial
institution represent the prrferred form of documentary support' 7
56, The claimants are also claiming InPhyNet shares held in esclow' Typically,
shares held in esclow are viewed as restricted shares and would not be included in determining
any loss amount. Fufihetmore, in filings with the SEC, the escrow shares for at least two of the
fourClaimantswel'esubjecttoapledgeandsecutityagreement.
57, For these four Claimants, the rccognized loss amount varies substantially
depe'ding on whether one includes the shares held iridirectly and/or includes the shat'es held in
escrow. Depending on the level of documentary support the Court is willing to accept and
whether it is willing to include the shares held in escrow, there are thlee possible ways to
determine the loss amount: (1) include the total number of shares clairned (both clirectly and
indirectly); (2) include the shares owned as inclividuals and thlough the S-corporations but
exclude those held in escrow; and (3) include only those shares held in these Claimants' names'
Exhibit F illustlates the impact of this decision on each of the four claims in question'
D. INF'ORMAL "OBJECTIONS"
58. In this matter, the deadline to object to any paft of the Settlement was July 22'
2016. f'here were two claimanls (claim Nos. 300251-9 and 400586-4) who submitted claims
after the objection deaclline and appear to have "objected" to the Settlement but failed to object
t Whil. the accountant who prepared these Claims swears in his enclosing letter that the inforrnationthe clairns is tr.ue and accurate,'the statelllent is not made undel penalty of periury'
Page22 of29
contained in
DOCUMENT 3728
in the manner required by the terms of the Settlement. True and correct copies of the relevant
portions of Claim Nos. 300251-9 and 400586-4 are attached to this declaration as Exhibit G.
59. Claim No. 300251-9, a valid paper Claim submitted in late September 2016,
more than two months after the deadline to object, contains an objection in its supporting
documentation. Here, the Claimant submitted an enclosure letter which states "I have enclosed
by[sic] proof of Claim and Release (Form "B"). Please be advised that I am protesting
attorney's fees in this matter as I feel they are excessive."
60. Similarly, Claim No.400586-4 was filed online on September 28, 2016. In the
documentation uploaded with the Claim, the Claimant included a typewritten note that, in
addition to a written summary of the transaction history, the Claimant remarks:
Regarding the fees, I strongly object to the extraordinarily high fees awarded the plaintiffs' attorneys, to be deducted from the funds awarded to shareholders. Especially because these are the same attorneys paid in the first litigation. The attorney's fees awarded are more than twice usual and customary for such cases, and 1 question a possible conflict of interest on the part of the awarding judge.
On substantive grounds, Claim No. 400586-4 is on the list of recommended Claims to reject on
the grounds that it failed to show any purchases and failed to show a calculated loss.
61. Not only were these "objections" untimely but they also failed to comply with all
or part of the specific procedural requirements outlined in Paragraph 5.4 of the Stipulation
regarding how objections were to be made.
VIII. FEES & DISBURSEMENTS
62. Settlement funds were received from Defendants AIG and Caremark in
September 2016 and, since their receipt, the funds have been held in an interest-bearing account.
In January 2017, this Court approved the non-distribution payments to Class Counsel and
Page 23 of 29
in the manner requifed by the terms of the Settlement. True and comect copies of the relevant
portions of claim Nos. 300251_g and 4005g6-4 are attached to this declaration as Exhibit G,
59. Clairn No. 300251-9, a valid paper claim submitted in late September 2016'
more than two months after the deadline to object, contains an objection in its supporling
documentation. Here, the claimant submitted an enclosrue letter which states "I have enclosed
by[sic] proof of claim and Release (Form "B"). Please be advised that I am protesting
attotney's fees in this matter as I feel they are excessive'"
60. Similarly, claim No.400586-4 was filed online on september 28, 2016' In the
documentation uploaded with the claim, the claimant included a typewitten note that, in
addition to a written summaly of the transaction history, the claimant remarks:
Regarding the fees, I strongly object to the exttaordinarily high fees awarded theplaintiffs, uttot*V*, t" Ue ieaucieO fiom the funds awa'ded to shareholders'Especially because these are the same attorneys paid in the first litigation' Theattorney,sre"suwuro"daremor.ethantwiceusualandcustomaryforsuchcases,and I questio"
" p"ttlur" conflict of interest on the parl of the awarding judge'
on substantive grounds, claim No. 400586-4 is on the list of recommended claims to reject on
the grounds that it failed to show any purchases and failed to show a calculated loss'
6l.Notonlywerethese..objections',untimelybuttheyalsofailedtocomplywithall
or pafi of the specific pt'ocedural requirements outlined in Paragraph 5'4 of the Stipulation
regalding how objections were to be made'
VIII. FEBS & DISBURSEMENTS
62. settlement funds wete received fi'om Defendants AIG and caremat'k in
september 2016 and, since their receipt, the funds have been held in an interest-bearing account'
In January 2A17, this couft appt'oved the non-distdbution payments to class counsel and
PageZ3 of29
DOCUMENT 3728
Intervenor's counsel for attorney's fees, expenses and Class Representative payments in the
amount of $126,735,932.71. Other disbursements from the Settlement Fund include:
a. One-time insurance premium payment in the amount of $59,864.00 to
AON Insurance to cover a policy in effect while the funds remained in escrow;
b. Court-approved payment on Gilardi's initial invoice for services rendered
through January 2017 which totaled $335,193.19; and
c. Payments of federal and state taxes owed on interest earned by the
Settlement fund including payments made in connection with the filing of the annual tax
return ($504,794) and quarterly payments for the first two quarters of 2018 ($243,418).
63. These amounts represent the only disbursements to date that have been made from
the Settlement Fund. The total amount of interest earned by the Settlement Fund through May
31, 2018 is $2,870,621.90. The current fund balance as of the date of this declaration is
$184,991,420.00. Gilardi will keep in reserve sufficient funds to pay the estimated quarterly tax
payments through the first two quarters of 2019.
IX. ADMINISTRATION COSTS AND EXPENSES
64. In addition to the submission of its report, Gilardi is also seeking Court approval
for payment on its current invoice for services rendered as Claims Administrator. Gilardi agreed
to be the Claims Administrator in exchange for payment of its fees and expenses. Under the
terms of the Settlement, including but not limited to Sections 6.3, 1.37, and 1.44, all Notice and
Administration Costs are paid out of the Settlement Fund prior to the application of the Plan of
Allocation. In June 2017, this Court approved Gilardi's initial invoice and authorized payment
from the Settlement Fund totaling $335,193.19 which represented administration fees and
expenses incurred through January 2017. Attached hereto as Exhibit H is a copy of Gilardi's
current invoice. The invoice covers the period of February 2017 through May 2018. Gilardi
requests Court approval of this invoice and authorization for Gilardi to pay itself $484,336.40
Page 24 of 29
Intervenor's counsel for attorney's fees, expenses and Class Reptesentative payments in the
amount of $126,735 ,932.7L Other disbursements from the Settlement Fund include:
a, One-time insurance premium payment in the amount of $59,864.00 to
AON Insurance to cover a policy in effect while the funds lemained in escrow;
b. Court-approved payment on Gilardi's initial invoice for services rendered
ttu'ough January 2017 which totaled $335,193'19; and
c. payments of federal and state taxes owed on interest eamed by the
Settlement fund including payments made in connection with the filing of the annual tax
retum (5504,794) and quarterly payments for the first two quarters of 2018 ($243'418).
63. These amounts represent the only disbursements to date that have been made fi'om
the Settlement Fund. The total amount of interest eamed by the Settlement Fund thlough May
31, 20ig is $2,870,621.90. The cuffent fund balance as of the date of this declaration is
$Ig4,gg1,420.00. Gilardi will keep in reserve sufficient funds to pay the estimated quarterly tax
payments thlough the first two quafiers of 2019'
IX. ADMINISTRATION COSTS AND EXPENSES
64. In addition to the submission of its report, Gilardi is also seeking Court approval
for payment on its curent invoice for services rendered as Claims Administrator. Gilardi agreed
to be the Claims Administrator in exchange for payment of its fees and expenses. lJnder the
terms of the Settlement, including but not limited to Sections 6.3,1.37, and I.44, all Notice and
Administration Costs ar.e paid out of the Settlement Fund prior to the application of the Plan of
Allocation, In June 2017, this Courl approved Gilardi's initial invoice and authorized payrnent
from the Settlement Fund totaling $335,193.19 which represented administration fees and
expenses incu.red through January 2017. Attached hereto as Exhibit H is a copy of Gilardi's
cuilent invoice. The invoice covefs the period of February 2017 through May 2018' Gilardi
rcquests Court approval of this invoice and authorization for Gilardi to pay itself $484'336'40
Page24 of29
DOCUMENT 3728
for payment in full on the balance of its outstanding administration fees and expenses incurred
through May 31, 2018.
65. In addition, Gilardi estimates that the costs to completion of the invoice will total
approximately $75,000 and requests that this amount be held in reserve for payment of services
yet to he performed. The tasks to be performed include, but are not limited to, the preparation
of and processing of confirmation of award and rejection letters, the continued maintenance of
the toll free telephone number, updating of website and training of customer service
representatives with respect to information surrounding the appeal period and other distribution-
related matters, processing of any appeals of the initial determinations listed in Exhibits B-1, B-2
and B-3, disbursements of settlement benefits to the Class Members, following up on any
uncashed checks with approved Claimants, continued funds management, and anticipated tax
compliance costs. Additional fees and expenses may be incurred if other tasks outside the scope
of the proposed Distribution Plan outlined below are required (e.g., a second distribution takes
place).
X. PROPOSED DISTRIBUTION PLAN OF NET SETTLEMENT FUND
66. Should the Court concur with Gilardi's determinations concerning the
provisionally-accepted and rejected Claims, including the Late Claims, Gilardi recommends the
following distribution plan (the "Distribution Plan"):
a. Upon the Court's approval of the proposed Distribution amounts and/or
rejection of the Claims, Gilardi will mail "Confirmation of Approved Claim" letters to
the Authorized Claimants whose Claims are approved and "Notice of Rejection" letters to
those Claimants whose Claims are rejected. The Confirmation of Approved Claim letter
will indicate the recognized loss amount and, if matched to a MedPartners class action
Claim, the previous amount distributed. The Notice of Rejection letter will identify the
Page 25 of 29
fbr payrnent in full on the balance of its outstancling administration fbes and expenses incuned
ttuough MaY 31,2018.
65. In acldition, Gilardi estimates that the costs to completion of the invoice will total
approxirnately $75,000 and rcquests that this amount be helcl in reserve for payment of services
yet to be pertbnnecl. The tasks to be perlbmrecl iuclude, but are not limitecl to, the pleparation
of and processing of confirmation of award and rejection letterc, the continued maintenance of
the toll fi'ee telephone number, updating of website and training of customer service
r.epresentatives with respect to infolrnation sunounding the appeal period and other distribution-
related matters, processing of any appeals of the initial determinations listed in Exhibits B-i' B-2
and B-3, disbursements of settlement benefits to the class Membet's, following up on any
uncashed checks with approved Claimants' continued funds management' and anlicipated tax
compliance costs. Aclditional fees and expenses may be incurreti if other tasks outside the scope
of the proposed Distribution Plan outlined below are requiled (e'g" a second distribution takes
place).
X.PRoPosEDDISTRIBUTIONPLANoFNETSETTLEMENTF.UND
66.shouldtlreCoutlconculwithGilar.di,sdeterminationsconcerningtheprovisionally-accepted and rcjected Claims, including the Late Claims' Gilaldi recomnrends the
following distribution plan (the "Distribution Plan"):
a. upon the courl's approval of the proposed Dish'ibution amounts and/or
rejection of the claims, Gilardi will mail "confir'mation of Approved c1aim" letters to
the Authorized Claimants whose Claims al'e apploved and "Notice of Rejection" lettets to
those Claimants whose Claims are rejectecl. The Confirmation of Approved Clairn letter
will indicate the recognized loss amount and, if marched to a MedPartners class action
Claim, the previous amount distributed. The Notice of Rejection letter will identifi, the
Page25 of29
DOCUMENT 3728
ground(s) for the rejection. Both the Confirmation of Approved Claim letter and the
Notice of Rejection letter will notify the Claimants that they have twenty eight (28) days
from the date of the letter to appeal the decision, in whole or in part, and the manner in
which to do so. The letters will direct the Claimants to submit their appeals to Gilardi
for processing either electronically through the case email (info@aiR-
careamarkclassaction.com) or via first class mail at the mailing address maintained by the
Claims Administrator for this Settlement (Gilardi & Co., LLC, P.O. Box 8040, San
Rafael, CA 94912-8040.)
b. Following the expiration of the time to appeal, and upon further
instructions from this Court regarding any decisions made during the appeals period,
Gilardi will prepare a second Administrator's Report containing the final decision on all
Claims. Upon authorization from the Court, Gilardi will then distribute 100% of the
available balance of the Net Settlement Fund, after deducting the payments previously
allowed and requested herein, and after reserving part of the Settlement Fund for payment
of any estimated taxes and estimated costs to complete, to the Authorized Claimants who
would receive at least $10.00 based on their recognized loss in comparison to the total
recognized loss of all Authorized Claimants (the "Distribution").
c. For those Claims matched to Claims filed in the MedPartners class action,
the total amount distributed would be reduced by the amount of the distribution to that
Claimant in the MedPartners action.
d. In order to encourage Authorized Claimants to cash their Distribution
checks promptly, and to avoid or reduce future expenses relating to unpaid Distribution
checks, all Distribution checks will bear the notation: "CASH PROMPTLY. VOID AND
Page 26 of 29
ground(s) for the rejection. Both the Confirmation of Approved Claim letter and the
Notice of Rejection letter will noti$z the Clairnants that they have twenty eight (28) days
fiom the date of the letter to appeal the decision, in whole or in pafi, and the manner in
which to do so. The letters will direct the Claimants to submit their appeals to Gilardi
for processing either electronically thlough the case email [email protected]
careamarkclassaction.corn) or via first class mail at the mailing addrrss maintained by the
Claims Adminisfi'ator for this Settlement (Gilardi & Co., LLC, P'O' Box 8040, San
Rafael, CA 94912-8040.)
b, Following the expiration of the time to appeal, and upon fuither
instructions from this Cout regarding any decisions made during the appeals period,
Gilardi will prepare a second Administrator's Repofi containing the final decision on all
Claims. Upon authorization fi'om the Court, Gilardi will then distribute 100% of the
available balance of the Net settlement Fund, after deducting the payments previously
allowed and requested herein, and after reseruing part of the Settlement Fund for payment
of any estimated taxes and estimated costs to complete, to the Authorized Claimants who
would rcceive at least $10.00 based on their recognized loss in compatison to the total
recognized loss of all Authorized claimants (the "Distribution").
c. For those Claims matched to Claims filed in the MedPartners class action,
the total amount distributed would be reduced by the amount of the distribution to that
Claimant in the MedPartners action.
d, ln order to encourage Authorized Claimants to cash their Distribution
checks promptly, and to avoid or reduce future expenses relating to unpaid Distribution
checks, all Distribution checks will bear the notation: "CASH PROMPTLY' VOID AND
Page26 of29
DOCUMENT 3728
SUBJECT TO RE-DISTRIBUTION IF NOT CASHED 120 DAYS AFTER ISSUE
DATE."
e. In an effort to have as many Authorized Claimants as possible cash
their checks, Gilardi will perform follow-up with those Authorized Claimants whose
checks are initially uncashed, either because they are returned to Gilardi as undeliverable
or because the Authorized Claimant simply did not cash the check after a certain
specified period of time elapses. More specifically, for Authorized Claimants whose
checks are returned as undeliverable, Gilardi will attempt to locate new addresses by
running the undeliverable addresses through the USPS National Change of Address
database and, where appropriate, via Internet search techniques and by calling the
Authorized Claimants. Where a new address is located, Gilardi will update the database
accordingly and re-issue a distribution check to the Authorized Claimant at the new
address. If, after a second mailing, the second check is again returned, no further efforts
need to be taken by Gilardi to resend the check. For any Authorized Claimants whose
checks are not returned but who simply do not cash their checks, Gilardi will use a mix of
personalized telephone calls and emails to urge such Authorized Claimants to cash their
distribution checks. In the event an Authorized Claimant loses or damages his, her, or
its check, or otherwise requires a new check, Gilardi will issue replacement checks. If a
check is deemed lost, Gilardi will void the initial payment check prior to re-issuing a
payment.
f. Authorized Claimants who do not cash their Distribution checks within the
time allotted will irrevocably forfeit all recovery from the Settlement. The funds
allocated to all such stale-dated checks will be available to be distributed to other
Page 27 of 29
SUBJECT TO RE.DISTRIBUTION IF NOT CASHED I2O DAYS AFTER ISSUE
DATE.''
e. ln an effort to have as many Authorized Claimants as possible cash
their checks, Gilaldi will perform follow-up with those Authorized Claimants whose
checks are initially uncashed, either because they are retumed to Gilardi as undeliverable
or because the Authorized Claimant simply did not cash the check after a certain
specified period of time elapses. More specifically, for Authorized Claimants whose
checks are returned as undeliverable, Gilardi will attelnpt to locate new addresses by
running the undeliverable addresses tlu'ough the USPS National Change of Address
database and, where appropriate, via Internet search techniques and by calling the
Authorized Claimants. Where a new address is located, Gilardi will update the database
accordingly and re-issue a distribution check to the Authorized Claimant at the new
address, If, after a second mailing, the second check is again retumed, no fuither efforts
need to be taken by Gilardi to resend the check. For any Authorized Claimants whose
checks are not retumed but who simply do not cash their checks, Gilardi will use a mix of
personalized telephone calls and emails to urge such Authorized Claimants to cash their'
distribution checks. In the event an Authorized Clairnant loses or damages his, her, or
its check, or otherwise requires a new check, Gilardi will issue replacement checks. If a
check is deemed lost, Gilardi will void the initial payment check prior to re-issuing a
payment.
f. Authorized Claimants who do not cash their Distribution checks within the
time allotted will inevocably forfeit all recovery from the Settlement' The funds
allocated to all such stale-dated checks will be available to be distributed to other
Page27 of29
DOCUMENT 3728
Authorized Claimants in any future redistribution of the Net Settlement Fund, or for any
other purpose approved by this Court. Similarly, Authorized Claimants who do not cash
subsequent distributions within the time allotted or pursuant to further action as set forth
above, will irrevocably forfeit any further recovery from the Net Settlement Fund.
g. Consistent with the Stipulation, if any funds remain in the Net Settlement
Fund after the Distribution because of uncashed checks or otherwise, then, after Gilardi
has made reasonable and diligent efforts to have Authorized Claimants cash their
distribution checks (which efforts shall consist of the follow-up efforts described above),
and all authorized payments on all outstanding administration costs, as defined under
Section 6.3 of the Stipulation, have been made, any balance remaining in the Net
Settlement Fund six (6) months after the initial distribution of the Settlement Fund
(whether by reasons of tax refunds, uncashed checks, or otherwise), or as reasonably soon
thereafter, Gilardi shall, if and to the extent logistically feasible and economically
justifiable, make a further distribution of such balance among Authorized Claimants in an
equitable fashion. After any further distribution, or if a further distribution is not
undertaken, any balance that still remains in the Settlement Fund shall be reported to the
Court in order to seek the Court's authority to donate the remainder to one or more
secular §501(c)(3) organization(s) selected by Class Counsel.
h. Unless otherwise ordered by the Court, one year after the initial
Distribution, Gilardi will destroy the paper copies of the Claims and all supporting
documentation, and three years after the initial Distribution, Gilardi will destroy
electronic copies of the same.
Page 28 of 29
Authorized Claimants in any future redistribution of the Net Settlement Fund, or for any
other purpose approved by this Courl. Similarly, Authorized Claimants who do not cash
subsequent distributions within the tirne ailotted or pursuant to further action as set forlh
above, will inevocably forfeit any furlher recovery fi'om the Net Settlement Fund.
g. Consistent with the Stipulation, if any funds remain in the Net Settlement
Fund after the Distlibution because of uncashed checks or otherwise, then, after Gilardi
has made reasonable and diligent efforts to have Authorized Claimants cash their
distribution checks (which efforts shall consist of the follow-up efforls described above),
and all authorized paynents on all outstanding administration costs, as defined under
Section 6.3 of the Stipulation, have been made, any balance remaining in the Net
Settlement Fund six (6) months after the initial distribution of the Settlement Fund
(whether by reasons oftax refunds, uncashed checks, or otherwise), ot as reasonably soon
thereafter, Gilardi shall, if and to the extent logistically feasible and economically
justifiable, make a fur1her distribution of such balance among Authorized Claimants in an
equitable fashion. After any further disttibution, or if a further distribution is not
undertaken, any balance that still remains in the Settlement Fund shali be reported to the
Court in order to seek the Court's authority to donate the remainder to one or mote
secular $501(c)(3) organization(s) selected by Class Counsel.
h. Unless otherwise ordered by the Coutl, one year after the initial
Distribution, Gilardi will destroy the paper copies of the Claims and all supporting
documentation, and three years after the initial Distribution, Gilatdi will destt'oy
electronic copies of tire same.
Page28 of29
DOCUMENT 3728
XI. CONCLUSION
67. For the foregoing reasons, it is respectfully requested that this Court enter an
Order:
(1) approving the mailing of the Confirmation of Approved Award and Rejection letters
to those Claimants listed in Exhibits B-1, B2 and B3 respectively;
.(2) providing further instructions and/or a final determination on those Claims discussed
in Section VII of this declaration;
(3) authorizing initial distributions of the Net Settlement Fund to Authorized Claimants
upon submission of a final report by Gilardi;
(4) approving payment of the outstanding invoice for the Notice & Administration Costs
attached as Exhibit I-I;
(5) approving the Distribution Plan, including the plan for re-distribution and/or donation
of any funds remaining in the Net Settlement Fund following the initial Distribution to
Authorized Claimants as set forth in the Plan of Allocation and Class Counsel's motion; and
(6) authorizing destruction of paper copies of Claim Forms and electronic copies of
Claim records after an appropriate time following distribution of the Net Settlement Fund.
I declare under penalty of perjury that the foregoing is true and correct and that this
declaration was executed thi§-1 day o fJu July, 2018, in S Rafael, California.
( MARC WALL
Page 29 of 29
XI. CONCLUSION
67. For the foregoing reasons, it is respectfully requested that this Court enter an
Order:
(1) approving the mailing of the Confirmation of Approved Award and Rejection letters
to those Claimants listed in Exhibits B-1, B2 and 83 respectively;
.(2) providing fuither instructions and/or a final determination on those Claims discussed
in Section VII of this declaration;
(3) authorizing initial distributions of the Net Settlernent Fund to Authorized Claimants
upon submission of afinal repoftby Gilatdi;
(4) approving payment of the outstanding invoice for the Notice & Adminish'ation Costs
attached as Exhibit I{;
(5) approving the Distribution Plan, including the plan for re-distrjbution and/or donation
of any funds remaining in the Net Settlement Fturd following the initial Distlibution to
Authorized Claimants as set forlh in the Plan of Allocation and Class Counselos motion; and
(6) authorizing destruction of paper copies of Claim Forms and electronic copies of
Claim records after an appropriate time following distribution of the Net Settlement Fund.
the foregoing is true and conect and that thisI declare under penaltl$ V"t:"ry that
declaration was executed thiy- day of July, 201 8, in
4/r*-MARC WALL
Page29 of29
DOCUMENT 3728
EXHIBIT A
DOCUMENT 3728
A I G - Ca re m ark C/ass ActionClaims Administratorclo Gilardi& Co., LLCP.O. Box 8040San Rafael, CA 94912-804041 5-458-3605
Date: October 6,2017
Claim Number:CXKIAccount Number:
Notice of DeficiencY
RE: A|G-Caremark Class Action Johnson v. Caremark Rx, LLC
Jefferson County (AL) Case No. 01-CV-2003-006630'00
Dear Claimant,
We have received and reviewed your claim and find it to be deficient for the reason(s) indicated below
For transaction-specific issues, all relevant deficiency codes will appear in the last column of the table below labeled
,,Deficiency code,,, next io e"c'tr transaction provided. A given traniaction may have mcre than one deficiency' Please
review the deficiency code column carefully to contirm an! supporting documentation which you submit will provide all of
the information required to validate your claim'
please refer to the following for an explanation of each relevant deficiency and direction for resolution'
No S u-ppo rti nq Documentation for Transaction(s)
code "NSTD" appears next to transactions which are deficient for this reason,
your claim did not include documentation suppofiing one or more of your claimed purchases andlor sales of MedPartners
stock held on the indicated date(s). you must sunriit adequaie supporting documentation for all purchases and sales of
the security type coverJ UVi[i* !6ttf "ment.
This includes one or more of the following types of transactions:
(a) purchased Medpartners common stock, including through open-market .transactions, mergers or
acquisitions in wrricrr Medpartners issued common si6ck inJeturn for consideration during the period
from October 30, 1996, through January 7, 1998, inclusive;
(b) purchased call option contracts or *'olO'put option contracts on MedPadners common stock during the
period October 30, 1996, through {"!Yq'V 7' 1999' inclusive;
(c) purchaseO 1teOpannbrs Thieshold Afipreciation Price Securities ("TAPS") in the September 15, 1997
itiering or thereafter through January 7, 1998; or
1Oy teriOereO rn"t"r of titUert Medical Management Holdings Corporation to MedPafiners between
August 20, 1997, and September 19, 1997,
lf the Transaction Type indicated is a "Holding" yoq mugt- .yPTi1 documentation showing the quantity of MedPaftners
stock held at close of tLJinl-on Ge transaction"date listed for that holding. An example of the requested documentation is
an account statement ror ir-r6 month which shows your holdings in MedPartners stock during that month.
lf the transaction type indicated is "purchase" or "sale," your supporling documentation must include the beneficial
owner/account name and the trade date, quantity and total dollar amount of each transaction'
Securitv Tvpe Transaction Date Transaction TYPe Number of Shares Transaction Price
MedPartnersCommon Stock
1011611997 Purchase 300 $ 8,208.00
MedPartnersCommon Stock
uta7n998 Ending Holding 300
Page 1 of 2
I
DOCUMENT 3728
you may need to contact your broker, investment advisor or tax consultant for assistance in gathering the necessary
information. Acceptable documents may include, but are not limited to, broker siatements, clearing house blotters or
other independent third party verification andlor confirmation of the transactions.
you must provide the information or documentation to the Claims Administrator on or before october 26,2017 ' lf you do
not do so, your claim may be rejected. Please return the information, along with this letter, to:
Al G-Caremark C/ass ActionClaims Administratorc/o Gilardi & Co., LLC
Attn: Administrative ReviewP.O. Box 8040
San Rafael, CA 94912-8040
lf you have any questions about this letter or your claim, you can email the Claims Administrator at
[email protected] or call (41 5) 458-3605.
Sincerely,
Gilardi& Co,, LLCAIG-Caremark Class Action Claims Administrator
Page 2 of 2
I
DOCUMENT 3728
AtG-Carem ark Cl ass Action
Claims Administratorclo Gilardi& Co., LLCP.O. Box 8040San Rafael, CA 94912-804041 5-458-3605 Date: October 6,2A17
Claim Numbet,cxK-fAccount Number:
Notice of DeficiencY
-Transaction Date Transaction TYPe Number of Shares, Transaction Price
- MedPartnersCommon Stock
01/07/1S98 Ending Holding 200
Page 1 of2
I
RE: A|G-Caremark Class Action Johns an v' Caremark Rx' LLC"- f"ff"i*n County (AL) Case No' 01-CV-2003-006630'00
Dear Claimant,
Wehavereceivedandreviewedyourclaimandfindiitobedeficientforthereason(s)indicatedbelow,
For transaction-specific issues, all relevant deficiency codes will appear in the last column of the table below labeled
,,Deficiency code,,, ""* i"
"""'r.', transaction pi""io"a. A given transaction may have more than one deficiency' Please
review ihe deficiency code column carefully t" ;;;fir".r ani supporting iolu*"i,tation which you submit will provide all of
itre intormation required to validate your claim'
Please refer to the foltowing for an explanation of each relevant deficiency and direction for resolution'
No S u pporti n g Documentation for Transaction{s)
Code,.NSTD,,appearsnexttotransactionswhicharedeficientforthisreason'your claim did not include documentation supporting one or more of your claimed purchases and/or sales of MedPartners
stock held on the indicated date(s). vou musrsuufiit aoequat".uppo'ting aocunientation for allpurchases and sales of
the security type covered by this settlement. This includes one or more of the following types of transactions:
(a) purchased MedPartners common stock, including through open-market transactions' mergers or
acquisitions in *ni"n nluoprrtn"r" i.;r;;fion st6cx in"retuin for consideration during the period
from October SO, tggO, through January 7' 1998' inclusive;
(b) purchaseO-caff option coniracts. or'"lfO n'i9p1i"1 contiacts on MedPadners common stock during the
period octon"iio' lsso, through January 7' 1998' inclusive;
(c) purchased'rrl'"ap",tnLr" rrriesrrorilipie.Liion price securities ('TAPS') in the september 15' 1997
iti"rlng or thereafter through January.7' 1998; or
(d) tendered .h;;;;";idln"tt nr"ii.!r'-rr,rrh"g"r"nt Holdings corporation to MedPartners between
higust 20, 1997, and September 19' 1997'
rf the Transaction Type indicated is a ,,Hording, yoq mugt- "lpTil
documentation showing the quantity of MedParlners
stock held at ctose of trading on the transaction'drit"lirt"o for that h"id;;g. il;xa1nr9 of tie requested documentation is
an account statementiJiiy,E ronL wrric6 srrowJv*i rloroing. in MedPa-rtners stock during that month'
rf the transaction type indicated is ,,purchase,, or "sare," your supporting documentation must include the beneficial
owner/account name unJ tn" trade date, qr"ntity and totai dollar amount of each transaction'
DOCUMENT 3728
you may need to contact your broker, investment advisor or tax consultant for assistance in gathering the necessary
information. Acceptable documents may include, but are not limited to, brokor statements, clearing house blotters or
other independent ihird party verification and/or confirmation of the transactions.
No Declaration of Representative Form
ln addition, from our initial review, it appears that you failed to submit a Declaration of Representative form as required
under the terms of the Settlement Agreement, ln filing your claim you have indicated that you are acting in arepresentative capacity for a Class Member who is either: (1) a minor, {2) deceased, or,(3) has been deemed by a coutt to
be incompetent. Repiesentatives who are acting in such a capacity must complete a Declaration of Representative form
verifying iheir status. No form was submitted with the Class Member's claim. We have enclosed a copy of lhe correct
form foi youi convenience, Fillable PDF versions of the Declaration of Representative form are also available online at
the case website, www.aig-caremarkclassaction'com.
you must provide the information or documentation to the Claims Administrator on or before October 26,20'17.lf you do
not do so, your claim may be rejected. Please reiurn the information, along with this leiter, to:
AlG-Caremark Class ActiottClaims Administratorc/o Gilardi & Co., LLC
Attn: Administrative ReviewP.O. Box 8040
San Rafael, CA 94912-8040
lf you have any questions about this letter or your claim, you can email the Claims Administrator at
[email protected] or call (41 5) 458-3605.
Sincerely,
Gilardi& Co., LLCAIG-Caremark Class Action Claims Administrator
Page 2 of 2
I
DOCUMENT 3728
Al G-C aremark Class ActionClaims Administratorc/o Gilardi & Co,, LLCP.O. Box 8040San Rafael, CA 94912-8040415-458-3605
Date: October 6,2017
Claim Number:CXKfAccount Number:
Notice of DeficiencY
RE: A|G-Caremark Class Action Johnson v' Caremark Rx' LLC"- Jefferson County (AL) Case No. 01-CV-2003-006630'00
Dear Claimant,
We have received and reviewed your claim and find it to be deficient for the reason(s) indicated below'
For transaction-specific issues, all relevant deficiency codes will appear in the last column of the table below, labeled
.Deficiency code,,, next to "a"'h
tran"action provided. R giu"n traniiction may have more than one deficiency' Please
review the deficiencv "oj" "orrrn carefully tb ;;f'rm an"y supporting documentation which you submit will provide all of
the information required to validate your claim'
please refer to the following for an explanation of each relevant deficiency and direction for resolution'
No Su pportin q Documentation for Transaction(sl
code ,'NSTD" appears next to transactions which are deficient for this reason'
your claim did not include documentation suppofting one or more of your claimed purchases andlor sales of MedPartners
stock hetd on the inoi.Jtljl"r;i;i: iou ;rsi submit adequate supporting documentation for all purchases and sales of
the security type coverJ uv]r,-i. lZttr"ment. This includes one or more of the following types of transactions:
(a) purchased Medpartners common stock, including through open-market .transactions, mergers or
acquisitions in wr.,icn Medpartners irsulJ c,lmmon stlo"k in-retuin for consideration during the period
from October 30, 1996, through January 7, 1998' inclusive;
(b) purchased call option contracts. or *ttO'put oition contiacts on MedPadners common stock during the
period October 30, 1996, through {"lY"ty 7' 1999' inclusive;
(c) purchased il;dpiltis ii'iesr'oriA6prLciatlon Price Securities ("TAPS") in the September 15, 1997
itiering or thereafter through January 7, 1998; or
(d) tendered .;,"iu. oi iitn"'t tvteolcat Management Holdings Corporation to MedPartners between
August 20,1997, and September 19, 1997'
rf the Transaction Type indicated is a ,,Hording' yo! mu:! .lpTil documentation showing the quantity of MedPartners
stock held at close ot tljiniln Le transactiorioate tlstec for that holding. An example of the requested documentation is
an account statement f;;ld month which shows your holdings in MedPartners stock during that month'
lf the transaction type indicated is "purchase" or "sale," your supporting documentation must include the beneficial
owner/account name and the trade date, quantity and total dollar amount of each transaciion'
Page 1 of2
I
DOCUMENT 3728
Code "PPS" appears next to all transactions which are deficient for this reason,
The total transaction price for one or more transactions claimed in your submission does not fall within the known price
range of Medpartners stock on that date and/or you did noi provide the total transaction amount for one or more of the
transaciions, you must submit adequate uuppo*lng documentation showing the trade date, quantity and lotal dollar
imount foi all transactions in Medpadners stock which are indicated as deficient for this reason.
Transaction Price Error
Securitv Tvpe Transaction Date Transaction Tvpe Number of Shares Transaction Price Deficienc$ 15,759,331,00 PPS, NSTDMedPartners
Common Stock06t27t1997 Purchase
you may need to contact your broker, investment advisor or tax consultant for assistance in gathering the necessary
iniormat'ion. Acceptable dlcum"nts may include, but are not limited to, broker statements, clearing house blotters or
other indepenOent ihirO parly verification and/or confirmation of the transactions.
you must provide the information or documentation to the claims Administrator on or before octob er 26, 2o17. lf you do
noi Oo io,'Vour claim may be rejected. Please return the information, along with this letter, to:
A I G -C a re m ark C/ass ActionClaims Administratorc/o Gilardi& Co., LLC
Attn: Administrative ReviewP.O. Box 8040
San Rafael, CA 94912-8040
lf you have any questions about this letter or your g|ary,_{ou can email the Claims Administrator at
[email protected] or call (415) 458-3605'
Sincerely,
Gilardi& Co., LLCAIG-Caremark Class Action Claims Administrator
Page 2 of 2
I
DOCUMENT 3728
Al G-C a re m a* C/ass ActionClaims Administratorc1o Gilardi& Co., LLCP.O. Box 8040San Rafael, CA 94912-804041 5-458-3605 Date: October 6,2017
Claim Number:CXKJAccount Number:
Notice of DeficiencY
RE: AIG-Caremark Class Action Johnson v' Caremark Rx' LLC'- .fefterton County (AL) Case No' 01-CV-2003-006630'00
Dear Claimant,
We have received and reviewed your claim and find it to be deficient for the reason(s) indicated below'
For transaction-specific issr.res, arr rerevant deficiency codes wifi appear in the rast corumn of the table below, labeled
,,Deficiency Code", n"*t io """'nlransaction
ptouiO"O. A given transaction may have more lhan one deficiency' Please
review the deficiency ""j" ."rurn carefuily tb
"onrirm an"y supporting Jo"ut"ntution which you submit will provide all of
the information required to validate your claim'
Please refer to the following for an explanation of each relevant deficiency and direction for resolution'
No Qu ppo rtinq Documentation for Transaetio n(s)
code ,,NSTD" appears next to iransactions which are deficient for this reason'
your claim did not include documentation supporting one or more of your claimed purchases and/or sales of MedPartners
stock herd on the indicated date(s). you must suoriit adequate =uppo*ing documentation for alr purchases and sales of
the security type covered by this seitlement. fnis inctuaes one or more of ihe following types of transactions:
(a) purchased Medpartners common stock, including through open-market transactions, mergers or
acquisitions in wrri"rr Medpartners l..ril "o**on stict< in'retuin for consideration during the period
from October 30, 1996, through January 7' 1998' inclusive;
(b) purchased call option conlracts. or "tto nu!ggliqn contracts on MedPartners common stock during the
period Octoner 30, igg6, through {"lY"y 7, 1999' inclusive;
(c) purchaseo rr,r"lp"ttnLii rriresnorinip*"Ltun Price securities ("TAPS") in the september 15, 1997
itiering orthereafterthrough January7, 1998;or .. . .:
(d) tendered -h;;. ;i i;trert ue"uillt MaL"gem"nt Holdings corporation to MedPartners between
August 20,1997, and September 19, 1997'
rf the Transaction Type indicated is a ,,Hording' you mu9! .ypTil documentation showing the quantity of MedPartners
stock held at ctose of trading on the transactioriaitelisteo ror that holding, An example of the requested documentation is
an account statement for tnE montir which shows your holdings in MedPartners stock during that month'
rf the transaction type indicated is ,,purchase,, or ,,sare," your supporting documentation must include the beneficial
owner/account name and the trade date, quantity and total dollar amount of each transaction'
Page 1 of2
I
DOCUMENT 3728
Transaction Price Error
Code "PPS" appears next to all transactions which are deficient for this reason.
The total transaction price for one or more transactions claimed in your submission does not fall within the known price
range of Medpartners "to.t
on that date and/or you did not provide the total transaction amount for one or more of the
transactions. you must submit adequate .rppotting documentation showing the trade date, quantity and total dollar
"rnount for all transactions in MedPartners stock which are indicated as deficient for this reason.
you may need to contact your broker, investment advisor or tax consultant for ass.istance in gathering the necessary
inlorr"tion. Acceptable dl"u*"nl* may include, but are not limited to, broker statements, clearing house blotters or
otfrer inOependent itrirA party verification and/or confirmation of the transactions'
No Declaration of Representative Form
ln addition, from our initial review, it appears lhat you failed to submit a Declaration of Representative form as required
under the terms of tre setilement Agreement. " ln filing your claim you have indicated that you are.acting in a
[pr"r.ntrtiue capacity for a class Mem-ber who is either: (i) i minor, (2) deceased, or (3) has been deemed by a court to
be incompetent. Representatives who are acting in !uc[i bapacity must complete a Declaration of Representative form
""riiving Gir status. tto toim was submittec r,iittr ttre class Member's claim. we have enclosed a copy of the correct
io-#toi youi convenience, Fillable pDF versions of the Declaration of Representative form are also available online at
the case website, www.aig-caremarkclqssaclibn'com
you must provide the information or documentation to the claims Administrator on or before october 26, 2017. lf you do
noiOo "o,'Vour
claim may be rejected. Please return the information, along wiih this letter, to:
A\G-Caramark Class ActionClaims Administratorc/o Gilardi & Co., LLC
Attn: Administrative ReviewP.O. Box 8040
San Rafael, CA 94912-8040
lf you have any questions about this letter or your claim, you can email the Claims Administrator at
[email protected] or call (415) 458-3605'
Sincerely,
Gilardi & Co., LLCAIG-Caremark Class Action Claims Administrator
Page 2 ol 2
I
Securitv Tvpe Transaction Date Transaction TYPe Number of Shares Transaction Price
adnersCommon
1 0i30/1 996 Purchase 4,000 $ 400,000.00 P
MedPartnersCommon Stock
0110711998 Ending Holding 4,000 NSTD
DOCUMENT 3728
A I G -Ca re m ark Class ActionClaims Administratorc/o Gilardi& Co., LLCP.O. Box 8040San Rafael, CA 94912-804041 5-458-3605
Date: October 6,2A17
Claim Number:CXK'fAccount Number:
Notice of DeficiencY
RE: AlG-Caremark Class Action Johnson v. Caremark Rx, LLC
Jefferson County (AL) Case No. 01-CV-2003-006630'00
Dear Claimant,
We have received and reviewed your claim and find it to be deficient for the reason(s) indicated below. Please refer to the
following for an explanation of each relevant deficiency and direction for resolution'
Shares Clqimed Are Not Balanced
This deficiency affects your entire claim and is not related to a specific transaction, Based on the transactions claimed in
your submission, your"claim appears to be.missing one or more purchases, sales, or holdings of MedPadners stock
irrring ih" relevani class period. The number of ihares which you claim to have purchased, sold and held does not
balance,
you must disclose and provide documentation for rhe nilmber of shares of MedPartners stock held at the close of trading
on the beginning and ending date for the relevant Class Period. The documentation must also include the date, number
of shares,-anC tlotal dottar airount of each transaction. You may need to contact your broker, investment advisor.or tax
consultant for assistance in gathering the necessary information. Acceptable documents may include, but are not limited
to, broker statements, clear"ing houle blotters or bther independent third party verification and/or confirmation of the
transactions.
you must provide the information or documentation to the Claims Administrator on or before october 26,2017. lf you do
not do so, your claim may be rejected. Please return the information, along with this letter, to:
A I G - C a re m ark C/ass ActionClaims Administratorc/o Gilardi & Co., LLC
Attn: Administrative ReviewP,O, Box 8040
San Rafael, CA 94912-8040
lf you have any questions about ihis letter or your claim, you can email the Claims Administrator at
[email protected] or call (415) 458-3605.
Sincerely,
Gilardi& Co., LLCAIG-Caremark Class Action Claims Administrator
Page 1 of 1
I
DOCUMENT 3728
AtG-Caremark Cl ass ActionClaims Administratorc/o Gilardi& Co., LLCP.O. Box 8040San Rafael, CA 94912-804041 5-458-3605 Date: October 6,2017
Claim Number:CXKJAccount Number:
Notice of DeficiencY
RE: A|G-Caremark Class Action Johnson v' Caremark Rx' LLC'- .f"tferson County (AL) Case No' 01-CV-2003-006630'00
Dear Claimant,
We have received and reviewed your claim and find it to be deficient for the reason(s) indicated below'
For transaction-specific issues, all relevant deficiency codes will appear in the last column of the table below labeled
,Deficiency code", next to """'h
tr"nr".tion provioeo' n givun transaetion may have more than one deficiency' Please
review the deficiency ""j" ."rr*n carefuily tb;;;firr ani'supporting Jo"u*"ntation which you submit will provide all of
the information required to validate your claim'
please refer to the following for an explanation of each relevant deficiency and direction for resolution
Shares Claimed Are Not Balanced
This deficiency affects your entire claim and is not related to a specific transaction' Based on the transactions claimed in
your submission, your'Jrit "pp"*"
to be.missing one or mo,." pu'"hut"t, sales, or holdings of MedPartners stock
during the relevant Cfass periJd. The numb", oi it't"t"t which you claim to have purchased' sold and held does not
balance.
you must disclose and provide documentation for the number of shares of MedParlners-siock held at the close of trading
on the beginning and ending date for the. relevant Ciari perioo. The documentation must also include the date' number
of shares, and total d"i; ;i.,;;;t of each transaction. You may need to contact your broker' investment advisor or tax
consultant for assistance in gathering the necessary intormation,' Acceptable documents may include, but are not limited
to, broker statements, clearing house blotteo oitti'"r independent itriro party verification andlor confirmation of the
transactions.
No Supporting Doiumentation for Transaclion{s)
code ,,NSTD" appears next to transactions which are deficient for this reason'
your craim did not incrude documentation supporting one or more of your craimed purgl3sry and/or sares of MedPartners
stock herd on the indicated date(s). you musi *uu,iit adequate "upporting
dolumentation for art purchases and sares of
the security type covered by this settlement. This includes one or more of the following types of transactions:
(a)purchasedMedPartnerscommonstock,includingthroughopen.markettransactions,mergersoracquisitions in \lvrri"rr Medpartners ir.uJ
"Lr*on stict< in-retuin for consideration during the period
from October 30, 1996, through January 7' 1998' inclusive;
(b) purchaseo cjrr optii,n coniracts or "tro
nut-oriii"l !:lL:*" on MedPadners common stock during the
berioO Octoner gO, 1g90, through January 7' 1998' inclusive;
(c) purchased rr,r"op"rt.Lii lriesrrorilfip*"Llion Price securities ("TAPs") in the september 15, 1997
idering or thereafter through January. 7, 1998; or
(d) tendered ,n"i". "i iirbert Medi;l ut"n"g"*"nt Holdings corporation to MedPartners between
nugust 2A,1997, and September 19, 1997'
Page 1 of 2
I
DOCUMENT 3728
lf the Transaction Type indicated is a "Holding" you must *!pTil documentation showing the quantity of MedPartners
stock held at close of traolng-on the transaction"date listed for that holding. An example of the requested documentation is
,n a".ount statement for ifr6 month which shows your holdings in MedPartners stock during that month'
lf the transaction type indicated is "purchase" or "Sale," your supporting documentation must include the beneficial
owner/accounl name and the trade date, quantity and total dollar amount of each transaction.
Securitv Tvpe Transaction Date Transaction TYPe Number of Shares n e
MadPartnersTAPS 12t3111997 Purchase 59
MedPartnersCommon Stock
1 0/3011 996 Beginning Holding 59
MedPartnersCommon Stock
12t3111997 Purchase 59 $ 1,320.42
MadPadnersTAPS a1n7n998 --Ending Holding 59
MedPaftnersCommon Stock
vn7h998 Ending Holding 59
you may need to contact your broker, investment advisor or tax consultant for assistance in gathering the necessary
iniorrution. Acceptable d6cuments may include, but are not limited to, broker statements, clearing house blotters or
oif,r"l inJ"p"ndent third party verification and/or confirmation of the transactions.
you must provide the information or documentation to the claims Administrator on or before october 26, 2o17.lf you do
noi Oo .o,'your claim may be rejected. Please return the information, along with this letter' to:
Al G-Caremark Class ActionClaims Administratorc/o Gilardi& Co., LLC
Attn: Administrative ReviewP.O. Box 8040
San Rafael, CA 94912-8040
lf you have any questions about this letter or your claim, you can email the Claims Administrator at
[email protected] or call (41 5) 458-3605'
Sincerely,
Gilardi & Co., LLCAIG-Caremark Class Action Claims Administrator
Page2 of 2
I
DOCUMENT 3728
A I G -Ca re m ark C/ass Acti onClaims Administratorc/o Gilardi& Co., LLCP.O. Box 8040San Rafael, CA 94912-80404'15-458-3605
Date: October 6,2017
Claim Number:CXK'!Account Number:
Notice of DeficiencY
RE: A|G-Caremark Class Action Johnson v' Caremark Rx, LLC
Jefferson County (AL) Case No. 01-CV-2003-006630'00
Dear Claimant,
We have received and reviewed your claim and find ii to be deficient for the reason(s) indicated below'
For transaction-specific issues, all relevant deficiency codes will appear in the last column of the table below, labeled
,,Deficiency code,,, next to """'h
tr"n.".tion provided. n giuen transaction may have more than one deficiency' Please
review the deficiency .oo" "olumn
carefully to "ontirm
an"y supporting documentaiion which you submit will provide all of
the information required to validate your claim'
please refer to the following for an explanation of each relevant deficiency and direction for resolution'
Shares Claimed Are Not Balanced
This deficiency affects your entire claim and is not related to a specific transaction, Based on the transactions claimed in
your submission, your'c-l;il;bp"{; to be.missing one or more purchases, sales, or holdings of MedPartners stock
during the relevant cra.s periii. The number of ihares which you claim io have purchased, sold and held does not
balance,
you must disclose and provide documentation for the number of shares of MedPartners stock held at the close of trading
on the beginning and ending date for the relevant ilass Period. The documentation must also include the date, number
of shares, and total ootiai a"mount of each transaction. You may need to contact your broker, investment advisor or tax
consultant for assistance in gathering tne necessary intormation." Acceptable documents may include, but are not limited
to, broker statements, "l"u;;s houie blotteo oi tt'"l. independent itriro party verification andlor confirmation of the
transactions.
Transaction Price Error
code ,,PPS" appears next to all transactions which are deficient for this reason'
The total transaction price for one or more transactions claimed in your submission does not fall within the known price
range of Medpaftners ;b.k-"n that date "noioivou
Jia not provide the total transaction amount for one or more of the
transactions. you must submit adequate rrpp.irting Jocumentation showing the trade date, quantity and total dollar
"rount for all transactions in MedPadners stock which are indicated as deficient for this reason'
No Supportinq Documentation for Transaction{s)
code ,,NSTD" appears nexi to transactions which are deficient for this reason'
your claim did not include documeniation supporling one or more of your claimed purchases and/or sales of MedPadners
stock held on the indicated date(s). you musi sunriit adequate supforting- do-cumentation for all purchases and sales of
the security type coverJ ovi[ir I6ttr"ment, This includes one or more of the following types of transactions:
Page 1 of 2
I
DOCUMENT 3728
(a) purchased Medpartners common stock, including through open-market transactions, mergers or
acquisitions in wtrictr Medpartners issued common stock in return for consideration during the period
from October 30, 1996, through January 7, 1g98, inclusive;
(b) purchased call option contracts or rold'put option contracts on MedPartners common stock during the
i*ribO O"toner 30, 1996, through Ja1yary 7' 1999, inclusive;
i"1 purct,rs"a ur"irp"*n'"rs Thieshold Appreciation Price securities ("TAPS")in the september 15, 1997
ofiering or thereafter through January 7, 1998; or(d) teridered shares of titUert Me'dical Management Holdings Corporation to MedPartners between
August 20,1997, and September 19, 1997,
lf the Transaction Type indicated is a "Holding" you must supmi! documentation showing the quantity.of MedPartners
stock held at close oi traling ;n the transaction"date listed for that holding, An example of the requested documentaiion is
an account statement for th6 month which shows your holdings in MedPartners stock during that month.
lf the transaction type indicated is "purchase" or "Sale," your supporting documentation must include the beneficial
owner/account name and ihe trade date, quantity and total dollar amount of each transaction.
you may need to contact your broker, investment advisor or tax consultant for assistance in gathering the necessary
iniorr"tion. Acceptable dlcumentr may include, but are not limited to, broker statements, clearing house blotters or
oif.r"l inJ"p"ndent ihird party verification and/or confirmation of the transactions,
you must provide the information or documentation to the claims Administrator ol o.r before october 26, 2o17 ' lf you do
not do so,'your claim may be rejected. Please return the information, along with this letter, to:
A I G -C are m ark Class ActionClaims Administratorcio Gilardi & Co., LLC
Attn: Administrative ReviewP,O. Box 8040
San Rafael, CA 94912-8040
lf you have any questions about this letter or your claim, you can email the Claims Administrator at
[email protected] or call (41 5) 458-3605'
Sincerely,
Gilardi & Co., LLCAIG-Caremark Class Action Claims Administrator
Page 2 of 2
SecuriW Tvpe Transaction Date Transaction TYPe Number of Shares Transaction Price
MedParlnersCommon Stock
10/30/'1396 Beginning Holding 771
MedPartnersCommon Siock
11l01/'19e6 Purchase 14 $ 254.38
MedPartnersCommon Stock
1111511996 Purchase 14 $ 251.44 PPS,
MedPartnersCommon Stock
11t2911996 Purchase 14 $ 263.10 S,
MedPartnersCommon Stock
1211311996 Purchase 14 PPS,
Stock1212711996 Purchase 14 PPS,
MedPartnersCommon Stock
01ta7fi9s8 Ending Holding 1,247 NSTD
I
DOCUMENT 3728
Al G-Carem ark CI ass ActionClaims Administratorc/o Gilardi& Co., LLCP.O. Box 8040San Rafael, CA 94912-B040415-458-3605
Date: October 6,2017
Claim Number:CXK'[Account Number:
Notice of DeficiencY
RE: AiG-Caremark Class Action Johnson v. Caremark Rx, LLC
Jefferson County (AL) Case No. 01-CV-2003-006630'00
Dear Claimant,
We have received and reviewed your claim and find it to be deficient for the reason(s) indicated below
For transaction-specific issues, all relevant deficiency codes will appear in the last column of the table below, labeled
,,Deficiency code,,, next to eac'h transaction provided. A given transaction may have more than one deficiency' Please
review the deficiencv "od" "orurnn
carefully tb;;firm an-y supporting documentation which you submit will provide all of
the information required to validate your claim'
please refer to the following for an explanation of each relevant deficiency and direction for resolution'
Shares Claimed Are Not Balanced
This deficiency affects your entire claim and is not related to a specific transaction. Based on the transactions claimed in
your submission, your'"f"i* "pp"1 to be.missing one or.more purchases, sales, or holdings of MedPartners stock
during the relevant crass Feri6d. The numuei oi Jh"t"" which you claim to have purchased, sold and held does not
balance.
you must disclose and provide documentation for the number of shares of MedPartners stock held at the close of trading
on the beginning and ending date for the relevant ctass perioo. The documentation must also include the date, number
of shares, and total ootiai a"mount of each transaction. You may need to contact your broker, investment advisor or tax
consultant for assistance in gathering tne necessary lnrormation.' Acceptable docume.nts may include, but are not limited
to, broker statements, clearing house blotter" oi i*r"r independent thiro paty verification and/or confirmation of the
transactions.
Transaction Price Error
code "PPS" appears next to all transactions which are deficient for this reason'
The total transaction price for one or more transactions claimed in your submission does not fall within the known price
range of Medpaftners lio"t on that date "naloivou
oid not provide the total transaction amount for one or more of the
transactions. you must submit adequate ""pp,i'ting
Jocumentation showing the trade date, quantity and total dollar
"**nt for all transactions in MedPadners stock which are indicated as deficient for this reason'
No Supporting Documentation for Transaction(s)
code ',NSTD" appears next to transactions which are deficient for this reason'
your claim did not include documentation suppoding one ot more of your claimed purchases and/or sales of MedPartners
stock held on the inoi.ut"J 0"i"1*1. Vou must sutrriit adequate supporting documentation for all purchases and sales of
the security type covered by this settlement. This includes one or more of ihe following types of transactions:
Page 1 of2
I
DOCUMENT 3728
(a) purchased MedPartners common stock, including through open-market .transactions, mergers or
icquisitions in which MedPadners issued common stock in return for consideration during the period
from October 30, 1996, through January 7, 1gg8' inclusive;(b) purchased call option coniracts or sold put option contracts on MedPartners common stock during the
period October 30, 1996, through January 7, 1998, inclusive;
ic) purchased MedPartners Threshold Appreciation Price Securities ("TAPS") in the September 15, 1997
offering orthereafterthrough January 7, 1998; or(d) teridered shares of Talbert Medical Management Holdings Corporation to MedPartners between
August 20,1997, and September 19, 1997,
lf the Transaction Type indicated is a "Holding" you must submit documentation showing the quantity of MedPartners
stock held at close of trading on the transactiondate listed for that holding. An example of the requested documentation is
an account statement for the month which shows your holdings in MedPartners stock during that month.
lf the transaction type indicated is "Purchase" or "Sale," your suppotling documentation must include the beneficial
owner/account name and the trade date, quantity and total dollar amount of each transaction.
you may need to contact your broker, investment advisor or tax consultant for assistance in gathering the necessary
informatlon. Acceptable documents may include, but are not limited to, broker statements, clearing house blotters or
other independent third party verification andlor confirmation of the transactions.
l..lo Declaration. of Representative Form
ln addition, from our initial review, it appears that you failed to submit a Declaraiion of Representative form as required
under the terms of the Setflement Agreement. ln filing your claim you have indicated that you are acting in arepresentative capacity for a Class Member who is either: (1) a minor, (2) deceased, or {3) has been deemed by a coutt to
be incompetent. 'Repiesentatives
who are acting in such a capacity must complete a Declaration of Representative form
verifying iheir status. No form was submitted with the Class Member's claim. We have enclosed a copy of the correct
forrnfoiyourconvenience. Fillable PDF versions of the Declaration of Representative form are also available online at
the case website, www.aiq-caremarkclassaction.com'
you must provide the information or documentation to the Claims Administrator on or before October 26, 2017. lf you do
not do so, your claim may be rejected. Please return the information, along with this lelter, to:
A t G -C are m ark C/ass Actio nClaims Administratorc/o Gilardi& Co,, LLC
Attn: Administrative ReviewP.O. Box 8040
San Rafael, CA S4912-B040
lf you have any questions about this letter or your claim, you can email the Claims Administrator at
[email protected] or call (41 5) 458-3605'
Sincerely,
Gilardi & Co., LLCAIG-Caremark Class Action Claims Administrator
Page 2 of 2
I
Securitv Tvpe Transaction Date Transaction Tvne Number of Shares Transaction Price Deficiency Gode
Common10/30/1 996 Beginning Holding 3,000 NSTD
MedPadnersCommon Stock
12t23t1996 Purchase 3,000 $ 81,000.00 PPS, NSTD
MedPartnersCommon Stock
01105/'1998 Sale 3,000 $ 0.00 PPS, NSTD
DOCUMENT 3728
A I G -C a re m ark Ciass Acti o nClaims Administratorc/o Gilardi & Co., LLCP.O, Box 8040San Rafael, CA 94912-804041 5-458-3605
Date: October 6,2017
Crarm Numoer: Cnr[Account Number:
Notice of Deficiency
RE: A|G-Caremark Class Action Johnson v, Caremark Rx, LLCJefferson County (AL) Case No. 01-CV-2003-006630,00
Dear Claimant,
We have received and reviewed your claim and find it to be deficient for the following reason. From our initial review, it
appears that you failed to submii a Declaration of Representative form as required under the terms of the SettlementAgreement.
ln filing your claim you have indicated that you are acting in a representative capacity for a Class Member who is either:(1) a minor, (2) deceased, or (3) has been deemed by a coutt to be incompetent. Representatives who are acting in such
a capacity must complete a Declaration of Representative form verifying their status. No form was submitted with the
Class Member's claim. We have enclosed a copy of the correct form for your convenience. Fillable PDF versions of the
Declaration of Representative form are also available online at the case website, www.aig-caremarkclassaction.com,
Please complete the form and return it, along with this letter, to the Claims Administrator at the address listed below.
A, I G -C arem ark C/ass Actio nClaims Administratorclo Gilardi & Co., LLC
Attn: Administrative ReviewP.O. Box 8040
San Rafael, CA 94912-8040
Forms must be postmarked no later than October 26,2O17. The failure to complete and return the form will result in the
denial of your claim.
lf you have any questions about this letter or your claim, you can email the Claims Administrator [email protected] or call (41 5) 458-3605.
Sincerely,
Gilardi& Co,, LLCAIG-Caremark Class Action Claims Administrator
Page 1 of 1
I
DOCUMENT 3728
A I G -Ca re m ark C/ass Actio nClaims Administratorc/o Gilardi & Co., LLCP.O. Box 8040San Rafael, CA 94912-804041 5-458-3605
Date: October 6,2417
Crarm irumoer, C,.,^fAccount Number:
Notice of Deficiency
RE: A|G-Caremark Class Action Johnson v. Caremark Rx, LLCJefferson County (AL) Case No. 01-CV-2003-006630'00
Dear Claimant,
We have received and reviewed your claim and find it to be deficient for the following reason. From our initial review, it
appears that you failed to submii a Declaration of Represeniative form as required under the terms of the Settlement
Agreement.
ln filing your claim you have indicated that you are acting in a representative capacity for a Class Member who is either:
(t) a riinor, (2) deceased, or (3) has been d'eemed by a coutt to be incompetent. Representatives who are acting in such
a capacity'must complete a beclaration of Representative form verifying their status. No form was submitted with the
Class Member's claim. We have enclosed a copy of the correct form for your convenience. Fillable PDF versions of the
Declaration of Representative form are also available online at the case website, www,aig-caremarkclassqction.com.
please complete the form and return it, along with this lettel to the Claims Administrator at the address listed below'
A I G - C a re m ark C/ass ActionClaims Administratorc/o Gilardi& Co., LLC
Attn: Administrative ReviewP.O. Box 8040
San Rafael, CA 94912'8040
Forms musi be postmarked no later than Octobe r 26, 2017. The failure to complete and return the form will result in the
denial of your claim.
lf you have any questions about this leiter or your claim, you can email the Claims Administrator at
info@aig-caremarkclassaction,com or call (41 5) 458-3605'
Sincerely,
Gilardi& Co., LLCAIG-Caremark Class Action Claims Administrator
Page 1 of 1
I
DOCUMENT 3728
EXHIBIT B
DOCUMENT 3728
EXHIBIT B - L
"Timely Eligible Claims"
DOCUMENT 3728
Exhiblt B-1 - Timely Eligible Claims
Claim No. Status Recognized Loss
MedPartners
Class ActionDistribution
(if applicable)
$ l-63,s3
$ oo,es
$ ror.+o
5 s0.88
$ 23.06
s 110,36
$ tg,+oz,og
s 86s.77
S ss.zs
5 szt.zc
s 35,041.11
$ so,zoa,zo
100016-0
100017-9
100020-9
100045-4
100088-8
100133-7
100180-9
100181-7
100182-5
100183-3
100184-1
100185-0
100258-9
100266-0
toa322-4100334-8
100335-6
100362-3
100481-6
100523-s100537-5
100595-2
L00600-2
100605-3
10L467-6
101468-4
1AL469-2
701,477-3
rat486-2101498-6
LOl-499-4
101505-2
L015L3-3
10r5r4-1.101533-8
L01804-3
101805-1
101986-4
10\987-2102069-2
1A?l.42-7
102209-1"
IO223s-O
$ s,zgz.oo
$ 1,961.00
$ 3,345,00
$ t,o+s,oo
$ z+s.e s
5 3,568.00
S 629,228.90
$ 27,991.35
$ 1,156.70
S lo,goz.oo
5 'J,,132,91-4.45
s 1,817,268,00
s 29L,eo
S 348.e0
$ 37,451.55
5 s2o.2o
$ ss4.oo
$ 2,086.00
$ 5,goz.oo
S tzs.qa
5 3",227.00
5 z+s.os
$ 7,925.00
$ sqs.oo
s e44.00
s 1,9+o.oo
s L,340.00
S 226.00
S s,sog.oo
s 16L.00
$ t,oot.oo$ tss,Sot.oo
$ 1,120.00
$ z.os
$ rsz.ss
S 1,398.90
$ +za,ts
$ oo.:o
$ og,oo
$ 3,got,oo
$ ro:.oo$ s,goz.ao
$ ssg.zo
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
r0,79
1,158.38
16.09
17.14
64.s2
179.61
22.44
37.95
23.1.4
245.72
16.98
29.20
4t.454t,45
$
s
$
s
s
$
$
s
$
$
s
s
$
$
$
(
s
$
$
$
t72.22
32.82
4,820.79
34,64
43.27
13.0L
103.96
11.23
1.81.34
30.61
$
$
$
$
Page 1 of 58
DOCUMENT 3728
Claim No.
102240-7
!02288-L102343-8
!o2349-7LO24Z9-9
L02439-6
7A2475-2
1A2479-5
102480-9
1,02481-7
102521-0
1A2fi9-2tozs4t-4102547-3
102553-8
102563-5
rc2574-O
102596-1
toz604-6LO26t2-7
102624-O
1.02628=3
102680-1
102690-9
ta27t3-1.to2731-O
!02776-0LO2797-2
102823-5
102840-5
102863-4
102892-8
3.02898-7
1.0297L-8
LA2916-9
to2947-93.02965-7
103025-6
LO3026-4
103029-9
1A3rc7-4ra3Lfi-3.to3t4s-7
Status Recognized Loss
Exhibit B-1. - Tirhely Eligible Claims
MedPartnersClass ActionDisUibution
(if applicable)
$ 6s,s1
$ roo.saValid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Vatid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
138.00
3,446.00
300.90
2,449,OO
2,186.006,422,00
I,467,OA
42.60
16.95
423.4s
6,569.00
2,O4B.AO
164.85
4,248.407I,828.00
1,130,00
83.3s
2,689.00665,505.00
165,30
11,650,00
8,139.00179.25
6,360.00
109.80
538.35
1,934.00
2,365.00
352.65
788.00
L,122.A4
1,621.00
217,6s
90.90
7,749.OO
1,582.00
3,57,\24.40
858.00
34,897.95
2,558,00
2,234,40
180.00
242.40
75,75
67.6L
198.63
45.37
13,10
203.18
63.34
131,39
36s.8434.95
83.17
20,584.11
360,34
251.74
L96.72
16,65
59.82
73.15
10.91
24,37
34,70
50.14
239.68
48.93
4,674.2726,54
r,o79.4479.12
69.11
s
$
$
$
s
s
$
$
$C
$
$
s
s
$
$
s
$
s
)5
s
s
$
s
$
$
$
5
Page 2 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistrlbution
(if applicable)
103149-0
1031s6-2
103151-9
103165-1
LA3fi3-2103190-2
103198-8
1A3212-7
103232-t!03247-O
103260-7
103263-1
103291.-7
103292-s
103306-9
70na7-7103308-5
103348-4
103391-3
7034fi-A1A3572-O
103591-6
103592-4
1A3625-4
to3642-4t03643-2103711--0
ro37t7-oro37t9-6103739-0
103766-8
1A3774-9
103792-7
103929-6
10393s-0
103956-3
103970-9
103975-0
103997-0104009-0
to4046-4104055-3
ta4073-1
3!2.407,812.00 s
94.80
L,LL3.OO $1",922".A0 $
275.55
7,158,00 s
206.74
16,842.00 $
2,973.AA s267.LA
e37.60 s
4,570.00 $
1,837.50 $197.30
143.!s65.30
2,219.50 s
!,a47.15 $
683.00 s487.9s $
9,381,00 5
1,422.00 s
2,9a7,o0 s462.s0 5
1,135.00 $
1,584,00 s246.45
r77.L53,547.AA st,7t4.oa $
11,153.00 s2,902.OA s4,852.20 $
1,L04.00 $108,594.00 s
341.80 $
15.60
fi7.s4936.90 $
9,169,12 se13.3s $
900.00 $
68,55
32.39
2t.1315.09
290.15
43.98
89.91
14.3,2
35.14
48.99
109.71
53.01
344.96
89.76
150.08
34.15
3,358.82
10.57
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
)$(
s
$
s
$
s(
s
$
$
$
$
s
ss
s
s
s
s
5
$
)$(
s
$
$
s
$
$
s
$
$
$
$
s
$
ss
s(
241.63
37.52
s9.45
221,.44
52A.92
91.96
29.00
L4r,35s47.04
28.98
2,699.80
28.25
27.84
Page 3 of 58
DOCUMENT 3728
CIaim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
{if applicable)
$ z+r,sE].a4087-2
1A4A97-9
LA4UA-3
104179-7
L04204-t7A4210-6
t04zL3-O
104251-3
].a4262-9
r04263-7
104287-4
104306-4
104315-3
104345-5
ta4370-6104371-4
104381-1
104388-9
104394-3
1o4423-O
ro4429-O
la4444-3t04445-rro4466-4ta4492-3!04493-L104508-3
104509-1
104513-0
104522-9
L04552-O
104582-2
104665-9
104690-0
104706-0704717-s
t04720-5to4740-a104749-3
104759-0
104772-8
104793-0
104822-8
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
ValidValid
7,8t2.04L87.35
50,793.00332.55
1,647,45
172.5A
5,502.0024.64
1,128.00
1",231.00
22.65
498.30
7,735.00130.9s
245.85
1",627,04
5,512.50
3,474.04
5,431.00
3.,A79.65
2,tL9.OO
8,374,O0
11,469.00
3,121.00
1,102,65
8,959.00
3,737.O0
4,521,041.24.95
4,429.O0
2,692.OO
52.05
57,767.70
2,658.00
L5,691.00
914.5s
8,689,00
10,079.00
250.00
271,74
755,00
M7.0485.20
7,577.O3
10.29
50.96
17a.t8
34.89
38.07
1"5.41
239.24
s
s
s
s
$
5
))$
s
$
s
s
$
s
$
$
$
s
$
$
s
s
$
s
s
$
$
$
$
s
$
5
s
s
s
s
)$
$(
$
$
5
$
$
s
$
$(
s
$
s
$
)$(
$
$
$
$
s
$
$
$
s
$
$
s
s
$
50.32
3",623,t3
1o7.45
1,893.58
33.39
65.54
259.01
3s4.7496,53
34.tr277.1,0
97.03
139,83
$
136.99
83.26
1,786.76
82,21
48s.32
78.29
268.75
311..74
Page 4 of 58
23.35
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDisftibution
(if applicable)
$ 4,001".33t0482s-2104856-0
104898-8
104926-7
LA4932-L
104951-8
104957-7
104e63-1
104967-4
704974-4
104988-7
7A4992-5
105019-2
105095-8
L05165-2
105186-5
105243-8
705262-4
LA5275-6
1a5326-4
10s354-0
105370-1
105384-1
105477-1
10542L-O
ta55t2-7!a5527-s105543-7
105544-5105545-3
105689-L
105690-5
105691-3
to57t7-o10s775-8
1A5787-t
105789-8
105811-8
1"0582s-8
105826-6
10s911-4105955-3
1.05980-7
s 129,367.00
$ 2s6.80
5 aos.oo
s 3ss,s0
s 3,497.00
$ 32,403.50
$ 2,443.00
$ 211,086,55
$ g,o+g.oo
S 1,625.00
$ rsg,ss
$ 3,725,00
$ o,ggo.oz
s 13,835.00
$ 2,097,30
S 4,L17.a0
s 6,482.00
s 7s,00
$ t,ztg.3s$ ssg,+o
$ t,t4g.oo$ 3,666,00
S 1,649.00
s 121-,0s
s 6,180.00
5 ns.7aS 8s6.so
S 68,238,50
$ ssa,so
5 4,252.00
S 11,446.00
$ 5,o3o.oo
5 7,737.oo
$ 9,219.30
5 2,77L,A4
$ 2,sos.oo
5 tog,sgo.+o
5 tze.zs$ ga,tzq.to
$ 26,486.70
$ zo6,gaa.oo
5 r+g.ss
$ s1s.60
26.75' 11.00
108.16
LAlZ,2475.56
6,528.92
94,31.
50.26
Lls.2t2,A28.9L
427.92
64,87
L27.34
200.49
37.71
16.68
35,54
113.39
51.00
191.15
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
26,49
2,L10.62
26.57
L31.51
354.03
155.58
239.3L
285.15
85.77
77.48
3,389,6422,52
2,682,38
819.24
6,400.60
s
s
s
)$
$
s
$
(
s
s
$(
$
$
$
$
$
s
$
s
s
s
$
$
$
$
s(
$
s
s
s
s
$
$
Page 5 of 58
15,95
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
$ 12e,6s105982-3
105990-4
106023-6
106032-5
106033-3
106035-0
106036-8
106043-0
105048-1
106050-3
L06052-0
106056-2
105064-3
106066-0
106067-8
106073-2
106108-9
106149-6
106155-0
106273-5
106334-0
106391-0
106443-6LO6444-4
106445-2
xo6446-0
to6447-91A6448-7
L06450-9
106451-7
LA6452-5
106482-7
106s09-2
10651s-7
106s80-7
106586-6
106592-0
106626-9
1a6677-3106688-9
106705-21067s3-2106758-3
s 4,191.85
S qe .so
$ 76,157.90
5 tqg,oes.oo
$ 14,429,068,80
s 30,458.70
$ 29,733,30
s 2os.6s
s 24,944.00
S 12,459.00
s 5,055.60
S 1,237,156.00
$ z,lsz,787.aa
S 164,125.00
$ 1,259.90
$ 269.8s
$ s,1J":.oo
$ 419,00
s 828,832.00
$ 2,438,00
S 12e.oo
$ 2,L49.75
S 4ee.oo
s 4ee.oo
$ ags,oo
$ 748.00
$ 2,038.00
$ z,ogg,oo
S t,t7g.oo$ 1,178.00
S t, tzg.oo
$ 6,051,00
5 gso.oo
S 32s.50
s 130.20
$ 56,370.00
$ s,z2g,oo
$ 3,339.00
5 774.1s
s 7,4r2,0o
$ e26,00
$ +,gzg.oo
S 2,063,00
2,355.57
4,442,64
446,29!,88
942.09
919.65
77L.52
38s,36
ts6.3738,255,30
116,073.90
5,O76.40
38.97
158,15
L2.96
25,635.82
75,41
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
vaiio
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
66.49
L5.43
15.43
15,43
23.14
63.04
63.04
36,44
36.44
36.44
t87.1.6
29,38
10,o7
s
s
$
s
s
s
s
$
s
s
$
s
$
s
$
S
s
s
$
5
$
5
s
$
s
s
)$
$
$
$
$
$
$
$
$
$
r,743.53L77.17
103.28
23.94
229.25
28.64
149.36
63.81
Page 6 of 58
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No. Status Recognized loss
MedPartners
Class ActionDistribution
(if applicable)
s 47.tL
5 402.06
$ 176,30
$ 71.,76
5 2s.8s
$ rs.sz
2L6.tL
44.91
33.47
37.83
169.56
29.04
56,26
3,488.29
204.08
23,79
696.33
101,88
4L8.6780.85
97.06
1,623.1.3
32.64
L7.33
1.62.63
96.16
50.63
188.55
70.49
462.50
241.63
47.42
106775-3
106797-4
106815-6
106816-4
106835-0
to6837-7106844-0
106944-6
106958-6
106959-4
106960-8
106961-6
106962-4
t_06963-2
107007-0
107015-0
107016-9
107762-9
1A7L9t-2fi7206-4!47247-2107272-Z
LO7288-9
ta7294-31.O7298-6
1-07301-0
t07323-0r07342-7
LO7476-4
1A74fi-2t07427-A147450-4
107530-6
107550-0
L07555-1
107558-6
LO7575-6
107587-O
107603-5
1o7607-8
1o7612-4L07627-2
rc7629-9
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
s
$
$
$
$
s
s
s
$
ss
$
$
s
s
s
s
$
s
s
s
s)s
s
$
s
s
s
)$
s
$
s
s
s
s
s
$
5
s
s
1,523,00
12,999.00
5,700.00
2,320,04835.65
503.25
152,L0
6,987.0069,00
253.50
250,50
85.05
L,452.O4
1,082,00
L223,AO5,482.00
939.00
1,818.90
tLz,780.446,598.00
769.00
22,512.95
3,294.00
L3,534.00
2,6t4.00258.00
3,1-38.00
5,512,501,053.90
560.40
5,258.00
3,109.00
7,637.AO
6,096.00
2,279.00
14,953.007,812.00
148.50
231.80
1,533.00
6s.00
6.40
3,536.00
$
s
$
$
$
s
$
$
s
$
s
s
$
$
$
s
s
s
$
s
$
$
$
s(
$
s
Pase 7 of 58
!o9.37
DOCUMENT 3728
Claim No. Status Recognized loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable!
107680-9
to7681.-7
r47723-6ffi7796-1107993-0
r47994-8108030-0
108036-9
108038-s108039-3
108040-7
108048-2
108049-0
1080s1-2
108102-0
108208-6
7082t4-0108218-3
108248-5
108269-8
L08278-7
108284-I108315-5
108334-L
L08377-5108523-9
108533-6
to8577-8108583-2
108s88-3
t08677-4to8678-2108579-0
108686-3
148793-2
108892-0
108930-7
108954-4
L08988-9
108990-0
109005-4
109009-7
109011-9
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
S rrr.ss$ 438,1s $
$ g,sgg.zs S
s 254,692.00 s
s L43,619.00 ss 43.es
$ 4,081.00 S
s 3,333.00 $
S t,7o6.oo S
5 1,7L2.OO $$ 1,718.00 s
$ s7o.oo s
s 2,517.00 s$ 3,232.00 s
$ 4,586,00 $
S 2,614.4s S
s 1,755.00 $
s 14,905.50 s
$ zs,ggt.oo $
$ 36,160.50 S
s 1,321.00 $
$ 42o.oo s
$ 5,002.00 s
$ 13,551.00 s
S tt,loz.qo S
s 5,527.OO s$ 5,333,00 s
s 89,530.00 s
$ 747,067.00 $
$ L27,674.5O $
s L2.30
$ 8,864.00 s
$ Ea.zo
s 693,A77,10 s
s tt,z7a.oo $
s 1,361,604.L0 s
$ ssr,rs $
$ 14,833.00 $
$ 9,7G1.00 S
s es4,7s 5
s 38,874.OA s
S 5,147.00 $
S 40,74735 S
13.55
111.00
7,877,644,442.14
126,23
103.09
52.77
52.95
53.14
26.9t77.8s
99.97
L44.94
80.87
54.28
46L.43
803.90
1,118.45
40,8612.99
154.71
419.13
423.82
170.95
164.95
2,769.17
4,548.79
3,948.98
274,16
21,436.91
348,5842,3,L4.49
29.42
458.79
301,91
29.53
L8,453.8L
159.20'J.,26A,3!
Page 8 of58
DOCUMENT 3728
Exhibit B-t - Timely Eligible Claims
Claim No. Status Recognized Loss
MedPartnersClass ActionDistribution
(if applicable)
s 18e.82
$ L8e.eo
$ 17s.22
$ 2s7.62
$ e7.8e
$ 21.s8
$ 120.69
56.51
3s.32
39.65
24L.63
l's.24t2.5999.38
119.67
94.62
87.78
62.42
484.89
26,54
12.54
70.7469.44
35.23
118.68
1,67.61
49.80
164.55
51.19'
109015-1
109041-0
109254-5
ro9279-0109282-0
109288-0
109338-0
L09342-8
109364-9
109380-0
109402-5
1_094L3-0
109420-3
L09429-7
109436-0
10944s-9
10g449-t109455-6
1a9462-9
1a9472-6
tog480-7109481-5
109485-8
1_09490-4
109538-2
109540-4
109550-1
109616-8109632-0
L09634-6
109637-0
109638-9
109643-5
109651_-6
109656-7
109683-4
109692-3
1-09739-3
109745-8
LO9748-2
109888-8
1_09889-6
1-09903-5
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
6,137.0O
6,139,50
5,665.008,329.00
3,165,00
710,55
3,902.00
99.00
1,827.OO
L,742.00
187.05
42.20
72.04
13.95
66^75
1L9.60
51,90
!21.20199.20
L,282,00
7,812.04492,80
4A7.20
3,2J.3.00
3,869.00
3,059.00
93.00
2,838.003.35
265.20
2,017,95
15,677.00
858.00
404.25
2,287.00
2,245.44
1,139.00
3,837.00
5,41-9.00
t92.AA
1,510.00
5,320.00
1,655.00
(s
$
s
$
$
s
s
$
$
s
$
$
$(
$
s
s
$
s
$
$
$
$
s
s
$
$
$
s
s
s
s(
)$
$
s
s
$
$
$
$
s
s
$
$
$
$
)5
$
s
$
s
$
$
$
$
s
s
s
$
s
$
Paee 9 of 58
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No. Status Recognized Loss
MedPartnersClass ActionDistribution
(if applicable)
s 44.es
$ 1s0.64
$ \3,777.64
5 14,212.98
$ s99,497.t4
$ 56,225.74
$ tsz,oq
$ 9,657,47
5 1:,a,74
5 2,636.79
5 373.32
s 1,893.58
s 7,622.98
S t,6zz.gg
$ 2,318.75
109906-0
109913-2
109917-5
109918-3
109932-9
109933-7
109947-7
109953-1
110230-3
1,to23r-r110247-81-10519-1
110566-3
110s70-1110657-0
110733-0
110789-5
110795-0
110797-6
3,ro798-4
110829-8
7ra844-t110863-8
110896-4r1a897-2110940-5
110950-2
110986-3
110988-0
111059-4
13"L077-2
11.1087-A
111101-9
111104-3
1111L5-9
111"1_19-1
rl7t67-3.1 11168-0
LLL194-917L195-7
ttt314-3111392-5
1L1394-L
$ t,Asg.zs
S 4,870.50
s 445,445.00
$ 459,520.00
s L9,382,350.25
S 1,817,835.30
5 25,284,25
$ 312,235,80
$ 4,227.OA
S 85,250,00
S Lzat.sT$ 6,431.00
$ 5,512,00
S 5,512.00
$ 7,875.00
S zss.oo
$ 104,00
5 34,334.00
$ 7,132.00
s 4,619,00
$ 213.00
s 437.OO
s s21.70
$ 3,411.00
$ g,zzo.oo
S 11,878,00
s L,257.OO
S 4,647,444.os
$ 149.60
$ 7,158.00
s 9,219.00
$ 3,299.00
$ 282.00
S 2,225.0a
$ 11,051.00
s 108,321.00
S s62.ss
$ gze .oo
$ 153,445,00
$ 6,826,00
5 24,792.00
S 30,248.00
$ 3s6.70
1,061,95
224.59
r42.87
13.52
1.6.1.4
105.50
99,59
367.39
38.88
L43,745.70
221,,40
285,14
toz.o4
68.82
341.81
3,350,37
!7.4028.64
4,746.09
zLl.t3766.82
935,57
11.03
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
s
$
s
s
$
$
s
$
s
$
)$
s
$
$
$
)(
s(
s
$
Paee 10 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
$ 11.03
$ 11.1s
s 11.1s
$ 12!,445.44
111395-0
111396-8
11"1397-6
111453-0
1l-1508-1
111509-0
111548-0
L1L603-7
7t1643-5711,647-9
17t673-8L7\678-9t1,7682-7
111685-1
111700-9
1l7707-6tt1766-1L1,1776-9
111793-9
111805-6
111809-9
11,1810-2
1l_1833-1
111850-1
111853-6
111859-5
!t1"861,-7
t11876-5111.899-4
1,11970-2
111990-7
711992-3
IL?AO4-2Ll2014-A112021-2
L12064-6
3.L2083-2
112085-9
L12086-7
L12089-1.
1L2090-5
712095-6112098-0
s 3s6.70
s 360.4s
s 350.4s
S 3,926,454,20
$ 56.7s
$ 2,616.00
$ 311.40
$ 2,224.00
$ 34,623.30
s 14.8s
$ 64,s0
S 280,8s
$ 103.20
S oas.ss
$ ro+.ro
$ zag.so
$ 34,20
$ e.os
$ +sg.os
s 1-,361.00
$ 3,213.00
$ 8,gt+.gs
$ z,ogg.oo
$ 6,144.00
$ gso.ro
$ 2,239.00
$ t,a8s.oo
$ zgz,olE.as
$ 1,743.45
$ aas,oo
s 572.00
S 2r7.3s
$ sr.oo
5 2,702.10
$ 2,604.00
s 100.1s
5 q,4s4.ao
s 468.7s
$ 143,635.00
$ t+g,ogs.oo
S 143,635,00
S 143,535.00
$ 44,882.00
137.76
14.s0
4,442.644,442.64
4,442.64
4,442.641,388.20
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
(s
80,91
99.72
7,O7A,90
21..33$
s
s
$
s
$
$
s
s
s
s
$
$
s
15.44
42.LO
99.38
275,74
64.92
190.03
30.62
69.25
58.30
8,879.2453.93
L3,76
20.78
$
$
$
$
s
s
$
$
s
83.58
80.54
Paee 1-1 of 58
DOCUMENT 3728
Exhibit B-1 - Tirnely Eligible Claims
Claim No. Status Recognized Loss
MedPartnersClass ActionDisilibution
(if applicable)
$ 3,331.97
$ 4,442,64
s 4,442.64
$ 4,442.64
$ L3.76
5 262.Ls
s 1s,24
S 16,23L.13
$ so.os
$ 186,42
$ 881.B2
$ 22.87
$ 17,20
$ 17.e7
$ i,,3.42.49
$ 408.73
112099-9
7t2tor-411"2103-0
t!2105-71L21"1,1-t
!t21,16-2L12r27-8
1t2195-2112331-9
112350-5
7t237s-O
L12382-3
1"L2388-2
112399-8
1r2400-5112401.-3
tt24It-o112424-A
112435-8
LL2438-2
L12487-O
112493-5
112534-6
1.12596-6
t12612-tLr26r3-OL12616-4
112623-7
L12637-8
1L7632-6
r12662-8
1.12705-5
112707-1.
11273A-6
112800-0
112810-8
112851-s
112855-6
1t2883.-7
113091-9
113228-8
1!3324-1.
113336-5
S to7,726.0a
$ 143,635,00
S 143,635.00
$ 143,635.00
S +++.so
$ 8,476.85
$ agz,so
$ 55,124.50
$ t,otg.ssS 6,oz7.oo
$ zg,sto.oo
$ 739,s0
$ ss6.2o
$ sar,ro$ ae,gaa,oo
$ 13,2L4J0
$ rzs.ro$ ztq.qo
$ rs.zs
$ 1,toz.gs
s 1,837.50
$ 1,165,00
s 2,017.95
$ 3,A27.O0
$ 2,035,080.90
$ 138.00
s ss.8o
S 9,619,295.00
5 za.oo
$ s,szo.oo
S 806.2s
s 81.30
$ e,og+.oo
$ 3,177,OO
S 228.a0
$ 2,009,10
$ 2,882.00
$ 4,593.75
$ o,o+o.oo
$ 41,561.50
$ 3,089,00
S 5,139.00
$ 362.70
1L.58
34,10
54t.O4
36,03
62.42
93.63
62,945.1,6
65,s1
297,525.3L
L70,92
24.94
188,18
98.26
62.14
89.1.4
1,352.61
L86.82
1,285,50
95.54
158.95
1.1.22
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
)s
$
s
$
$
$
s
$
$
$
s
5
$
$
$
$
$(
$
Pepp17of58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
'J.13342-O
113365-9
113393-4
1134t9-r1,13442-6
113451-5
113452-3
113453-1
LL346t-2
tt347ta113480-9
113492-2
113493-0
113s01-5
113520-1
113544-9
113560-0
113580-5
1L3581-3
113656-9
1.t3714-A
t13752-2tr3769-7t13773-5113944-4
113946-0
1L3955-0
113957-6
114003-5
114004-3
114010-8
LL4044-2
114485-5
r14496-0
114523-t114525-8
tt4526-6t14527-41r4528-211.4s29-O
114685-8
114757-913"4783-8
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
vaiioValid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
300.24
234.17
L17.34
38.66
269.28
764,28
58.30
257.00
1"6.47
46.70
s
s
s
$
$
s
$
5
s(
$
$
$
$
s(
$
s
)s
$
$
s
s
s
s
s
$
)$
$
$
$
s
s
$
sC
s
$
ss
$
194.10g,7o7.oa 57,573'A0 $3,793.75 $
1,250.00 $8,706.00 s
24,7\0.OA s1,885.00 s8,309.00 $
s32,so s1,510.00 s
23.25
675.70 s
3,786.00 s9,958,00 s4,1"66.00 s
8s.00
6,372.00 s2,280,00 $
34,680.30 s5,319.00 $
3,256,00 $
262.94
189.60
1"45,844.00 s2,209.0A $
38,47 s
6e4.0s s
3,675,00 $
fi7.041,086.00 $
369,60 s
9,187.00 $
36.30
9,187.0A $
13,091,00 $
to,276,35 s3.,432.00 s
1,038,00 51,038.00 s1,506.00 sL,59L.00 $3,070.00 $
20.90
177.10
308,00
128.8s
197.O9
7A.52
L,O72,66
164.52
too.73.
4,510.9668.32
11.33
21,,47
1,082.09
33.59
11.43
2,7O5.O7
2,705.O7
444.93_
317,85
44.29
32.1.1.
32.1,1
46,58
49,2L
94.96
Page 13 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDisribution
(if applicable)
s 1,352.39
$ 71.s1114815-0
1.14844-3
714897-4
115012-01"1s037-5
1L5088-0
115185-1
11s381-1
115383-8
r.15384-6
115390-0175404-4
115455-9
115488-5
115553-9
115556-3
115572-5
115580-6
115583-0
1,15644-6
115650-011s686-1
11s691-8
Lts692-6115693-4
115744-2
715922-4
115961--5
116010-9
116018-4
n6a62-1116113-0
tr6152-0116L53-9
116188-1
Lt6229-2tr623r-41"16244-6
tL6259-4116285-3
176330-2116448-L
1_16590-9
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
4,593.00
23t2.AO215.55
4,915.00
55,659.30
782.r0348.80
313.50
2,658.00
3,430.00
5,236.00
5,895.25
12,376.50
LL7,218.40
41.,25
2,t74,OO
949.00
3,089.00
588.50
2,280.00
133.20
68.40
9,453.00
1,165.00
2,554.00
4,375.05
215,s5
209.70
3,479.00
4,557,00
390.45
3,217.0O
4,492.404,492,04
332.25
1,681.25
L,397,7O
4,486.00
182.10
9,187.00
5,279.O0
9,433.00
13,312,00
L52.42
1,721.55
24.L9
I0.79
82.2'1,
106.09
161.95
r82.34382.81
3,625,57
65,39
29,35
95.54
21_.30
70.52
292.38
35.03
79.00
L35.32
s
$
s
ss
$
s
s)s
s
$
s
s
$
s
$
s
$
s
$
$
s
$
s
$
$
s
s
s
$
$
s
$
s
s
$
$
s
s
$
s
s
$
$
$
s
s
s
s
$
$
$
$
$
s
$
s
5
$(
$
s
$
$
$
$
$
$
$(
s
$
$
$
to7.67140.95
12,08
99.50
138.94
138.94
10,28
52.00
43,23
138,75
2,705,47
L63.28
29r.7641,1,.74
Drca 1rl nf (Q
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No. Status Recognized Loss
MedPartnersClass ActionDistribution
(if applicable)
$ 364.s7
5 266.40
$ zs.ss
s s4.68
5 L62.4L
$ :o.sos r.38,e4
s 24,0s
18.88
1r9.1.4
L,821..73
2,705.2Lu"4.9A
tt6626-3116651-4
116658-1
1.16664-6
1L6738-3
L16743-O
L16787-t116799-5
116833-9
116860-6
116884-3
116897-5
116898-3
116967-0
1t6987-4177008-21L7042-2
117069-4
7!714s-4Ifi724-8LL7121.-6
1,17139^9
1.77233-6
tt7241.-71"!7260-31.L7325-L
t17327-8tr7347-2t17348-07L7353-7
1.r739L-O
1.17410-0
t17411.-8
r174t2-61.17474-6
L17482-7
117483-5
tL7484-3L1753L-9
1.17532-7
1,17548-3
LL7s63-71L757s-0
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
11,787,AO
9,613.00
2,446.00
1,768,00
5,251.00
986.00
4,492.00
777.40
91.05
610.50
3,852.00
6,187,00
9,187.50
13,414.00
248,85
48.15
L,923.65
5,896.00
37,819,00
365,70
563.00
568,05
2,961..OO
103,20
918,805,35
968,10
s2,05
104.00
188.25
6,937.00. 693.15
2,987,4A
6,895.00
6,923,00
7,245.44
1,284.O0
2,770.00
1,030.00
262.65
2,616.00
7,93',J",O0
195.00
2,794.0O
59.s03,82.36
3-,L69.74
L1.31
17.41
17.57
91.58
s
s
$(
s
s
s
s
$
s
ss
s$
$
$
s
$
$
)s
s
ss
s
s
s
s
$
s
s(
s
s
s
s)s
$
s
s
s
s
(
$
)$
s
s
s)ss
s
s
s
s
s
$
$
$
$($
s
$
s
s
$
27O,521,37
29.94
2L4.56
27,44
92.39
213.26
2r4.1337.28
39,71
85.68
31.86
80.91
24s.3r
Page 15 of 58
86.47
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No.
117s81,-5
IL7588-21"17617-O
Ltl623-41.77626-9
t77636-6177645-5
rt7659-2],77671-4
1t7675-7
300002-8
300005-2
300008-7
300017-6
300018-4
300019-2
300025-7
300030-3
300032-0
300033-8
300039-7
300040-0300041-9
300042-7
300045-1
300048-6
300050-8
300054-0
300055"9
300056-7
300058-3
300060-5
3AAA67-2
300068-0
300070-2300077-0
300080-0300086.9
300089-3
300090-7
300091--5
300092-3
300093-1
$ 2,173,90
$ 126.00
S 46,510,65
$ t,glz.oaS 2,765,00
5 1,340.00
S 29,733,30
$ 4,593.00
$ 4,593.75
$ 3,629.80
$ s,os
s 1"4.04
S 3,140,00
$ 1,646.00
$ 14,515.00
$ z+.ro
$ l,sgo.oo
s 44s,ss
$ 2,591.40
$ 8,766.00
$ s75.60
5 qrcst$ 82.e2
S 145.40
s 5,237,00
s 303,36
$ s86.62
s 2,508,00
$ 1e1.8s
$ 1,855.00
$ l,gge.zs
$ 1,72434
$ l,atg.oo$ 3,794,00
$ e,ggo.oo
S 1se.4s
$ t,zzz,oo
$ 1,362.00
S 100,716,19
S 273.60
$ 8,311,110.37
s 450,666.53
$ 3,339,207.00
Status Recognized Loss
MedPartners
Class ActionDistribution
(if applicable)
$ at.zq$ sg.ar
S 610.s4
S qz,+q
S 8s.s2
5 41,4s
$ e19.6s
S 1,352.39
$ 1,352.61
5 712.27
57.38
53.32
43,70
L17.35
39.81
42,13
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
s
$q
sq
Paee 1-6 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
{if applicable)
Clairn No.
300095-8
300100-8
300101-6
300102-4
300104-0
300106-7
300108-3
300109-1
300112-1
300119-9300126-1
300128-8
300129-6
300130-0
300131-8
300143-1
300144-o
300147-4
300148-2
300149-0
300152-0300155-5
300156-3
300157-1
300158-0
300159-8
300160-1
300161-0
3041.64-4
300165-2
300156-0
300167-9
300168-7
300169-5300171-7
300186-5
3001-87-3
300189-0
300L90-3
300192-0
300195-4
3AO2A4-7
300205-5
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
S tE,qlz.so
s 2,849.00
$ rzr.gss 60,731.88 s
S 248.64
$ 467,7e
$ 78,63
$ 273.60
s 16.11
s 2,849.00
$ 2,652,187.50
S o.ss
$ 6L6,227.50
$ 85,931.30
$ to+Jqa.ooS 1,690,757.00 $
$ 2,019,986.00 $
$ z,tlo,lqs 1,468.38 s
$ 66.4s
$ 52,443-.35
$ z,z7z.ao $
S z,q+8.00 $
$ 3,370.00 S
$ 33,11s.00
s L22,793.A0
$ tzo,+zg,oo
S 13,330,36
s 2,77
S 5,027,00
$ z,g45,oo
$ 35,019,35
S 28,895,14
$ 281.8s
$ 1,321.00 s
$ 17,290.00
s 1,646.00 s
$ 67,237.00 ss 1,458.00 s
S 6,050.00
s 3s.2s
s 11,663.00
$ z,o54.oo
I,878.44
52,295.23,
62,475.!8
45.42
70.30
75.72
LO4.23
40.86
30.62
2,079.6445.07
Page 17 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
$ rg.o+300213-53AO215-2
300216-0
300219-5
300220-9
3AA223-3
300225-0
3AA226-8
300230-6
300231 4
300236-5
300240-3
300241"-t
300242-O
300243-8
3AO245-4
300246-2
300247-O
300251--9
300254-3
300258-6
300259-4
300263-2
300254-0300265-9
300266-7
300271"-3
300273-0
34A277-2
300278-O
30a279-9
300282-9
300?83-7
300284-5
300286-1
300291-8
300299-3
300300-0
300306-0
300307-8
3003!?-4300313-2
300314-0
615.60
10,384.00
343.05
2,42A.00
6,228.0455.35
43,95
172.05
1,910.00
2,448.A0
536.55
4,555.00
!3,974.53
1,222.O0
985.00
26,574.AO
L16,000.00
362.70
739.86
2,899.00
10s.81
549.30
14,899.00
3,892.00
34,05
270.00
3,293.00
9,975.00
8,229,25
8,689.00
14,666.00
1,953.00
3,509.00
3,553,1-3
3,874.04
5,565.00
L,7L2.OO
3,277.35
3,337.00
L,378.65
1,4a9,74
11,831.00
tL,232,OO
10.61
59.08
75,72
16.60
37.80
34.47
821.94
460.82
L08.50
772.13
34.36
LO3.21
42.62
365.93
347.41
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Vatid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
s(s
s
s
$
$
s
s
$
5
$
$
5
s
)s
$
s
s
$
s
)ss(
s
$((
5
$
s
$
$
$
$
s
$
s
s
s
s
s
$
5
5
s
5
$
$
s
$
$
$
$
s
Page 18 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
{if applicable}
Claim No.
300315-9
300320-5
300324-8
300325-6
300333-7
300340-0
300343-43AO347-7
300349-3
300357-4
300358-2
300364-7
300371-0
300372-B
300378-7
300379-5
30038r.-7
300383-3
300385-0300388-4
300389-2
300391-4
300392-2
300398-1
300399-0
300401-5
300402-3
300404-0
300406-6300408-2
30a412-0
300413-9
30041,4-7
300415-5
300416-3
300417-734O424-4
300426-0
300427-9300434-l_
300435-0300436-8
300437-6
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
s
s$
s
s
s
$
)s
s
5
s
s
s
$
$c
$
s
$q
$
s
$
5
s
s
s
)s
$
$
s
s
$
$
$
s
)$(
s
4,156,00
1,836.00
346,38
127.95
1,L75.O0 s3.,L78.20 $
7,732.0A s
269.44
18,900.00 $
4,346.00
711.t511,634.86
1,L,L25,A0 s81.34
7,112.95 $12,090.00
L64.70
5,992.0064.50
444.8A $
2,438.O4
596.25
s6,48
8,586.00 $5.70
1_,467.97
3,076.25
1,199.00 s
39,920,00
1,328.00
1,086.60
794.O4
444.40
5L0,75 $
4,680.00447.45 s
7,241,44
7,24r.006,457,47
16,1"04.00
L,265.00 $620,4A
465.54
36.34
36.44
53,51
584.58
344.IO
279.94
13.76
265.50
37,09
15.80
L3.76
Pase 19 of 58
39,13
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No, Status Recognized Loss
MedPartnersClass ActionDistribution
(if applicable)
S so.go
$ 70.30
5 tzt.zt$ 44.L7
s 136.87
85.00
78,93
1,031.55
502.86
70.30
43,80
53,3.4
70.30
40.6r179.99
215.30
14.88
53,32
72.78
70.30
70.30
s17.00
300440-6
30a44}4300442-2300443-0
30a445-7
300446-5
300448-1
300454-6300455-4
300457-0
30a459-7
300460-0
300464-3
300466-0
300467-8
300468-6
300469-4
300470-8
300471-6
30a472-43AO474-A
300475-930a476-7
300477-5
300483-0300497-O
300499-6300s00-3
300503-8
300504-5
300506-2
300509-7
300s10-0
300514-3
300515-1300516-0
300517-8
300521-6
300524-0
300527-5
300530-5300531-3
300534-8
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
1,193.00
2,273,O0
3,919,00L,428.O4
5,167.00
L,434.O0
7378.402,748.O0
2,552,00
34,508.90
LA38.423,405.00
1,590.00
30.27
16,258,00
483.65
31,509.18
2,273.OO
159.00
323,85
1,417.OO
1-,73.8,40
180.54
2,273.00
3,705.00
L,313,75
5,829.71
1,621.00
6,961,00
263.44
48L.40
3,672.60
L,724.04
2,353.00
2,273.O4
6,394.00
2,273.00
12.79
L6,7L5.O0
4,468.O0
5,876.00
343.05
699,33
$
$
s
$
$
$
s
s
$
s
s$
ss
$
s
s
s
$
$
$
$
s
)s
$
$
$
$
$
$
s
s
s$
$
$
$
s
$
ss
s
5
$
s
s
$
s
s
s
$
)
$
s
))s
$
s
s
Paee 20 of 58
10.61
DOCUMENT 3728
Claim No, Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
$ zr.ag
$ +z,go300538-0300539-9
300541-0
300542-9
300547-0
300548-8
300549-5
300553-4
300554-2
300561-5
300567-4
300571-2
300572-0
300579-8
300580-1
300581-0300584-4
300586-0300589-5
300591-7
300s93-3
300596-8
300597-6
300s98-4
300599-2
300601-8
300603-4300604-2
300608-5300610-7
300620-4
300622-0
300623-9300625-5
300629-8
300631-0
300634-4
300638-7300542-5
300643-3
300653-0
300659-0300660-3
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
$(
$
$
$
$
$
s
s
5
$
s
$
$
s
$
)$
s)$
$
$
$
$
$
$
$
$(
s
$
$(
s
s
s
s
s
s
s
7A1..40
1,388.00
2,554.O0
289.65
6,237,40
8,864.005,337.00
443,60
!2,956,44673.05
3,403.80
143,635,00
2,577.86351.75
7.50
2,47A.40
159,70
7LO.47
2,446,00
185.60
4,228.0012,75
5,550.00
5,559.00
2,296.0O
782.25
1L,318,00337.05
5,341.00
4,593,00294.00
45.90
820.98
27.60
L,343.75
13,780.00
2,035,05
6,297.O4
5,074.001_,496.7O
965.00
3,377.OA
2,864,00
13.72
105.28
4,442,64
10.88
76,40
40.49
7s.65
L34.77
771.66
17t,947LAz
350.07
10,42
16s.20
!:,352.39
25,36
41..54
426.22
s8.84
194.77
156.94
46,29
29,85
104.45
88,58
$
$
$
$
5
s
s
s
s
s
s
s
s
$
$
s
s
s
$
$
s
5
$
s
$
Paoe 71 of \R
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No. Status Recognized Loss
MedPartners
Class ActionDistribution
(if applicable)
S zz.ts$ 7s,95
5 1t2.43
s 2e1.07
$ 17,089.49
S 23.66
811.49
774,7s
1,715.28
271.1.6
54,485.30
766.24
533,98
88.58
5t9,7483.53
44.72
12.23
430.4s
300661-1300662-0
300563-8
300664-6
300668-9
300669-7
300671-9
300675-1
300678-6
300681-5
300682-4
300685-9
300688-3
300689-1
300690-5
300691-3
300692-1
300693-0300700-6
300702-2300703-0
300704-9
300705-7
300706-5
300707-3
300708-1
300709-0
300710-3
300712-O
300774-6
300715-4
300718-9
300719-7
300720-0300721-9
300722-7
3AO724-3
3AO725-t
30a727-8
300728-6
300729-4300730-8
300731-6
$ zss.ss
$ z,+so.oo
s 3,635.00
S e88,s4
$ 36,000.00
S 76s.oo
s s6.80
s 2,756.0A
$ 5,650.00
$ 36,058.94
s 8,767.00
S 1,761,555.0o
$ 24,77210
S 17,264.00
$ z,go+.ge
5 16,803.70
s 2,7O4.AO
$ zg.so
S 1,446,00
$ zse.as
s 3ss,4o
s 13,917.00
s 2e2,6s
s 18e.60
$ 3s7.1s
$ z,t67.ao
s 8,519.90
S 2,762.aa
s 3so.8o
5 ?,689,522.45
$ res,so
$ 13.3s
$ 10,528,00
s 1,059.75
S 1,740.00
$ s+.ao
$ L2,51"4.0a
5 32,583.00
$ ras.+o
s 1,553.40
$ 1,376,00
S 3,472.a0
s 3,7A4.04
11.05
67.03
263.52
66.87
10,85
575,244,75
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
s)s
s
$
$(
s
s
5
$
s
$
)s
s
s
$
s
$
s
$
$
5
$
$(
325.63
32.78
53.82
387.06
1,007.79
48.05
42.56
107,39
114.56
D:op ?? nf ER
DOCUMENT 3728
Exhibit B-1 - Timelv Eligible €lairns
Claim No. Status Recognized Loss
MedPartners
Class ActionDistribution
(if applicable)
$ 356,031,12
$ 17,089.49
$ eos.s:
$ 2,024,25
$ :za,sa
$ 28,L4
S l-os.so
$ 447,22
s 11.48
$ 'tgt.zt
$ 27ss6
333.64203.33
5,410.43
7,96L.24
399,00
18.50
85.09
L2.78
84.44
200.52
t94,24L45.68
534.16
1",L65,44
12.99
31,46
207.73
524.51
300733-2300734-0
300736-7
300737-5
300738-3
300739-1
300740-5
30a747-3300744-8
300745-6
300747-2300751-0
300752-93007s3-7
300754-5
300756-1
300757-0
300758-8
3007s9-6300760-0
300764-2
30076s-0300766-9
300767-7
300768-5
300769-3
300770-7
30077L-5
300786-3
300787-1
300792-8
400011-0
400019-6
400033-1
400062-5400089-7
400093-54001"01-0
400109-5
4001L5-0
400L26-s400133-8
400L34-6
750,000.0036,000,00
9,975.00
65,446.00
10,633.00
909.90
3,424.O0
1,4,459.40
2,929,25
6,184,63
8,922,0O
2,74
ta,787.AO
6,573.55
18,375.00
63,409.00
12,900.00
598.00
L32349.15
2,751.OO
4L3,tA2,730,446,483,00
6,280.00
4,770,00
L7,27O.OO
37,680,00420,00
675.74
L,0!7.O0
5,716.00
55.62
16,958.00
136.50
158.75
84.80
t96.205,308.005,308.00
85.05
1,47.45
438,00
164.tt164.1.L
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
q
$
s
$
)$
$
s
s
s
$
$
$
s
s
$
$
ss
$
s(
$
s
$(
)s
$
$
s
s
$
$
s
s
s
$
$
s
$
$
5
s
$
s
s
s
s
s
$
)s
$
$
$
s
ss
s
s5
Page 23 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 'Timelv Eligible Claims
MedPartners
CIass ActionDistribution
(if applicable)
Claim No.
400156-7
400159-1
400163-0
400164-8
40aL77-O
4}0fi9-6400186-9
400193-1
400214-8
400i24-s400234-.2
400258-0
400259-8
400268-7
400270-9
400277-6
400280-6
40a284-9
400289-0
4A0292-0
400297-O
400308-0
40a3r7-9
400321.-7
400322-5
4AO329-2
400331-4
400332-2
400339-0
400343-8
400353-5
400354-3
400356-040037t-3400373-0400376-4
400377-2
400378-0400383-7
400386-1
400387-A
400399-3
40a402-7
150.45
42,300.00 s
870.00
692.40
86.40
81"5.55
4,723.35 $
1-,296.00
80.64
41s.0s s5,457,0O s
83.85
83.85
330.30 s300.00
283.80
725.75 $
4e4.to $
3,106.00
57.90
65.64
6.60
328.29
3,609.10 sL,236.75 s4,O32,OO $
968.70
79,715.29
43s.2A $
92.10
2s1.58
269.55
43.53
696.70 s1",204.OO $
12,427.50
2,002.00 s7,847.OO s1,378.00
228.O0
162,186.55
2,642.O0
2,600.00
1,308.34
127,54
12.84
1,68,79
LO.zZ
22.45
15.28
111,53
38.19
124.71
13.46
2t.5437.24
61,.92
242.7I
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
5
s
$
s
s
$
)$
5
s
$
s(
$
S
$
$
s
s
s
s
5
$
s
s
s
$
$
$
$
$
5
s
s
s(
$
5
$
)$
$
Paee 24 of 58
DOCUMENT 3728
Claim No Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDlstribution
(if applicable)
400406-0
400408-6400449-4
400417-5
40a419-t40a424-5
400421-3
400431-0
400432-9
400435-3
400439-6
400440-0400443-4
400456-6
400459-0
400468-0
4A0474-4
40a475-2
400485-0
4A0487-6
40a491.44A0494-9
400497-3
400499-0
400510-4400s17-1,
400518-0
400525-2
400526-0400528-7
400529-5
400531-7
400535-0400536-8
400538-4
400544-9
40054s-7
400548-1
400549-0
400550-3
400s51-1
400553-8
400s59-7
85.20
1,1"66.00
2,570.00
3,7L9.43
1,257.00 $
775.35
61.65
330.60
702.90
!7L.303s2.46 $
7,819.00
13,630.00 $
4,593.75e62.8A $
196.08
1,258.00 $
33,903.60 $
309.29
1,060.00
337.50
5,882.00
288,00
860.00
741.0O
2,840.14
18,740,00
24,057.9A $9L3.32
4,560,00 $
4,560.00 $
2n3A19,20
4A.62
5,655.00 53,766,60
226.Os
4,793.64808.80
7,213.20
74.37
90.59
89.70
38.88
72.14
421,58
29.78
38.91
3.,A48.64
744.!L
t41.011,4L.Ot
L74.9L
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Vatid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
s
$
5
s
$
s
$
$
s
s
s
s
$
s
$
$
ss
$
s(
$
s
$
$
s(
$
$
$
s
$
s
$
s
)$
s
$
s
)s
Page 25 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDisffibution
(if applicable)
400560-0
400565-0
400567-8
400569-4
400573-2
4A0574-0
400575-9400578-3400579-t400s80-5
400587-2
400589-9
400592-9
400595-3
400597-0
400598-8
400599-5
400600-340a612-7
400625-9400629-1400649-6
400650-0
600008-8
600018-5
600021-5
600026-6
600033-9
600074-6
600083-5
600086-0600090-8
600105-0
600106-8
600107-6
600109-2
6001L0-6
600711,-4
600113-0600116-5
500117-3
600118-1
5001 21-1
$ 1,g7g.oo
s 33s.s8
5 376.44
$ 374,322,07
$ 3,940.00
$ t2,458.a4
$ a,g+o.oo
S 809.40
S gag.zo
$ 28.50
S 43,580.00
5 3,727.95
S 39,715,46
$ 20,041,963.50
s 1,,777,568,73
$ 73,148.00
$ 102,559.00
s 64,299,00
$ 76a,784.oa
$ 207.es
$ zgs.oo
s 1s4,s3
$ rs+,ss
$ 1s.se
S s87.10
$ 32,544.50
S 16,904.00
$ zzg.ss
$ ts,ge z.go
S l^,648,80
S 7,929.28
S 3,388,13
S 6,508.90
$ !a,414.24
$ 1,202.85
S 10,149.40
s 1,236.60
$ +g,tEo.St
5 39,92'J,.75
S L0,41-4.24
$ 23,600.70
S 5,770,80
s 22,0L6.00
s 3,757,255.98
$ 49,097.35
5 2,262.47
5 E,tlz.toS t,gg8.zz
S zg,sgt.og
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
5
$
$
I2L,86
t2L.8625.03
27.50
1-8.16
710.22
522.84
24.49
301.01
37,24
313,92
38.25
1,340.5!974.48
235.38
729,97
178,49
680.96
$
s
s
)
s
$
s$
s$
s
5
$
s
Paee 25 of 58
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No.
600126-2
60a127-A
600128-9
600137-B
600138-6600139-4
600140-8600141-6
60a1,42-4
600144-0
600145-9
6AOt46-7
600147-5600150-5
600151-3
600154-8600155-6
500156-4
6001,57-2
600158-0
600159-9
600170-0
6AOfi3-460afi4-2600175-0600176-9
500179-3600180-7
600181-5
600182-3
600184-0500185-8
600186-6600187-4
6001"89-0
600192-0
600195-5
600196-3
600197-1
600198-0600201-3
600206-46A021A-2
$ g,oeo,oo
5 t,441.70
$ 133,118.03
$ 12,097.50
s 4,839.00
S 17o,7oo.oo
$ t,ggz.gs
$ 12,376.00
$ 7L,497.24
$ oz,zoo,oo
$ 11.,117.52
s 20,588.75
s 1"6,391.70
$ 1,449.75
$ o,ggs.oo
S 13,778.00
$ tgt,toq,qt$ 16,335.00
$ 27,264.25
$ z7,zo+.zs
$ ta+,sgz.so
S 918.00
s 40,355,18
S gt,ogs.oo
s 22,260.78
s 3,870.00
S g,6g+.oo
$ o,7go.s5
$ 3,229.05
S o,gEz.e o
$ 0,+og,zg
$ l,azg.lz$ zta.qo
S 226,366.00
s 101,80
$ z,egg.oo
s 15,480.00
$ go,+so.oo
5 too,ozo.oo
$ 42,341.25
$ 129,294.05
$ r,786.24
S 9,458.00
58.69
382,79
355.61
3",923,85
343.86
636.79
507.00
44.84
195.94
426.15
5,929.42
505.24
843.28
843.28
4,156.60
270.30940.03
980.33
543.90
119.70
268.91
208.18
Status Recognized Loss
MedPartnersClass ActionDistribution
(if applicable)
S 279.30
$ 44.s9
5 z,aqz.ae
$ ztq.rc5 L4e.67
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Vatid
Valid
Valid
Valid
Valid
Valid
Valid
Vatid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
s
s
s
s
$
)$
$
$
s
$
$
s(
$
$
s
$
$
s
Is
5
s
$
ss
$
s
$
)
128.51.
1A8.41
7,0A7.51
238.13
478.84
r,t27,402,348.92
1-,O82.92
2,113,,69
55.25
292.54
D:op 77 nf (R
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No. Status Recognized Loss
MedPartners
Class ActionDistribution
{if applicable)
$ ++o.rs
$ s80.s3
$ 3,310.32
$ 1,269.37
S 1,303.98
s 37s.85
$ 1,364.36
S 1e9.so
$ 180.26
s 3,048.09
5 282.64
s 17,s6
$ s27.eg
5 2,129.85
$ 62e,08
600214-5
60021_5-3
6002L8-8600219-6
60a221-8
600222-66A0223-4
600225-0600226-9
600228-5
600229-3
600230-7
600231-5
600232-3
600233-1600234-0
600235-8
600236-6
6A0237-4
600238-2600249-8
600250-L600260-9
60a261-7
600270-6600281-1
600283-8
600291-9600292-7
600293-5
6A0294-3
600298-66AA299-4
600304-4
600306-0
600310-9
600312-5500313-3
600314-1
600315-0
600316-8600317-6
600318-4
s L4,23A.0A
s 26,035,60
S 140,446,30
s 41,040.00
$ qo,qzg.aq
5 62,267.48
S g+,ots,zo
$ g,+so,oo
$ 9,863".3L
$ 140,850.69
$ 20,828.48
s s67.60
S 17,o7o,oo
S og,goo.zs
S zo,gE8.e s
$ 2,201.63
$ t,g+g.gz
s 21,966.00
s 29,034.00
S z,eoE.se
5 5,ZZI.ZO
$ 25,901.00
$ 1t,sos.oo
$ g,aeg,oo
$ tJoozq$ to,got.oo
s 13,017.50
$ i",269,1.r8.77
$ +,aoo,og
5 z,gts,ze
S g,zg3,e g
$ 3-,L57,625.o0
S Tzt,lso.oa$ 467,273.63
S 702,858,88
S 756,395.40
$ qq,ltl.oo
$ 59,127,78
S 52,888,11
$ 1,481.34
$ 3,ozg.oo
5 235,733.29
$ qg,qtz.sg
41.72
679.4t407.38
37,t516t,49801.12
355.85
260.99
334.08
42,315.9040.52
67,55
27t.99
14,448.73
22,058.97
23,395.18
1,383.10
1,828.74
1,635,74
36.18
7,291,74
1,527.35
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
ss
$(
$
s
s
$
s
s
5
$
s
$
s$
s
$(
s
s
Page 28 of 58
DOCUMENT 3728
Exhibit B-1 'Timely Eligible Claims
Claim No. Status Recognized Loss
MedPartners
Class ActionDistribution
(if applicable)
s 4,961.61
$ 7,227,09
$ 1,948.35
5 284.78
$ 2,828.71"
5 r+.+s
5 342.21.
$ 'J.,297.79
$ 360.s4
$ tz,sgt.ols 2,302.53
$ 39,231.96
S 40,538.14
S 1,995.77
5 61.77
5 2,078.34
$ 34,955.04
49,969.09L3,557.36
33A9.42
7,345.89
L1,875,59
13,943.81
72.72
963.36696.17
128,3L
600319-260a322-2
500323-0
600324-9
600325-7
600326-5
600327-3
600328-1
600329-0
600330-3
600331-1
600332-0
600333-8
600335-4
600336-2
600337-0600338-9
600340-0600342^7
600344-3
600345-1
600346-0600349-4
500351-6
600352-4
600353-2
600354-0600359-1500360-5
600363-0
600364-8
600366-4
600367-2
600368-0
600369-9600370-2
600371-0
600372-9
6A0 tt-3600418-0
6AA42t-O
6AA423^7
600425-3
$ 160,414,00
$ 233,659.44
$ 89,420.25
$ 9,2oz.go
$ 91,455.00
$ 468.20
$ 11,064,05
S 41,959.45
$ 11,657.50
$ 407,082.29
$ 74,443.OO
$ t,z6g,qog.7o
S 1,310,639.00
$ 66,916.55
$ t,ggs.to$ 67,195.00
S 1,130,132.00
5 L,405,842.75
$ 1,826,250.13
$ 438,323.10
S 106,997.00
s 237,500,00
S 383,950.00
S 450,817.60
S z,gso.gs
$ 31,146.95
$ 43,082.00
S 4,148.52
s 6s1.63
$ 163,873.31
$ 70,299.63
$ ao,gso.oo
S 3s,glq.zs
5 179,425,00
S 2,237.95
$ 718,338,60
s 6s4.80
$ 571,563.08
s 138,41
$ s,zts,oo
$ 493,685.00
$ s38,eo
$ +s,otg.oo
5,068,23
23,805.B8
3,331.45
69,22
22,218.23
20.25
16,522.26
L76.77
15,269.70
16.67
7,392.41
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
s
5
$
s
5(
)
$
s
s
)s
$
s
$
(
ss
$
P:oe 7Q of 5R
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No.
600428-8600429-6600430-0
600433-4
600435-0
600438-5600440-7
600441-5600442-3
600443-1
600444-0
600446-6
604447-4640448-2
600450-4
600451-2
600453-9
600454-7
600456-3
6AO4s7-3.
600458-0
600460-1
600463-6
600464-4
600465-0
6A0467-9
600468-7
500469-5
604471-7
600472-5
600473-3
600474-7
600476-8
604477-6
600478-4
604479-2600481,-4
600483-060a484-9
600485-7600486-5
604492-O
600493-8
720,085.56505.17
247,A88.44
2,435.09
24,084.00
4,913.08
50,970.00
15,291.00
826,875.00
84,398.24
74,686,08
2,747.75
38,587.00
7L.57
213,r35.3O
601,489.34
371,594.O4
1,87L,10
225,246.4O
7,350.85
23,160.00
1,915.30
39,455.25
t92,6t1",162,466.70
153.65
339.09
13,217.75
59,856,56
999.90
2,126,83
385,763.53
39,125.20
589,818.001,200,05
60,242.40
956.10
14t,937,4297,4A4.00
10,269,00
702,486,21,
9,187,50
747,48
MedPartnersClass ActionDistribution
(if applicable)
S 20,595.43
s 18.72
5 7,027,48
S ts.tzS 744s2
$ rsr.gss 1,s76,s0
2,6L0.37
\1a2.2584.99
tL,36t.75
Status Recognized Loss
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
6,592.28
L8,544.70
tL,493.42
57.87
6,966.87
227,34
716.34
59.11
936.22
5,957.47
76.28
$
s
$
s
(
$
s
ss
$
$
$
$
$
$
s
s(
$
s
s
$
s
5
(
$
5
$
408,83
17,6243430.93
la,994.771",210.14
L8,243.1O
37.72
1,863,30
29.s7
3,O12.7L
317.62
9,032.60
^--^ 1n ^t ro
14.48
DOCUMENT 3728
Exhibit B-1 - Timelv Eligible Claims
Claim No.
600494-6
600495-4500496-2
600497-0600498-9
600500-4
600501-2
600502-0600505-5
500508-0600509-8
600511-0600s12-8600514-4
600518-7600526-8
600527-6
600535-7
600536-s
500537-3
600539-0
600s40-3
600544-6600546-2
600548-9600549-7
600551-9600553-5
500556-0600557-8
600558-6
600559-4
600560-8
600s61-6600562-4
600563-2
600564-0
600565-9
600566-7600567-5
600568-3600569-1
600570-5
S 281.,339.44
S 1,632.45
$ 3s6,sL
5 24o,374.ot
S 61,305.35
$ 67,888,00
5 27,625,a4
$ 3,453.37
$ 95,455,62
$ 51,816,25
$ ttg,Egs.oo
S 30,663.85
5 Lo,ozz,so
s 105,695.00
$ 381,903.64
s l-.8s
s 3.ss
$ at,sso.oo
$ s3,t28,825.54
$ 113,020.80
s 6,149.30
$ 5,015.25
$ 7s6.76
s 5,824.65
$ 1,936.55
$ qs,llz.tz
$ 13,819,35
S 8,384.00
$ 18,526,02
S 24,L31,466.62
S 5g,oo+.12
$ 6,079,915.29
$ 5,891,006.32
$ 432a,502.93.
s 4,365,377.54
$ 716,285.42
S 12,247,917.23
S 2,270,392.84
$ 5,889,142.69
S 2,257,664.67
$ 90,459,510,27
$ 119,619.05
$ 2,482,936.21
s 1,285.14
$ 1,643,278.89
5 3,495,74
$ Leo.2o
5 rss.rz
180.16
s9,90
427.43
259,32
Status Recognized Loss
MedPartnersClass ActionDistribution
{if applicable}
$ 8,703,.77
$ so.4e
$ rr.os$ 5,005.04
S grz.e s
$ 2,A99.78
S 8s4.44
$ Lo2,8o
$ 2,952.43
$ 1,602.68
S 3,506.97
5 4e2.64
S 4es,s6
$ 3,269.15
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
$
$
$
Page 31 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
600571-3
600s72-7
600573-0
600583-7
600584-5
600587-0
600588-8
600589-6600603-s
600605-1-
600620-5
600621-3
600625-56A0627-2
600633-7
600634-5
600638-8
600644-2
600660-4
600662-0
600664-7
600565-5
600666-3
600668-0600672-8
600673-6
600674-4
600676-0600677-9
6A0678-7
600691-4
600692-2600693-0600694-9
600698-1600706-6
600708-2
600709-0
6A07tO-4
600716-36007L9-8
600722-8604724-4
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
s
s
s
$
s
s
$
s
$
5
s(
$
s
s
$
s
$
s
$
$
$
$
$
$
$
$
$(
$
$
$
s
s
s
$
$
$
$
$
s(
69.t44.50
110.25
L23,895.00
12,748.00 $
10,857.00 s
47,462.00 $5,211,00 5
33,681.25 $
655.16
105,117.83 s72.60
56,683.50 $
t4,828.0842, 42.30 s
2,2A7,OO $
39.00
94.44
45,937.5O
19,658.53 $
3L,447.45 $
69.47
2A,620.7A $
55,345.00 $
289.13
9,113.50 $
33,L69.50 $
34.24
3,370.224.49
8,656,00 s72,396,00 $
1,300.05 $
780.00 s23,7t8.2413,668.50
87,447,0O s7,975,0A s1,158.00 $
L,317.75 $53,542.00 s
28s.02
54,676.8O
394.30
335,81
1,282,42
t6!.!8LA4t,75
3,25L.21,
t,753.21
#oas768.26
608.02
972.67
637.78
7,7r1.82
28r.87'J.,O25.92
267.73
2,239.2t40.21,
24.13
2,704.74246.67
35.82
44.76
1,656,06
n^d^ "l ^f Eq
DOCUMENT 3728
Claim No Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
$ 128,227.L3600734-1
600746-5
600752-0
600757-0
600758-9
60a774-A
600775-9
60a776-7
600777-5
600782-1"
600786-4
600799-6
500800-3
600806-2
600809-7
600810-0
6AO8t2-7
600819-4
600821-6
600840-2
600841-0600846-1
600847-0
500858-5
600859-3
600868-2
600869-0
600870-4
600872-0
600875-5
600876-3
600884-4
600893-3
600895-0
600899-2
600900-0
600901-8
600902-6600903-4
600904-2
600915-8
6009t7-4600923-9
$ 870,975.00
5 264sA
S 50,513.00
5 123,320.30
$ 50,116.10
$ 127.70
S 2,390.00
$ z.ez
S 195,768.72
$ z3,gzg.oo
$ 5,945,63
S 8s.60
$ e1.30
5 1,713.!5
S 73,,6t2.00
s 8,038.20
$ 45,087.00
S 2,683.73
$ zz,qgq.eg
S 2,905.88
s eLs.ss
S 58,730.35
$ 15,950.00
$ 13,1"27,88
s 12s.ss
$ 14,26L.85
S 6,795,00
s 4,012.29
s 25,851,00
$ 12,935.00
S 16,555.00
5 3,157.88
5 47.3e
$ zs+.ro
S 3,670.95
s 8,660.00
S tz7,+oo.oo
s 1,799.90
s 266,897,65
s 1s.es
$ 1s,e8
S 7e,e1
$ 4,814,00
s t,562.37
73.92
6,055.11
736.85
52.99
2,214.96
248,62
7,394,54
82.99
89.88
1,816.53
405.99
447.12
210.17
r24.to
400.08
512,05
97.67
1L3.54
267.85
5,486.99
55.67
8,255.16
$ 148,90
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
$
))(
$
s
s
s
s
$
$
s
s
s
$
s
$
ss
D^da ?? ^f EQ
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 'Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
$ szq,tzs 41,216,83
Claim No.
600928-0
600938-7
6AA944-t
600948-4
600949-2
600950-6
6009s1-46A0952-2
600953-0
600954-9
600955-7
600957-3
600961-L
600964-6
600969-7
600972-7
600973-5
600975-1
500976-0
600977-8
600980-8
600982-4
600983-2
500984-0
600985-9
600985-7
600987-5
600988-3
600989-L
600990-5
600991-3
600992-1
600993-0
600994-8
600995-6
600996-4
501000-8
601001-6
60LOA2-4
601005-9
601006-7
601010-5
601014-8
26,664.00
329,831.25
9L.31
3,414.25
282,664.OO
5,990,00
15,370.00
77A,47LAO
3L,489;00
20,388.00
29,841.00
30,352.75
98,72L.A0
148,520,957,898.42
280.50
27,562.50
73,5L3.50
91,875.O4
45,937.54
26,787.60
9,L87.50
18,375.00
91,875.00
19,375,00
45,937.50
18,375.00
9,187.50
23,697,50350,63
45.00
27,562.54
4,593.759,187.50
22,968,7545,937.50
121.50
7,334,84
36,750.00L.52
20.89
8,A59,27
17.09
105.48
9,742.8L
475.39
5,272.68
973.96
630,60
272.96
938.81
3,053,45
4,593.76
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
$
$
$
$(s
$
s
s
$
$
s
$
s
s
$
$
$
$
s
s
$
$
$
$
$
$
)$
$
$
s
$(
s
$
)$
$
$
$
$
$
s
$
$
$
$
$
s
$
Pase 34 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B'1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
Claim No.
60101s-6
60LAfl-2601018-0
601019-9
601020-2
601021-0
60to22-9601a73-7
601024-5
601025-3
601026-1
601036-9
601037-7
601038-s
601039-3
501041-5
601043-1
601044-0
601050-4
6010s1-2
601053-9
601054-7
601056-3
601058-0
601059-8
601061-0
601063-6
601064-4
501_065-2
601067-9
601068-7
601069-5
60L072-5
6Afi79-2601080-6
601081-4
501084-9
601096-2
6A1-104-7
601105-5
601106-3
6A1107-t601108-0
$ +,sos.zo
$ 220,500.00
5 3,042.00
$ 15,780,00
$ zz,zzo.oo
$ 10,056.00
$ 82,zt8.oo
$ 40,926.00
$ go,zoz,oo
$ ts,+g6.oo
S 7so,9s
S ag.os
$ 6.34
$ 1.6e
$ z.gs
s 40.s0
s 2o.2s
$ 134,2s
$ 17.03
s 6,s3
s 4.0s
s 1s2.8s
s 1.s3
s 3.63
$ 20.44
$ 23.68
s 3".63
5 24.s3
s 17.40
$ 43.13
$ 82,587.00 s
$ z,gos.oo
$ 90,064.00 S
s 6,325.90
5 9,474.54
s 722.s4
S 545,663.68
$ s,t6z.oo $
$ 38s.os $
S Lo2.2o
s 3ee.1s $
$ se,gtg,tt S
g aor,so $
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
2,554.42
2,785.68
159.66
L2,A0
12.35
1,515,70
L2.43"
Page 35 of 58
DOCUMENT 3728
Claim No Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
5 21,74
$ 24L.3e60L109-8
60111L-0
601112-8
601-113-6
60tt1"4-460Lt1,s-2
601116-0
60\rt7-96011L8-7
60112L-7
601125-0
601727-6
603-128-4
6011 30-6
601134-9
601135-7
601136-5601139-0
601140-3
60Ll4L-t6A1"3,42-A
601143-8
60tt44-6601,t45-4
6A11"46-2
601147-0
601148-9
60!149-7601150-0601151_-9
6AL152-7
601153-5601154-3
601155-1
6011s6-0
601157-8
601158-6
601159-4
601160-8601161-6
60Lr62-46A1163-2
601164-0
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
.ValidValid
Valid
702,75
7,804,30
37,537,5O
13,101.00
L1,66o.0o
15,785.00
1-7,636.00
27,958,00
35,402,00
25,41"6.O0
80,352.00
91,51"2.00
60,348,00
55,082.30450.00
262,093,82
232,85
30,229.00
32,732.00
52,530.00
2A8,943.46
136,993.00
80,868.00
77,286,L7167,25
L6.70
174,405,25
ro,275.OO
13,679.AO
135,387.15
11,309.00
LO,2r2.OA
21,298,00
13,487.04
174,912.5O
11,105.10
79,733.OA
32,398.00
107,394,04
48,018.009,478.00
49,477.OO
133.80
405.2L
360.64
488.23
545,48
864.74
LA94.99786.L2
2,485,29
2,830.47
1_,866.57
$
s
s
$
$
s(
$
s
s
)s
s
$
s
s
$
$
s(
$
$
$
5q
s
s
s
s
s
$
$
s
s
$(
s
$
$
5
$
s
$
s
s
s)$
$
s
s
s
s
s
s
$
s
$
s
ss
t4.236,865.92
934,98
t,olz.4AL,624.76
6,377.44
4,237.2O
2,50!.25L,967.62
$
s
s
5
$
$
$
s
$
s
s
)s$
)$
5,089,88
317,81
423.A9
3,773,O3
349.79
315.86
658.75
417.1,5
4,573.87
343.48
2,466.15
1.,OA2.07
3,32L.70
1,485.20
293.L6
l_,530,14
Page 36 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 'Timely Elicible Claims
MedPartnersClass ActionDistribution
(if applicable)
60116s-9
60L166-7
601167-5
501168-3
601169-1
601"170-5
601171-3
60t\72-1.6A3.L73-O
601175-6
6Arfi6-46AL\77-2
6011_78-0
501179-9
601180-2
601182-9
601183-7
601186-1
601187-0601188-8
601190-0
601192-6
601193-46011-94-2
601195-0
601196-9
6ALr97-7
601L98-5
601199-3
601702-7
601203-5
60t204-3601205-1
601206-0
601207-8
601218-3
601219-1
601220-5
601222-t601223-O
601224-860L225-6
601227-2
s 33,4s
$ :s.+s
S gg.+s
$ tz+,gle.sa S
$ 10,212.00 $
$ 234,180.00 $S 209,905,49 $
S 49,137.55 $
$ 63,297.AA s
S 46,411.00 S
S 100,388.75 S
$ 77,062.50
s 101,564.33 $$ zsz,too,oo $
$ qzz,+t3.+s S
$ ttg,:as.oo $
$ rz,so
$ ooo,szt.ga $
$ 42,936.00 S
5 134,198,00 $
$ L,A16.28
S zgg,zos,zl
$ tzz,lg.gas 679,875.00 s
S 864,510,91
s e63.1s $
$ 29,785.67 S
$ 8,1L5.78
$ ztl,toz.oo$ 3,872,115.00
s 3,573.75 $5 2,474,482,50 5
s e17.48
$ g,zoo.8g
$ t6,ttz.oq$ 100,100,00
s 44,525,00
s 87,958.03
S 70,774.76
$ 26,831,63
$ l"z,ogg.og
s 5,694.80
$ 248,935.35 S
3,t4t.387,797.65
13,096.L6
3,506,97
L8,759.73
1.,328.01
4,r5O.75
200,185.81"
29.79
905.57
1",454,68
728,598,92
7,699.51
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
3,469.3031s.86
7,243.205,495.28
1,519.83
L,957.78
1,435.49
3,105,01
Daoo ?7 nf tr9
DOCUMENT 3728
Status Recognized loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
{if applicable)
Claim No.
601228-0601230-Z
601231-0601232-96A7233-7
601235-3
6A1236-1
601237-O
601238-B
601241-8
60L242-6
6At244-2
60L248-5
6At2s0-7
601251-5
6A1252-3
601253-1
601254-0
601255-860L257-4601258-2
601259-0607260-4
60126t-2607262-A
601263-9
601265-5
601266*3
50L267-t601268-0
601269-8
601270-t60L271-O
6A1272-8
60t273-6601275-2
60t276-06A1278-7
6A1279-5
60x280-9
60t281-76A1282-s
601283-3
S 14,501.25
S 62,724.45
$ 134,986.45
$ 13,933.91
$ tzt,soz.as$ zet,sto.szS 12,801,03
$ 3,952,409.95
S 1,,798,682.40
s 1,034,10 s$ 382.7e
S 238,460,76 $
S 849,577,69
$ 7,893,75
$ 38,312.63 $
5 t,7og,se
S 8,85L.13
5 7o,eog.5+
S 33,848.32
$ s,799,228.49 $
$ tto,s++.go $
S 183,374.00 $
$ 679,155.00 S
S 285,923.10
s 277,523.L0 $S qz,lal.ze S
$ 738,847,50
s 176,400.00 $
$ 121,140,22 s
$ tze,+oo.oo $
s 42,442,98 $
$ 35,157.50
S 23,2!s.75 $
$ 30,644.79 S
$ 465,880.75
5 3,Lo3,124.77
5 z6,e3o.os $
s 90,693,50 s
$ 5,070.00 s$ 15,492,073.00 $
$ s,493,274.00
S 541,579.30
$ 6,153.75
31.98
2,277.33
1,185,01
!72,O93.76
3,382,03
5,67r.7721,006.30
8,583,807,463.2L
51,940.10
3,7!9.4751,940.10
L,3L2,67
7L8.04
947.82
237A.11
2,805,14
756.82
479,L74.65
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
n^^^ 20 aS Ea
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Tirnely Eligible Claims
MedPartners
Class ActionDistribution
{if applicable)
s 95,292.39
$ 90,456,2160L284-t601285.0
601287-6
60L288-4
601292-2
501293-0
6A1294-9
64L295-7
601296-5
601297-3
601298-1
601299-0
501300-7
601301-5
60L302-3
601303-1
601304-0
601306-6
601347-4
601308-2
501310-4601313-9
6At3t4-760131"5.5
601319-8
601322-8
601324-4
6AL325-2
60L328-7
601333-3
601334-1
601335-0
601338-4
601339-2
601340-660L341.-4
607342-2
601343-0
601344-9
6A1347-3
601348-1
601349-0
601353-8
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Vatid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
55,48
39.I499,01
16.03
98.51
5,414,43
S 762,s62.5a
$ 2,932,555.01
s 200,505.06
S 7,596.10
$ 3,148,50
$ 82,687.50
S 8,149.80
$ 77,6!2,50
5 3,411.00
5 16,033.55
$ 31,650,10
5 zsz,zza.g+
S t+g,gsg,e +
$ 27,297.52
$ 144,564.23
S 61,155.60
$ 6i.,841.23
$ t,zla.soS 8,zoa.za
s 3,815.43
$ 8,872,814.10
$ si-0.68
s 864,007.15
s 3,558,92
S +,1go.e g
S 295,028.42
s 606,567.70
S 292.60
5 sL3,272,55
$ 6,227.5L
s 36,908.41
s 121.81
s 11,590.98
5 L,794.20
s 1,265.55
5 3,201'75
$ s18.40
$ 3,185,63
$ 18,375.00
s 3,ooo.oo
s 106,104.87
$ 22,2A9.56
S szz.tz
s
s
$
s)
97.38
252.O5
1_05,50
495.92
978.87
S t,8gt.5s
274,436.62
19,764.50
110.05
9,125.23
18,763".17
192.60
1",141.57
s
$
$
s
$
s
I
s
$
$
s
s
s
6^*^ tn ^t ro
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
{if applicable}
601354-6
601355-4601356-2
601357-0
601358-9
601359-7
601361-9
601363-5
601364-3
601365-1
601366-0601367-8
601368-6
601369-4
601370-8
601371-6
601376-7
6AL377-5
601378-3
601379-1
601380-5
601381-3
601382-1601383-0
601384-8
601385-6
601386-4
6A7387-2
601388-0
601389-9
601390-2
601391-0
60L392-9
601393-7
601394-5
601395-3
601399-6
501400-3
601401_-1
60!442-O
601403-8
601405-4601410-0
1,039,20
25,728,56
3,917.55
130.01
393.32
130.01"
3,595,26
325.01
8,641.65
10,024.80
7,424.00 s602.19
2,473.55
1.,732.0O
866,00
2,165.00
6,210.00 $
4,500.00 s2,25O.A0 s
2,250,00 s31,89
429.O8
572.10
2,064.78
L1,000.70
57,237.64
25,234.27 $
5,184.00 s
52,734.7O
70,260,67
15,751-.72
258,428,20 sLL,964.t53,380.13
93,937,00
51,843.66 $
5,543,30
5,336.92
9,961.88 52t,925.5049,000.0047,935.67 $
3.,363.29
229.62
L92.O8
139.19
69,59
69.59
780.46
160.34
7,993.10
1,603.51
308,12
1,482,57
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
)s)s
$
$
$
$
$
$
$
$
5
s
s
$
$
$
s
s
s
s
s
$
$
s
$
$
$
$
$
$
$
)$
$
)s
s
$
$
s
s
Page 40 of 58
DOCUMENT 3728
Claim No, Status Recognized Loss
Exhibit B-1 - Timely Elisible Claims
MedPartnersClass ActionDistribution
(if applicable)
601411-9
607412-7
601_413-5
501415-1601418-6
6At4L9-4
601420-8601.424-O
603,425-9
601427-5
601428-3
60L429-3.
601430-5
601431-3
601432-t601433-0
60L434-8
601435-6601436-4
601,444-5
6At445-3
601453-4
601456-9
601459-3
601468-2
601469-0
6At472-O
601476-360r.479-8
601480-1
601482-8601483-6
60L484-4601485-2
601486-06A1488-7
601489-5
501490-9
601491.-7
60t494-L601495-0
501496-860L497-6
$ 69,466.32
$ 211,s0
5 7,zoz,ls
s 5,334.99
5 2O7,95L.6L
5 agg,zzl.ta$ 9,415.00
5 zo,zta.u,$ to,7go,og
5 11.t,t3L.28
$ 29,914.50
$ 13,847,30
$ 459,375.00
$ zzl,stl,zos 2,189,83
s 44,417.63
5 L73,356.79
$ zzg,q3zlaS 103,837.00
$ 8,033.07
s 8,033.07
S 3,359,04
S zt,tgo.tq$ z,gtz.to5 14,580.60
$ 1,188.00
S s,zge .gz
S 15,169.94
5 L,251,6r8.27
s 68,739.48
s 1.,230.29
5 145,821,00
S 45,742,00
s 12,966,250.00
$ e 3t,6e g.oo
$ 538,971.00
s 39,134.70
s 37,023.70
5 1",763,754.2A
$ z,zog,zo
$ 1"7,454.64
s 34,033.00
$ 367,195,20
40.29
6,43L.90
s 3,211.68
103.89
673.95
86,98
4s0,96
153.81
S z,L!9.9r
s 2,975,735.06
$ 19,537,37
5 \6,67a.4o
5 r,210.44
$ t,t+s.ts
$ t,osz,o+
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
s
(
$
$
$
$
Page 41 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
601498-4
601"499-2
601501-8
601502-6
60J.503-4
601504-2
601505-0
601506-9
6075A7-7
601508-5
601sp9-3
60151.4-0
60r.515-8
6A15fi-4601518-2
601523-9
601525-5
601526-3
601528-0
601529-8
601531-0
6AL534-4
601535-2
601536-0
601537-9
601538-7
501540-9
601542-5
601543-3
6A1.s44-r
601545-0601546-8
601547-6
601548-4
601549-2
601s51-4
601552-2
601553-0
601554-9
601557-36015s8-1
601559-0601s60-3
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Vatid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$ zgo,ogo,zo
$ 104,995.00
5 62,913.02 s5 627s4
$ 224,253.72
$ 124,305.00
s 812,500.00
5 gq,sgz,gs
$ 72,7L7.oO
$ 66,458.10
$ e1.88
S 86,183,51
s 99,788.00 $
$ s71,907.00 S
s 864.ss $
S 2,733,105.53
S 2,a33,782.!7 $
$ 744,012.75 S
5 3,tsg,ll S
s 101,03
s 13,703.09
$ g,o8+.20 $
$ z,9gg.+o $
$ g,7ts,zs $
I rgs.zo
$ tgo,6se .Eo
$ 3o,zgt,tgS 3L6,838.32 S
S 1,004,636.73
5 252,627,95
$ 6,szt.e s $
$ o,sso.zs
s 75,169.52
S sg7,oos.:o S
s 27,625,50 $
s 286,097.59 $
$ 65,529,25 5
S 33,043.00 $
S 17,317.99 S
$ 812,00 $
$ gg,ttg.og S
$ +7,gog,so $
$ 35,542.00 $
1,000,06
3,086.45
17,689.L!26,74
62,904.77
23,A12.!8
97,54
95.39
92.46
269.56
9,718.04
201,.71
16,609.56
8s4,44
8,843-,26
2,026.82
1,022.02
535.62
25.72
1,209.86
L,48L.8A
!,o99,32
Daoa A) nf \9
DOCUMENT 3728
Claim No Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
601551-1
601562-0
601563-8
601564-660L565-4
601566-2
601567-0
601568-9
601569-7
60L570-0
601s71-9
601573-5
601574-3
601575-L
601576-0
60L577-8
60L578-5
601,579-4
601580-8
60L582-4
601583-2
60L584-0
601s85-9
601586-7
601s87-5
601588-3
601589-1601590-5
601591-3
501592-1
601593-0
601594-8
601595-6
601596-4
6A$97-250L598-0
601s99-9
601600-6
601601-4
601603-0
601604-960160s-7
601608-1
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
3-,754,15
L26,84
84,56
42.28
42.28
42.28
42.28
3-,669.26
10,632.47
3,758.03
566.97
t78,375,119.39
2,837.41
4,118,53
48,998,22
3,346.08
42,385.99
44,743.07
4,190.83.
23,859.85
5,295,29
3,369.2L
7A5.02
5,790.69
200.81
3,394.88
S 4,J.o1.oo
S 56,733,75 $
$ 4,101.00 $
5 2,734,aa $
S 1,367,00 S
$ 1,367,00 s
s 1,367,00 s
$ t,:6z.oo $
S 53,969.50 S
$ 34s.7s
S E+g,zss.oo S
$ 2,524.00
$ rzs,+oz,oo S
S 18,330.75 $
$ s,z67.oo S
S 166,202,!2 $
5 101,791,35 $
5 133,847.70 s
$ g+z.gg
$ 2,930.00
5 734,645.53
$ 1,584,162.00 s
$ 108,182,00 S
$ 1,370,382.00 S
5 r,079,376.L0 S
$ 135,493.00 S
$ saz,gzz.Ts
$ 20,747.96
$ 1,288.31
s 15,957.51
$ 77i",4t3.o0 $
5 t7t,2o2.oa $
$ 108,930.00 $
5 t,zg8,gtS 16,806,76
$ L54,571..52
s 709,232,89
$ 22,794J0 S
$ g,asa,zs
$ 187,219.00 $
$ 34,950.00 $
S 187,876.44
S 109,760.00 $
Pape 43 of 58
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
s 3,830.50601609-0
601611-1
601617-0
601618-9
60!619-7
601620-0
603"629-4
601641-3
607642-L
601.646-4
60t647-2601549-9
601650-2
60L651-0
601652-9
601653-7
601654-5
601655-3
601656-1
601658-8
601661-8
6A1667-7
501669-3
601"678-2
601767-3
601768-I6Afi69-0601793-2
601894-7
601920-0
601929-3
601933-1_
601934-0
60t937-4601940-4601949-8
601952-8
601955-2
601956-0
6A1967-6
601968-4
601 969-2
601970-6
s 123,844,00
5 2i.4,227.t2
S 23,315.00
$ 8,366.00
S 86,069.00
S 16,906.25
$ tg,zoa.oo
$ 158,325,00
s 1,124,00
$ 8,341,4t3.67
$ 3,666,452.40
S 6,107,615.20
$ 487,839,45
$ sqg,qqq.zo
s 219,332.27
$ 1.,869,772,13.
S 26,635.00
$ 47,94!.70
$ azq,zzt.so
s 6,343.00
$ 836,405.70
$ 93,357.00
s r,183,1"44.!5
s 425,475.00
$ 76,355.00
$ 58,443.00
$ 178,386.85
$ 101,250.45
$ 8,953,73
s 4,593.75
$ 41,007.50
$ 101,655.00
$ gat,gst.gs
5 24,770.a0
5 tzqsqgzs$ 130.00
$ +,zeg.sg
s 1,150,05
$ 1,978.60
$ 364.48
S 380,s1
s 42e.s6
$ sss,73
578.48
4,897,0434.77
258,000.29
113,403.56
188,908.83
L7,274.95
20,925.46
6,L16.61,
57,82A.91
999,55
!,959.4631,095.65
196.L9
25,870,47
721.73
258,76
2,662.12
36,594.7r
13,159,89
2,36L.66
L,807,65
1",519.L0
573.96
L,268.35
766,14
3,846,t2
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
132,05
35,57
6L.20
1.L,27
1.1..77
L3.28
17.31
$
$
s(5
$
ss
s
5
$
$
)s
$
$
s
$
$
s
s
$
$
s
s
)
$
$
s
s
$
s
s
n^^^ r1 zl ^{ Eo
DOCUMENT 3728
Claim No
607971.-4
64fi72-2601973-0
601974-9
601975-7
601976-5
601982-0
601984-6
601"985-4
601987-0
601993-5
601994-3
601996-0
601997-8
601999-4
602008-9
602010-0
602013-5
6020t4-3602015-1
602016-0
602AL7-8
602018-6
602019-4
602020-8
64202L-6
602025-9
602029-1
502030-5
602031-3
602432-7
602033-0
602046-1_
602051-8
602054-2602056-9
602467-4
602069-0
602070-4
6A2A7b2602072-A
602073-9
602090-9
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
82,34
82.34
3,654.76
1.64.67
Status Recognized loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistrlbution
(if applicable)
s 1s.18
$ 26e,60
$ s08.93
620.64
12,562.L7
16,455.15
22A.25
1-,067.39
598.78
7,A04.39
29,696.17
3,800.96
280.00
33,993.75
15,950,50
6,725.25
10,951,75
3,165,00
359.38
5,644.00
846,689.00
26,500.0018,L52.00
11,656.50
4,300.00
2,662.00
2,662.Q0
2,662.O0
7\8,L62.885,324,00
1,556.86
839,33
L,878,75
12,488.64
52,A28,84
10,100.00
7,482,00
4,761.40
529.50
28,600.0046,899.95
12,839.00
47,7L5J039,678.00
58,956.00613,800,00
33.01
18.52
216.64
918,50
r77.56
10,009.29
493,34
3.,980.22
338.72
L1.11
174.57
26,1,88.1.4
8L9.65
2,982.36
360.54
133.00
s
s
$
s
$
$
$
s
$
s
$
s
s
$
s
s
)q
$
s
)s
s
$
58.1L
386.25
1,6a9.23
312,39
397,11
7,475,83
1.,227.24
1,823.51
18,882,80
s
$
s
ss
Dnca /lE nf EQ
DOCUMENT 3728
Claim No.
6A2091.-7
602492-5
6027t3-76021.1.6-6
602134-4
602L4t-7602144-1.
602150-6
602157-4
602161,-t
6021.62-0
6A2767-A
602178-6
607197-2
60220r-4602282-A
602293-6
6A2377-7
602319-3
602325-8
602343-6
602344-4
602345-2
6023s0-9
602374-6
602385-1
602388-6
602409-2
60243L-9
602434-3
602483-r602494-7
502498-0
602499-8
502s00-5
602507-2602508-0
602570-2
602518-8
602s2t-86A2578-t602610-9
602614-1
$ 518,037.00
$ 22,1.48.70
$ q,ztg.al
$ 553,480.00
$ 113,868.00
S 2,199,172.00
$ 13.s0
$ 4,365.00
S 96,000.00
S 16,996.00
S 18,111,00
s 2,152.00
$ 3,4s9,477,o0
$ 57,092.00
S 44,729.oa
$ 1,259.10
$ zqz,gtg.oo
s 10,211,65
5 zzt,gzl.oo$ ao.oo
$ L,326,247.74
S L,34t,2L6.70
s 74,855.38
s 24,590.80
$ 6,930.00
S og,4+e .oo
$ 411,415.00
$ zq,gzq.aa
S g,2ge.oo
$ 73,494.AO
$ 3,654.00
$ z,o+s,oo
S 29,057.00
S 56,980.00
S 7s,ggg.oo
S 41,502.00
s 35,352.00
$ 3o8,2oo.oo
S 8i.,436.00
S 40,680,00
$ 751,397.00
5 6,179,264.7O
S 1,360,752.00
3,52r.9468,020.51
134,98
2,969.29
5,004.39
560.17
1,765.86
1",383.47
38.94
6,898.86
31s.8s
7,173,5t
s 35,222.71
S r2,725J9
Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
$ 15,942.63
s 681.38Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
236,46
898.73
L,762.39
2,350,65
1,283.66
\ae3,44
$
s
($
$
5
s
s
$
5
$
$
$
$
$
5
s
s
$
$
$
$
2,5L8.82
23,240.75
19L,124,99
42,088.13
Page 46 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
Claim No.
602616-8
6A26t8-4
602629-0
602647-8
6A2656-7
602657-5
602677-O
602703-2
60273s-0
602737-7
602763-6
602773-3
602784-9
6A2789-O
602804-7
602817-9
602862-4
602873-0
6A2882-9
602884-5
602886-1
602887-0602888-8
602889-6
602890-0
602891-8
602892-6
602893-4
502899-3
602900-0
6A2902-7
602903-5
602915-9
60291,6-7
602917-5602942-6
602943-4
602954-0
6A2964-7
602969-8
6A2974-4
602982-5602983-3
$ rzz,oo
5 3,,007,782.00 $
$ sos,gtz:oo S
S 264,134.00
$ 73,L4!.70 $
$ zg,qsq,lo $$ eeo.1s s
$ 49,314.00 S
S g,sss.+s
S 353,769.00 S
S 17,181,00
$ 168,810,02
$ ogo,gzz.oo $
S g,ttg.so S
$ 30,325.00 S
$ 337,841.60 s
$ 283.20
$ oz,o+s,oo $
5 15,a44.20
$ zga,7q+.ql S
s es6.oo s
$ 1,501.00 $
S 26,521.00 $
$ 7,207.23
S 77,797 ,oo $
5 qJtq.oo S
g 631.23 s
$ 406,35
$ 1,155,00 S
$ zsa.+o
S 2a5,276.0a S
$ os,+sz.oo S
$ 146,630.00 $
$ 44,785.00 S
$ 7,015,00
$ 3,154,115.0o
$ 685,367.60
S 129,758,00 S
$ gs,gzo,oo $
s 34,542.00
$ 166,880.70 s$ sao,zta.gz
S 126,496.00
3L,770.75
L48,785.61,
406.46gtt.02
30,63
1,525.28
10,942.09
18,470.59
96,44
937,9s
ro,449.46
L,919.A6
82.95
30.50
46.43
820,30
2,406.27
145.80
19,52
35.20
6,349.24
2,A24.59
4,535.27
67s,39
4,0L3,42
1,090,07
2,L25.54
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Page 47 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicableI
Claim No.
602987-6
602989-2602992-2
6A2997-3
602999-0
603001-7
603Q12-2
603016-5
603017-3
60301"9-0
603024-6
603026-2
603047-5
603055-6
603056-4
603060-2
603061-0
603062-9
603066-1
603075-0603076-9
603A77-7
603078-5
603080-7
603085-8
603091-2
603094-7
603097-1
603101-3
603104-8
603105-6
603116-1
603125-0
603128-5
603130-7
6A3144-7
603145-5603146-3
6031.47-1"
603148-0
6031s9-5603165-0
603167-6
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
4L5.82
397.79
3L7,87
53.31
267.t316,557.51
LO4.t4
3,986.49
4,577.94
19,273.29
3,637,63
L,997,L8
77.17
2,579,9L
t2,717.57
44,43
95,12
765,88
3,524,56
9,150.93
3,953.42
3,265.35
12,094.80
30,327.38
4A4.78
2,778.09
7,424.13
1A,t72.Ot8,822,71
26,503.38
9,502.7t3,621.26
716,34
5 84,159.00
$ 1,094,250.00
$ 117,608.51 $
S 64,571,00 S
$ z,+gs.oo $
$ 83,4!1,,70 $
5 4r1,174.a7 S
s 2,182.05
$ t,+ao.ss $
5 3,075.62 $
$ 31,683.00 5
$ 113,962,36 s
5 321.,214.A6 s
S 138,122,18 S
s 15,202.60
$ 13,444.88 $
S 12,861.28 $
$ 10,083.66 $
5 z,oql.sa $
$ 8,636.70 $
S 579,689,83 S
S 3,368.30 $
$ tzg,ssg.og S
$ tqg,oog.tz $
$ ozg,tal.gg S
$ 414,539.00
$ 228.90
$ tos,szz.so $
5 423,522.28 S
$ g8o,stz,gs $
$ oo,zg:.gs
S 313,326,13
$ 13,087.50 S
$ 89,819,95 $
$ z4o,ogo.oo $
S 328,87r,43 $
S 309,809.09 S
5 920,252.78 $
s 30,341.55
$ goz,zeg.e s $
5 117,079.00 5
s 2,698,50
$ 23,160.00 $
Dana rlQ nf (Q
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicableI
::
Claim No
503176-5
603L78-t503179-0
603181-1
603184-6
603196-0
603199-4
603200-1
603203-6
603204-4
603210-9
603217-6
603218-4
603219-2
6A322A-6
603223-0
60322.6-5
603228-1.
603229-O
503294-0
603298-2
603303-2
603307-5
603308-3
603309-1
603310-5
603311-3
603312-1
603313-0603314-8
603328-8603329-6
603465-9
603466-7
603457-5603468-3
6A3469-t
603470-5603471.-3
603472-L603473-0
603484-5603485-3
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
z22.OO
7,903,00
43..t3
5,558,56
6,36t.4257,473,88
1,728,49
1.,678,14
t,L3?.9712,689,74
32,12
3",076,66
969.44
201.69
66,047;2t
2,194,12
11,613,96
30,794.22
4,495.37
78,881,13
109,560,93
54,645.17
16,159.84
4,328,34
654.63
8,030,34
1,46.74
2,645,75
3,599.04
319.83
11.45
100.15
44.64
68,87
13.77
s 238,092.50
$ 176.10
s 7,t77,55 $
5 27s3a6.1s $
s 1,329,75 $s r79,7L5,07 s
5 223,LA4.94 $
$ 2,o74,704.72 $
S 55,883.90 $
s 54,256.49 $$ 36,630,50 S
$ 4t0,272.a0 S
$ 730,945.66
$ t,o3g.ss S
s 91,959,60
$ 34,810.54 $
$ 31,343.80 s
$ 1,553.54
$ 3t,zgz.so S
s 5,876.40 s
$ 70,938.40 $
$ 407,977.75 5
S 995,486,26 S
$ 145,340.00 s
$ 2,6i.0,160.89 $
5 372,093.75 $
s 185,587.50 s
$ szz,+aq.to S
S t+,zoo.oo $
S 2,383.50
$ zt,tos,+s $
5 259,629.52 $
S 4,745.45 $
5 4,137.63
$ ss,s+o,oe $$ r!6,36L.41" S
S to,E+o.ao S
$ szo,ar $
S 188,10
$ g,z3g.og $
$ Lqqg,qq $
5 z,zzals S
$ 44s.3s $
D^-^ /lCt ^$ Ea
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
{if applicable}
603486-1
6A3487-0
603489-6603494-2
603495-0603496-9
6A3497-7
603498-5603499-3
603s03-5603505-1
603510-8603511-6
603513-2
603516-7
603527-2
603528-0603535-3
603536-1
603538-8
603542-6
603543-4
603554-0
603563-9
603564-7
603568-0
6A3574-4
603707-O
6037A9-7
6A37tZ-7
60373"4-3
6A3715-1"
603720-8
6A372L-6
503734-8
603739-96A3748-8
603751-8
603752-6
603766-6
603767-4603776-3
603788-7
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s 63.7s
$ 190.9s
$ 20,597.99 $
$ 1i.9,502.56 S
s 17,920,00 $
S 10,354.82 $
s 6,053.54 $
$ tss,zso.oo S
s 52,085.65 $
s 1,356,354.00 $
$ 851,501,00 ss 1,083,632.18 s
$ 2,240,387,82
s 394,735.40
5 4,570,72 5
$ 4s.oo
$ 43,628,43 S
s 474,0A $
S 24,658.25 $
$ 9,069,30 s$ 979,387.50 S
$ 60,637,50 $
$ 378,593.55 $
$ 12,286.89 $
s 73,851.86
$ 136,918,86 $s 1,036.55 $5 22,363.25 $
$ z,zlo,oo $
S 5,931.00 S
$ !,877,75
$ t,stl.ls S
5 205,424.00 s
5 9,007.50 $
$ 36,120.00
5 5z,oaz,5o S
S 1,43"1,56L.42 $
5 1.42,388.70 $
$ 2,502.76
S tot,sqg.qz
s 227,324.00 $
S 1"2,482.25 $
$ 42,898,34 $
637.A4
3,696,22
5s4.27
320,27
787,24
5,838.05
1,61"0.95
169,494.59
24,1"77.93
31,139,95
741".37
3,,349.42
1,4.66
762,64
280.51
722,387,58
7,577.47'1,L,709.87
380,01
4,234.88
32.06
691.69
73.30
183.45
58.06
6,353.78
278.60
L,629.61"
43,659,63
17,793.29
7,O31.t4386.08
48.12
h^-^ rn ^, ro
DOCUMENT 3728
Exhibit B-1 - Timely Eligible Claims
Claim No
603793-3
603798-4
603799-2
603806-9
6A3847-7
603808-5
603809-3
603810-7
603811-5
603820-4603825-5
603832-8
603835-2
603836-0
603837-9
603838-7
603887-5
603976-6
6A3977-4
603978-2
603980-4603982-0
603983-9
603984-7
603985-5
603986-3
603988-0
603993-6
603994-4603995-2
603996-0
603998-7
604070-5
60407I-3604072-L
604073-0604074,8
604096-9
604097-7
6043.1.3-2
60411.4-A
604115-9604Lr6-7
Status Recognized Loss
MedPartners
Class ActionDistribution
(if applicable)
$ 5,190.12
s 2,302.56
s 1,876,65
S 377.47
$ 32.8s
s 33.73
$ 33.78
$ +,e :g.st$ 9,945.74
5 4,521.57
$ 1s1.31
$ 18,961.41-
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
5
s(
s
s
$
$
$
s
)$
$
$
$
s
s(
s
$
s
5
$
s
s
s
$
$
$
$
$
s
s(
$
$
$
$
$
$
s$
s
167,803,95
74,444,14
60,674.29
!2,2A4,00
1,062.00
L,A92.OO
t,o92.oa150,000.00
321,556,00L46,787.50
4,894,11.
15L,735.68
51,069.79
24,333.84
35,379.50
41,279.78
100,440.69
37.80
89.27
s59.50
13.15
12.70
n.7a22.86
7.1.5
77,918.75
25,15
175.1L
37.Ot
33.05
2L.40
3,879,00
875,51
700.40
525.30
1,667.3,8
L,66L.18
6,941,00
s95.80
L0.95
t7.1-1
4,923.41
30,85
s
$
752.62
I,A94.29'J,,276.78
3,106,63
t7,6L
863.53
11_9.98
27,A8
21.66
L6.25
s1.38
51.38
21,4,69
L8.43
$
$
$
$
$
s
$
$(
$
$
$
$
h^-^ c{ ^$ co
152,25
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
604717-s
604119-1
604120-5
604145-0
604146-9604166-3
6043"67-t
604185-0
6A4242-2
604243-O
604256-2
604257-O
604258-9
604259-7
604263-5
604292-9
604307-A
604308-9604323-2
604366-5
604367-4604368-2
604392-5
604393-3
604409-3
60441L-s
604447-6
644448-4
604475-t604479-4604493-O
60466L-4
644667-3
604669-060471,4-9
6A4724-6
604876-5
605003-4
605010-7
605035-2605036-0605117-0
505184-7
1,2.75
. 96.80
22,86
2,L62.09 $
190.20
1,239.53 s221,.34
44L.43 $
31.05
860,48 s
t,7;r.o'J. s
1,400,81 s
t,75t,01" $
L,75',J".0t s
t,845.75 sL,827.O0 $
46t,44 s
461.44 $
3,630.00 $
12.L5
1.95
lL.743,916.50 s4,372.00 $
e13.s0 s
6,2L5.00 $
78.12
6,651".A2 $
6.s5
7s2.s7 $
s77.8r s
t44,t33.0o s112,735.02 s
16,306.73 $
145,340.00 s144,L30.30 $
11,835.52 $
2,7t4.85 s384,e8 $
1,602,00 $
844.s4 s3,988,02 $
t3.44
23.28
30.24
4,458.44
3,486.87
544374,495,37
4,457.89
366.0s
83,97
11.90
49.55
26.12
L23.35
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s
s
)s
$
s
$
s
$
$
s
$
s
$
$
s
$
s
$
$
s
5
)$
$
$
$
$
s
$
$
$
)(
$
s$
$
$
s
$
$
s
66.87
38,34
13,65
26,6L
54,1"6
43.32
54.1,6
54.16
57,09
56.51
1,4.27
14.27
112.28
L21.r2
135,23
28.25
192,23
205,68
Pasp 57 of 58
DOCUMENT 3728
Claim No Status Recognized loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
6051.98-7
605204-5
605210-0
605211-8
605221-5
605222-3
605237-L
605238-0
605382-3
605385-8
605390-4
6054L6-1
60s419-6
605443-9
605444-7
605445-5
605545-1
60s546-0
605547-8
60s654-7605670-9
605671-7
6A5672-5
605694-6
605695-4
605697-0
605698-9
605699-7
605700-4605701-2
605702-0
605703-9
6A5704-7
605705-5
605706-3
605707-1,
605708-0
605709-8
605710-1
605711-060s712-8
605713-660s73.4-4
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
$
s
s
$
s
s
s
s
s((
s
$
$
s
$
s
s
$
$
$
s
s
$
s
$
$
$
s(
5
$
s
s
$
$
$
$(
s
$
$
$
15.55
44,50
162,08
47.45
4,039.70 sL62.48
1,203.00 $
13.70
74,80
8,610,00 s74,80
52.05
15a,L22.25 s
7,624.0A s
38,473.75 $
38,473,75 s
9,558.13 $
30,254.00 s15,068,20 s
s1s.0o s720,59 s
72A.6A $
720.59 $
19,681.06 sla,39t.25
108,654.30 $
23,017.02
700.40 ss2s.30 s
3,822,75 . $
3,822.75 $
3,922,75 s268.43
4e0.80 s3.,751..0L $
1,400.81 $
L,7sL,O'.J- $1",751,A1 s2,9a4,00 s
346.6s s
2,566.50
1",1,63,18 $738,30
124.93
37.21
266,31
4,643.29
235,81
t,r89.971,L89,97
295.63
935,76
466.05
28,30
22.09
22.O9
22.49
608,73
3,360.68
21.66
16.25
718,2t718.21
1-t8.2t
15.18
54,16
43.32
54.16
54.15
89.82
ro.72
n--^ aa ^Ilo
35.97
DOCUMENT 3728
Exhibit B-1- Timely Eligible Claims
Claim No. Status Recognized Loss
MedPartners
Class ActionDistribution
(if applicable)
$ 22.84
s . 22,84
S 80.41
$ 419.26
S tzs,gs
s 113.07
s 1,811.25
5 l,qzg.te$ 6s6,89
S t,aog.oa
$ ss,ss
$ sr,gz
S 340,60
$ zs,so
s s41.8e
$ rs4.e7
$ t+.zt$ n.qzS 67.s0
6A5715-2
605716-0
60s7L7-9
6057L8-7
605723-3
6A5724-t6As726-8
60s727-6
6A5728-4
605729-2
605730-6
605736-5
605737-3
605739-0
605742-A
605744-6
645745-4
6A5746-2
605747-O
605748-9
605749-7
505750-0
505751-9
605754-3
605755-1
60s756-0
605757-B
605758-6
605759-4
60s760-8
505761-6
605762-4
605763-2
605764-0
605765-9
605766-7
60s767-5
605777-3605773-0605774-8
605775-5
6A5776-4
6A5777-?
738.30
738.30
2,599.88
13,555.00
30,139.50
3,655.88
58,562.!4240,!61-.92
2L,239.89
44,283.50
1",926.15
1,678.50
11,012.50
839.25
L7,52O.OA
5,010.6046L.44369.15
2,182.5494.50
2,3.52.50
510.50
27,759.64
454,936.73
633.75
949.20
12,057.95
2,9A3.77
46,2A3.99
14,485.67
462.75g,842.5A
2,7A5.99
39,7L2.0O
2,903.85
12,133.13
2,741",55
1,276,25
5,130,00
3,153,006,43L,25
1,053.30
8A7,978.L6
66.56
15.79
858,59
t4,o7L.2O19.50
29.36
372.95
89.81
r,429.O3
448.O2
14,3t304.41
83.69
1,228.29
89.82
21,.98
84.80
39.47
Lsg,67
97.52
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
q
$
)s
s
s
s
$
s
$
s
s
s
)$
s
s
5
s
$
s
s
$
s
s(
$
$
s
$
s
$
s
s
$
$
s
s
$
$
$
$
$
s
s
$
$
s
s
$
$
$
s
s
$
s
s
$
s
$
s
s
s
$
$
32,58
24,990.77
DOCUMENT 3728
Claim No. Status Recognized Loss
Exhibit B-1 - Timely Eligible claims
MedPartners
Class Action
Distribution(if applicable)
60s778-0
6As779-9
605781-0
605783-7
605788-8
605791-8
605794-2
6A5797-7
605804-3
605810-8
605811-6
605812-4
605819-1
605827-2
605828-0
605829-9
605832-9
60s833-7
605837-0
605838-8
605839-6
605844-2
605846-9
645847-7
605848-5
605851-5
605853-L
505854-0
605855-8
605856-6
505857-4
605862-0
605864-7
505870-1
6A5872-8
605873-6
6A5875-2
60s876-0
605886-8
605891-4
605892-2
605893-0
60s894-9
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s 8,000.27
5 l,sotza$ 36.17
$ 1,199,321.08
$ 25,381-.37
$ 6t9,257.59 ss 241,700,00
s LAtz.zsS 885,545.35
s 14,395.50
S 85,101.70
$ 4,582.76
$ :l+,sgo.qg
$ z,5z+.59
$ 57,050,00 s
$ 17,115.00 s
$ +,se+.oo
$ lo,+tg.zs$ 1,709,998.00 S
S r,922,446.27 S
$ 7,948,308.62 s5 7,940.22
5 2,792.93
$ 59,4 1.25 $
$ zs,sgs.7S s$ go,ozt.t+
$ 87,764.26
S g,zzz.ss $
$ zo+,sa
$ 1,059.52
$ 30,594.75
$ 66,137,00
$ rs,657.27 S
$ 490,056.32
S 27,879.98 S
s 4,200.91
$ 1,,490,354.7a
$ 24,5LO.A3.
$ 98,562.25
$ 2,s+z.La S
$ 32,552,50
$ 30,492,00 S
$ ts,ogg.sz
7,072.01
1,764,56
529.37
52,890.33
59,461..27
245,841".56
1,839.L0
2,337.32
10r.22
484,24
862,30
74.25
943.t2
Page 55 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartnersClass ActionDistribution
(if applicable)
Claim No.
605895-7
605896-5
605898-1
605899-0
605900-7
605902-3
605903-1
605907-4
605908-2
60s909-0
605910-4
605911-2
605912-0
605913-9
605914-7
605915-5
605916-3
60591_7-1
605918-0
605919-8
60s920-1
605921-0
605922-8
605923-6
605926-0
605929-5
605930-9
605931-7
605933-3
605934-1
605935-0
605936-8
605939-2
605940-6
60594L-4
605942-2505943-0
605944-9
605945-7
60s946-s
605947-3
6059s0-3
605951-1
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
s 10,465.00
$ 3,178.s0 $
S 18,935.98
s 43,503.00
$ 990,169.55 $$ za,ttz.oo $
s 9,165,00 $
$ t,zog.oo
s 39,639.60 s
s 4s8,10 $g 4s8,1_o 5
$ 5,738.75 $
$ qaS,zaz,oo
5 99,922.80 s
$ r7,67s.!o $
s t44,7s
$ tz,ze$ rzs.so
S 2,325,60
$ 444,968.38
$ 26,320,00 s
5 s26,247.64
5 74,938.50
$ gat,ott.sg S
S 14,375,99
s 1s2,263,00 $
s 172,941",38 s
S s2,174,62 5
S 23,651-.00 $
s 21,195.00 $
$ 42,7!230 $
$ g,tsg.zs
S gsg.ss
$ 1,646,905.06 S
$ u,413.83 5
$ 2,510.16 $
s 38,329.28
s 8,735.91
$ 8,soz.ge
$ L,245.00
$ go,zga.+s
$ oa,ooz,oo $
S 18,295.00 $
98,30
30,626,00
714.86
283.47
1,,226,04
t4,17t4.t7
t77.48
3,090,62
304.35
814.08
10,547,43
4,749.54
1,982.62
1,673.74
731,53
655,56
7,32r,08
50,938.80
538.59
77.60
2,122,Q2
565,87
Page 56 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 - Timely Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
s e43.L2
Claim No.
605952-0
605954-6
605956-2
605957-0
605958-9
605960-0
605961-9
605963-5
605964-3
605965-1"
605966-0
60s967-8
605968-6
60s969-4
60s970-8
605971-6
605972-4
605973-2
605974-0
60s975-9
605976-7
605977-5
605978-3
605979-1
605980-5
605987-2
605988-0605989-9
605990-2
605991-0
605992-9
605993-7
605994-5
605996-1
60s997-0
605999-6
606000-5
606001-3
606002-1
606010-2
606011-0
606014-5
606015-3
S 30,492,00
S rrr.zs$ 27.e0
5 zz,lzs.ao
$ 66,211.10
S Et,+go.oo
S 7,057.00
$ ].4,?OOjJ'O
$ ag,sgz.so
s 3,660.00
$ 13,512.50
s 9,830,08
$ 3,519,00
$ aso.rg
5 4,330.1L
$ 2t,tog.go
$ 6,817.67
S 7,598.79
$ taa,zgz.+z
$ z:,gts,toS 68,493,12
S 892.88
S 6,019,52
$ 7,755,21"
$ z,oog,qq
$ 3L,947.00
$ 1,053.30
s 1,053.30
$ 1,053.30
S 1,053.30
$ tto,++a,oo
S +o+,9+g.oo
$ zz,3gs.e g
$ 33,647.90
S 7,372.29
5 tz,zal.oo$ 666.30
$ 232,525.00
s 3,115.02
s 312.47
$ 422,88
$ as,gos.zs
S 3g,gzq..oo
703,19
2.,047.91,
973.68
218.27
108.84
26,48
L33.93
21a.82
739.66
186.14
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
ValidValid
Valid
Valid
Valid
Valid
63,96
988.12
32.58
32.58
32,58
32.58
3,60L74
$
$
$
$
$
)$
s
$
s
(
5
s
$
$
$(
$
)$
227.99
zo,6L
7,19r.98
1,41"6.87
t,236.44$
$
Paee 57 of 58
DOCUMENT 3728
Status Recognized Loss
Exhibit B-1 - Timelv Eligible Claims
MedPartners
Class ActionDistribution
(if applicable)
Claim No.
606A27-7
606028-5
606033-1"
606034-0506036-6
606037-4606039-0
606043-9
606044-7
606046-3
606047-3.
606055-2
606056-0
606057-9
606058-7
606060-9
606070-6
606071-4
606073-0
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
Valid
1,995.02
47.51
54.3L
6,898.73
ro,8t4,57147,92
175.44
55,23
L6.1.1
S 4,41"6,00
$ 64,501.00 $
$ 1,536.50 sS t,7s6.oo $
$ 223,043.00 S
$ 349,646.00 s$ q,zgz.sg $
$ 5,olz.zo $
$ t,zss.oo Sg s20.es sS 1,517,10
$ 30,232.00 $
s 20,814.90 $
s 166,133.82
$ 35,708,50
$ 20,157.96
S 7,754,a6
5 197,977 .OO s$ 412,146,80 $
93s.08
643.81
6,123.44
12,747,72
Page 58 of 58
DOCUMENT 3728
EXHIBIT B 2
"Late Claims"
DOCUMENT 3728
Claim No.
103319-0
1a3320-4
103665-3
106505-0
tLl785-8117583-1
300138-5
300139-3
300411-2
300570-4
3A0672-7
300778-2
300780-4
300781-23AA782-O
300784-7
300785-5
300788-0
300789-8300790-1
300791-0
400653-4
4A0654-2
400655-0
4006s6-9
400657-7
400658-5
400659-3
400660-7
400661-5
400662-3
400663-1
400664-0
606075-7
606076-s
606A77-3
606078-1
506079-0
606080-3
506081-1
606082-0
605083-8
606084-6
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
. Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 1 of 32
DOCUMENT 3728
Claim No.
606085-4606086-2
606087-0
606088-9
606089-7
606090-0
606091-9
606092-7
605093-5
606094-3
606095-1
606096-0
606097-8
605098-6606099-4
606100-1.
606101-0
606102-8
606103-6
606L04-4
606105-2
606106-0
606107-9
606L08-7
606L09-5
606110-9
6061,L1.-7
6061-12-5
606113-3
606114-1
60611s-0
606116-8
605117-6
606118-4
606119-2
6063,20-6
606\21-4606L22-2
606L23-0
606L24^9
606!25-7
606126-5
6A6127-3
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 2 of 32
DOCUMENT 3728
Claim No.
606128-L606129-0
606130-3
606131-1606132-0
606133-8
606134-6
606135-4
606136-2
606L37-0
606138-9
606139-7
606140-0
606141-9
606142-7
606143-5506144-3
606145-1
606146-0
6A6t47-8
606148-6
6061.49-4
606150-8
606151-6606152-4
606L53-2
606154-0
6061s5-9
606156:7
606157-s
606158-3
506159-L
606160-5
606151-3
606L62-L
6061-63-0
606164-8606165-6
606166-4
6061,67-2
606168-0
606169-9
606170-2
Late Claim StatusLate
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late'Late
Exhibit B-2 - Late Claims
Page 3 of 32
DOCUMENT 3728
Claim No'
606171-0
606172-9606L73-7
606174-5
606175-3
6A6fl6-1606L77-O
606178-8
606179-6
606180-0
606J.81-8
606182-6
506183-4
606t84-2506185-0
606186-9
6A6L87-7
606L88-5
606L89-3
606190-7
606191-5
606L92-3
606193-1
606194-0
606195-8606196-6
6A6L97-4
606198-2
606199-0606200-8
606201-66A6202-4
606203-2
606204-0606205-9
6062A6-7
6A6207-5
506208-3
606209-L605210-5
6A6ZL3.-3
606212-t606213-0
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 4 of 32
DOCUMENT 3728
Claim No.
6A6214-8
6062L5-6606216-4
6462fi-2606218-0
606219-9
606220-2
606221-0
6A6222-9
606223-7
606224-5
606225-3
606226-L
6A6227-A
6A6228-8
6A6229-6
606230-0
606231-8606232-6
606233-46A6234-2
606235-0
606236-9606237-7
606238-5
606239-3
60624A-7
6Q624t-5
606242-3606243-t606244-A
606245-8606246-6
606247-4606248-2
6A6249-O
606250-4
606251-2
6A5252-0
606253-9
6A6254-7
606255-5606256-3
late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
. Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 5 of 32
DOCUMENT 3728
';
t:il:
i-
,j
:
..
li
5
rl
i
it
Claim No.
606257-1606258-0
605259-8
6A626A-I
606261-0
606262-8
606263-6
606264-4
606265-2606266-0606267-9
606268-7
606269-5
606274-9
606271-7
606272-5
606273-36A6274-t606275-0
6A6276-8
606277-6
606278-4
606279-2606280-6
60628L-4
606282-2606283-0
606284-9
606285-7
.606286-56A6287-3
606288-1
606289-0
606290-3
606291-16062-92-O
606293-8
6A6294-6
606295-46A6296-2
606297-A
606298-9
606299-7
Late Claim Status
Late
Late
Late
Late
' Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - late Claims
Page 6 of 32
DOCUMENT 3728
Clalm No.
606300-4
606301-2
606302-0
606303-9
606304-7
606305-5606306-3
606307-1
605308-0606309-8
606310-1
606311-0
5063J_2-8
606313-6
606314-4606315-2
606316-0
606317-9
60631S-7
606319-5505320-9
60632L-7
606322-5
606323'3
606324-t60532s-0
606326-860ffi27-6606328-4
606329-2
606330-6
606331-46A6332-2
606333-0
605334-9
506335-7605336-5
606337-3
605338-1
606339-0606340-3
606341-L
6A6342.O
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 7 of 32
DOCUMENT 3728
Claim No,
606343-8
606344-6
606345-4
6}ffi46-2606347-0506348-9
606349-7
606350-0605351-9
6063s2-7
606353-5
606354-3
606355-1
606356-0
5063s7-8606358-6
605359-4
606360-8
606361-6
606362-4606363-2
606364-0606365-9
606366-7
506367-5
606368-3
606369-1
606370-5
606371-3
606372-1
606373-0
606374-8
60637s-6606376-4
6A6377-2
606378-0
605379-9606380-2606381-0
606382-9
605383-7
606384-5
606385-3
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late' Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 8 of 32
DOCUMENT 3728
Claim No.
606386-1
606387-0
606388-8
606389-6
606390-0
606391-8606392-6
606393-4
606394-2
606395-0606396-9
606397-7
606398-5
606399-3606400-0
606401-9605402-7
606403-5606404-3
606405-1
606406-0
606407-8
606408-6
606449-4
606410-8
6A647t-6
6064L2-4606413-7
606414-0606415-9
6064L6-7
606417-5
606418-3
606419-1
606420-5
606421,-3
606422-1
606423-O
606424-8
606425-6
606426-4
606427-2606428-0
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 9 of 32
DOCUMENT 3728
Claim No.
6A6429-9
606430-2
606431-0
6A6432-9
606433-7
605434-5
606435-3
606436-1
606437-0
606438-8
605439-6
606440-0
606441-8
6A6442-6
606443-4
606444-2
606445-0
606446-9606447-7
606448-5
606449-3
606450-7
606451-5
606452-3
606453-1
606454-0
606455-8
606456-6
606457..4
60645B-2
606459-0
606460-4
606461,-2
606462-0
606463-9
606464-7
60646s-5
606466-3
606467-t606468-0
606469-8
606470-'J.
606471-O
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page L0 of 32
DOCUMENT 3728
Claim No.
606472-8
606473-6
606474-4
606475-2
606476-A
6A6477-9
606478-7
606479-5
606480-9
506481-7
606482-5
606483-3
606484-t606485-0
606486-8
606487-6
606488-4
606489-2
606490-6606491-4
6A6492-2
606493-0
606494-9
6A6495-7
606495-5
606497-3
606498-1
606499-0506500-7
606501-5
606502-3
506503-L
606s04-0506505-8
606506-6
606507-4
606508-2
605509-0606510-4
606511-2
606512-0606513-9
60653.4-7
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 1L of 32
DOCUMENT 3728
I
.t
Li
ir
{:I
Claim No.
60651s-5
606s16-3
6Q6517-7
606s18-0
606519-8
606520-1606521-0
606522-8
606523-6
6A6524-4
606525-2
606526-0606527-9
606528-7
606529-5
606530-9
606s31-7
606532-5606533-3
606534-1
60653s-0606536-8
606537-6
506s38-4
606s39-2
606s40-6
606s41-4
6A6542-2
606543-0
606544-9
606545-7
606546-5
606547-3
606548-1
606549-0
606550-3
6065s1-1
606552-0
606553-8
506554-6
606555-4
606556-2
606557-0
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
.LateLate
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 12 of 32
DOCUMENT 3728
Claim No.
606558-9
606559-7
606560-0
606561-9
606562-7
606563-5
606564-3
606565-1606566-0
606s67-8
606568-6
606569-4606570-8
606571-6
606572-46A6573-2
606574-0606575-9
6A6576-7
606577-5
606578-3
606579-1
606580-s606581-3
606582-1
606583-0
606584-8
606585-6606586-4
606587-2
606588-0
606589-9
606590-2
606591-0
606592-9
606593-7
606594-5
606595-3
606596-1
606597-0606s98-8
606599-6
606600-3
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 13 of 32
DOCUMENT 3728
Claim No,
606601-1
606602-0
506603-8606604-6
60660s-4606606-2
606607-0606608-9
506609-7
60651.0-0
606611-96066L2-7
606613-5
606614-3
606615-1606616-0
606617-8606618-6
606619-4
606620-8
606621-6606672-4
646623-2606524-0
506625-9
6A6626-7
606627-5
606628-3
606629-L
506630-5
606631-3
606632-1606633-0
606534-8
606635-6
606635-4
606637-2
606638-0606639-9
606640-2606641-0
606542-9
606643-7
Late Claim Status
Exhibit B-2 - tate Claims
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Page 14 of 32
DOCUMENT 3728
Claim No.
606644-5
606545-3
606646-1
606647-0
606648-8
606649-6506550-0
606651-8
606652-6
606653-4606654-2
606655-0
606656-9606657-7
606658-5
606659-3
606660-7
606661-5
606662-3
606663-1-
606664-0
606665-8606666-6
606667-4
606668-2605669-0
606670-4
606577-2
606672-O
606673-9
606674-7
606675-s
606676-3
606677-t606678-0
606679-8
606680-1605681-O
606682-8
606683-6
606684-4605685-2
606686-0
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 15 of 32
DOCUMENT 3728
Claim No,
606687-9
606688'7
606689-5
606690-9
606691.-7
606692-5
606693-3606694-1506695-0
606696-8
606697-6606698-4
606699-2606700-0
606701-8
606702-6
606703-4
606704-2
60670s-0
506706-9
606707-7
606708-5
606709-36A67LO-7
606711-56A67L2-3
606713-1606714-O
606715-8
506716-6
6067L7-46A6718-2
606719-0606720-4
606721-2
60672?-O
6A5723-9
6A6724-7
606725-5
6A6726-3
606727-L
606728-A
606729-8
Late Claim Status
Exhibit B-2 - Late Claims
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Page 16 of 32
DOCUMENT 3728
t.
Claim No.
606730-1
606731-0
6A6732-8
606733-6
6A6734-4
606735-2
605736-0
606737-9
6A6738-7
506739-5
606740-9
606741-7
606742-5
6A6743-3
6A6744-t
606745-0
606746-8
606747-6
6A6748-4
606749-2
605750-6606751-4
6A6752-2
606753-0
606754-9
6A6755-7
606756-s
606757-3
606758-1-
606759-0
606760-3
606761-1
606762-A
606763-8
606764-6
606765-4
606766-25A6767-O
606768-9606769-7
6A6770-O
60677t-96A6772-7
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page t7 of 32
DOCUMENT 3728
:l
Claim No.
606773-s646774-3
606775-7506776-0
6A6777-8
606778-6
606779-4
606780-8
606781-6
606782-4
606783-2606784-O
60678s-9
606786-7
606787-5
506788-3
606789-1
606790-5
606791-3
606792-t606793-0
606794-8
606795-6
606796-4606797-2
606798-0
606799-9
606800-6606801-4
6A6802-2
606803-0
606804-9
606805-7
606806-s506807-3
606808-1
606809-0
606810-3
606811-1
606812-0
606813-8
606814-6
606815-4
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - late Claims
Page 18 of 32
DOCUMENT 3728
Claim No.
606816-2
6068fl^A505818-9
606819-7
606820-0
605821-9
606822-7
606823-5
606824-3
606825-1
606826-0606827-8
606828-6606829-4
606830-8606831-6
606832-4
606833-2
606834-0
606835-9
606836-7
606837-5
606838-3
606839-1
606840-5
605841-3
6A6842-1.
606843-0606844-8
606845-6
606846-4
606847-2
606848-0
606849-9
606850-2
6068s1-0606852-9
606853-7
606854-5
606855-3
606856-1
606857-0
606858-8
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - late Claims
Page 19 of 32
DOCUMENT 3728
Claim No.
606859-6
606860-0
606861-8
606862-6606863-4
606864-Z
606865-0
606866-9
606867-7
606868-5
606869-3
606870-7
606871-5
6A6872-3
606873-1
606874-0
60687s-8606876-6
6A6877-4
606878^2
606879-0
606880-4
606881 -2
606882-0
606883-9
606884-7
606885-5
606886-3
606887-1
606888-0
606889-8
606890-1
606891-0
606892-8
606893-6
606894-4
606895-2
606896-0
606897-9
606898-7
606899-5
606900-2
606901--0
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
lateLate
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - late Claims
Page 20 of 32
DOCUMENT 3728
t
Claim No.
606902-9
606903-7
606904-5
60690s-3
606906-1
606907-0
606908-8
606909-6
506910-0
606911-8
606912-6
606913-4
6A691+2
60691s-0606916-9
6A69t7-7606918-5
606919-3
606920-7
606921-5
6A6922-3
606923-t606924-0
606925-8
606926-6
606927-4
606928-2
606929-0
606930-4
606931-2
606932-0
606933-9
606934-7
606935-s
606935-3
606937-1
606938-0
606939:8
606940-1"
606941-0
606942-8
606943-5
606944-4
Late Claim Status
Late
Late
Late
Lat€
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 2t of 32
DOCUMENT 3728
Claim No.
606945-2
606946-0
606947-9
606948-7
606949-5
606950-9
606951-7
606952-5
606953-3
606954-1
606955-0
606956-8
606957-6
606958-4
606959-2
606950-6
606961-4
606967-2
606963-0
606964-9
606965-7
606966-5
606967-3
606968-1606969-0
506970-3
606971-1
6A6972-0
606973-B
606974-6
606975-4
606976-2
606977-0
606978-9
606979-7
506980-0
606981-96A6982-7
606983-5
606984-3
606985-1
606986-0606987-8
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late €laims
ir
PageZ2 of 32
DOCUMENT 3728
Claim No.
606988-6605989-4
606990-8
606991-6
606992-4
606993-2
606994-0
606995-9
606996-7
606997-5
606998-3
606999-1
607000-0
607001-9
607AO2-7
607003-5
607004-3
607005-1
607006-0
6070a7-8607008-6
607009-4
607010-8
6A7A1b5
607012-4
6A70t3-2
60701"4-0
607015-9
607016-7
607017-5
607018-3
6070L9-1
607020-5
607021,-3
6A7A22-7
6A7AB-0607A24-8
6A7A25-6
607026-4
6A7027-2
6A7028-A
607029-9
6A7$O-2
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-Z - Late Claims
Page 23 of 32
DOCUMENT 3728
it.:
i
:l
it!
!'
li'l
.i
!l
::
I
?
:'
II
:;jj
':
'1,
itii:
l
l.
ll
Claim No.
607031-0
6A7032-9
607035-7
507034-5
607035-3
607036-1
6A7A37-0
607038-8607039-6
607040-060704J.-8
607042-6
6A7043-4
607044-2
60704s-05A7A46-9
607047-7
607048-s
607049-36A7A5A-7
607051-5607052-3
607053-1
607054-0
60705s-8607056-6
607057-4607058-2
607059-0607060-4
6A7061"-2
607062-0
607063-9
607A64-7
607065-s507066-3
6A7067-L
607068-0607069-8
607470-1
6A707L-A
607072-8
607073-6
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late'
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit 8-2 - Late Claims
Page 24 af 32
DOCUMENT 3728
tj
,'
:
;j
t;
lIil
:
Claim No.
607A74-4
6A7A75-2
607076-A
6A7077-9
6A7Aii78-7
607079-5
607080-9
607AU-7607082-5
607083-3
607084-1607085-0
607086-8607A87-6
607088-4607089-2
607090-6
607A9L-4
607092-2
607093-0
607094-9607095-7
607096-5
607A97-3
607098-1
607099-0607100-7
607101-5607t42-3607103-16A7LAA-A
607105-8
607106-5
6A7LA7-4
6A7108-2
607109-0
6A7fiO- 607tLL-2607LIZ-A
6071L3-96A7L14-7
607115-5607116-3
Late Claim Status
Exhlbit B-2 - Late Claims
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Page 25 of 32
DOCUMENT 3728
li:.
ii
;iiiI.
II
i
:
Claim No.
607t17-1"
607118-0607L19-8
6A7t20-16A7t2L-06A7122-86A7123-6
6A7L24-4
607L25-2607t26-A607127-9607L28-7
6A7129-s
607130-9
607L33"-7
607t32-5607133-3607134-L
607135-0
607136-8
6A71.37-6
507138-4
6A7L39-2
6A7MA-6607141-4
607t42-2607143-06A7M4-9607145-7
607L46-5
607t47-36A7M8-t607149-0
607150-3
607t5L-1.6A7L52-O
607153-8
6A7154-6
5A7L55-4
607156-2
607157-0
6071s8-9607159-7
Late Clalm status
Exhibit B-2 - Late Claims
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
.Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Page 26 of 32
DOCUMENT 3728
Claim No.
607L60-06071.61-9
607162-7
6071-63-5
607764-3
607165-l_
607166-0607767-8607168-6
607169-46A7fi0-860717L-6607172-4
6A7773-26A7174-O
607175.9
607176-7
607177-5
607L78-3
607L79-t607180-s6071 81-3
6A7182-L
607183-O
607184-8
6A7785-5
6071.86-4
6A7787-2
607188-0
607189-9
607L90-2
607191-0
607192-9
607193-7
607L94-s
607195-3
607196-t607197-A
607198-8607199-6
607200-3
6072A1-1
6072A2-O
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page27 of32
DOCUMENT 3728
Claim No.
607203-8
6A72A4-6
607205-4
6A72A6-2
6A7207-0
607208-9
607209-7
607210-A
607211-9
6A72L2-7
6A7213-5
6072L4-3
6A7215-L
607216-0
6A72fi.-86A72L8-6
60itz19-4
6A7220-8
6A72Zt-6
607222-4
607223-2607224-A
6A7225-9
607226-7
6A7227-5
607228-36A7229-t
607230-5607231-3
6A7232-3.
607233-0
607234-8607235-6
6A7236-4607237-2
607238-0607239-9
607244-2
607z4l.-A
607242-9
607243-7
6A7244-5
607245-3
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 28 of32
DOCUMENT 3728
ri
I
Claim No.
6A7246-t
607247-0
607248-86A7249-6
507250-0
607251-8
607252-6
607253-4
607254-2
607255-0
607256-9607257-7
607258-5
607259-3
607260-7
6A7261.-5
6A7262-3
607263-t607264-0
60726s-8
607266-6607267-4
607268-2
607269-06A7274-4
6A7271"-2
607272-O
6A7273-9
607274-7
6A7275-5
607276-3607277-1
607278-0607279-8
607284-L
6A728L-0
607282-8
607283-6607284-4
607285-2607286-0
6A7287-9
607288-7
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 29 of 32
DOCUMENT 3728
1l
Claim No.
6A7289-5
607290-9
60729L-7
6A7292-5
607293-36A7294-1
607295-0
607296-86A7297-6
6A7298-4
607299-2607300-0
607301-86A7302-6
607303-4
607304-2
607305-0607306-9
607307^7
607308-5
607309-3
607310-7
607311-5
6073t2-3607313-1-
60731,4-0
6073L5-8
6073L6-6
607377-4
6A73t8-2
507319-0
6A7320-4
6A732L-2
607322-0
607323-9
60v324-7
607325-56A7326-3
607327-1
6A7328-A
607329-8
607330-1
607331-0
Late Claim Status
Laie
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 30 of 32
DOCUMENT 3728
Claim No.
6A7332-8
607333-6
6An34-4607335-2
607336-0607337-9
607338-7
607339-5
607340-9
60734t-7607342-5
607343-3
607344-t607345-0
607346-8
607347-6
607348-4
607349-2
607350-6
6A7357-4
607352-2607353-0
607354-9
607355-7
607356-5
607357-3
607358-1
607359-0
607350-3
607361-t607362-0
607363-8
607364-6
607365-4
6A7366-2
607367-O
607368-9
607369-7
607370-0
6A7371.-9
6An72-7607373-5
6A7374-3
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Exhibit B-2 - Late Claims
Page 31 of 32
DOCUMENT 3728
Claim No.
6}n75-t.6A7376-0
6A7377-8
6A7378-6
607379-4
607380-8
607381-5
607382-4607383-2
607384-0
607385-9
507386-7
607387-5
607388-3
607389-1
607390-s
607391-3
6A7392-t607393-0
6A7394-8
607395-6
607396-4
607397-2607398-0
607399-9
607400-6
607401"-4
6A74A2-2
607403-A
607404-9
60740s-7
607406-5
607407-3607408-1
607409-06074L4-3
60741L-1.
607412-0
607413-86A74t4-6
6074ts-4
Late Claim Status
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
Late
' Late
Late
Late'
Late
Late
Exhibit B-2 - Late Claims
Page 32 of 32
DOCUMENT 3728
EXHIBIT B A 3
"Rejected Claims"
ii
ai
t:i
1l
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No,
115839-2
300001-0
300003-6
300004-4
300006-0300007-9
300009-5
300010-9
300011-7
300012-5
300013-3
300014-1
300015-0
300016-8
300020-6
300021-4
30a422-2
300023-0
300024-9
300026-5
300427-3
300028-1300029-0
300031-1
300034-6
300035-4
300036-2
300037-0300038-9
300043-5
300044-3
300046-0
300047-8
300049-4
300051-6
300052-4
300053-2
300057-5300059-1
30006L-3
300062-1
300063-0
300064-8
300065-6
300066-4
300069-9
Status
Duplicate
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DuplicateDuplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
^---. -t4^^
DOCUMENT 3728
Claim No.
300071-0300072-9
300a73-7
300074-5300075-3
300076-1
300078-8300079-6
300081-8300082-6
300083-4300084-2
30008s-0
300088-5
300094-0300096-6
300097-4300098-2
300099-0
300103-2
300105-9
300107-5
300110-5
300111-3
300113-0
300114-8300115-6
300116-4
3AOlg-2300118-0
300120-2
300121-0
3AOt22-9
3AOL23-7
300124-5
300125-3
3AOn7-O
300132-6
300133-4300134-2
300135-0300136-9
3AOB7-7
3AAt40-7
300141-530ar42-3
StatusDuplicate
Rejected
Duplicate
Duplicate
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Excluded
Excluded
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DuplicateRejected
Duplicate
Rejected
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Rejected
DuplicateDuplicate
DuplicateDuplicate
Rejected
Excluded
Duplicate
Rejected
Rejected
Duplicate
DuplicateDuplicate
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 2 of 124
DOCUMENT 3728
Claim No.
30014s-8300146-6
300150-4300151-2
300153-9
300154-7300162-8
300163-6300170-9
300172-5300173-3
3AOr74-3.
3001 75-0
300L76-8
300L77-6
300178-430a!79-Z300L80-6
300181-4300182-2
3001 83-0
300184-9
300185-7
300188-L300191-1
300193-8
300194-6300196-2
300197-0
300198-9
300t 99-7
300200-4300201.-2
300202-0
300203-9
300206-3
3AO2A7-L
300208-0300209-B
300210-1
30021J-A
300212-8
300214,4
3042fi-9300218-7
300221-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DuplicateDuplicate
Duplicate
DuplicateRejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 3 of 124
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
300222-5
344224-]300227-6
300228-4304229-2
30an2-2300233-0
300234-9
300235-7300237-3
300238-1
300239-0
300244-630a248-9
3AA249-7
300250-0300252-7
300253-5
300255-1300256-0
300257-8
300260-8300261-6
300262-4
300267-5
300268-3
300269-1300270-s
340272-t30a274-8304275-6
300276-4
300280-2
300281-0
300285-3
300287-A
300288-8
300289-6300290-0
340292-6
300293-4340294-2
300295-0300296-9
300297-7
300298-5
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Excluded
Rejected
Duplicate
Rejected
Rejected
Excluded
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Excluded
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DOCUMENT 3728
Claim No.
300301-9
300302-7
300303-5
300304-3
300305-1
300308-6
300309-4
300310-8
300311-6300316-7
300317-5
300318-3300319-1300321-3
300322-I300323-0
300326-4
300327-2
300328-0
300329-9
300330-2
300331-0
300332-9300334-5
300335-3300336-1
300337-0
300338-8300339-6
300341-8
300342-6
304344-2
300345-0
300346-9
300348-5
300350-7
300351-5
300352-3
300353-1
300354-0
30035s-8
300356-6
300359-0
300360-4300361-2
300362-0
Status
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Excluded
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Duplicate
Duplicate
Rejected
Excluded
Rejected
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Pase 5 of L24
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
300363-9
300365-5
300366-3
300367-L
300368-0300369-8
300370-1
300373-6
300374-4
300375-2
300377-9
300380-9
300382-5
300384-1
300386-8
300387-6
300390-6
300393-0
300394-9
300395-7
300396-5
300397-3
300400-7
300403-1
300405-8
300407-4
300409-0
300410-4300418-0
300419-8
300420-1
3AO42t-A
340422-8
300423-6300425-2
30a428-730a429-5
300430-9
3AO$b7300432-5300433-3
3A0$8-4300439-23AO444-9
304447-3300449-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DuplicateRejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Excluded
Rejected
Rejected
DOCUMENT 3728
Claim No.
300450-3
300451-1
300452-0
300453-8
300456-2
300458-9
300461-9
30a462-7
300463-5
300465-1
300473-2
300478-3
30a479-1.
300480-5
300481"-3
300482-1
300484-8
300485-6
300486-4
300487-2
300488-0
300489-9
300490-2
300491-0
300492-9
300493-7
300494-5
300495-3
300496-1
300498-8
300501-1
300502-0
300505-4
300507-0
300508-9
300511-9
3AO5t2-7
300513-5
300518-6
300519-4
300520-8
30as22-4
300523-2
300525-9
300526-7
300528-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Excluded
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 7 of 124
DOCUMENT 3728
Claim No.
300529-1_
300532-1
300533-0300535-6
300536-4
300s37-2300540-2
300543-7
300544-5
300545-3
300546-1
300551-8
300552-6
30055s-0
300556-9
300557-7
300558-5
300559-3
300560-7
300562-3
300563-1
300564-0
300565-8
300566-6
300568-2
300569-0
300573-9
3AA574-7
300575-5
300576-3
300577-L300578-0
300582-8
300583-6
300585-2
300587-9
300588-7
300s90-9
300592-5
300594-r.
300595-0300600-0
300602-6
300605-0
300606-9
300607-7
Status
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Duplicate
Exhibit B-3 - Rejected Claims
Paee 8 of 124
DOCUMENT 3728
Claim No.
300609-3
300611-5
300612-3
3006L3-1
300514-0
300615-8
300616-6
3006!7-4300618-2
300619-0300621-2
300624-7
300626-3
300627-L300628-0
300630-1
300632-8
300633-6
300635-2
300636-0
300637-9
300639-5
300640-9
30a64L-7
300644-1
300645-0
300646-8
300647-6
300648-4
300649-2
300650-6
300651:4
300552-2
300654-9
300655-7
3006s6-5
300657-3
300658-1
300665-4
300666-2
300667-0
300670-0
300573-5
300674-3
300676-0
3AA677-8
Status
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Rejected
Duplicate
Rejected
Rejected
Duplicate
Exhibit B-3 - Rejected Claims
Page 9 of L24
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No,
30a679-4
300680-8
300683-2
300684-0
300686-7
300687-5
300594-8
300695-6
300696-4
3A0697-Z
300698-0
300699-9
30a707-4
3007t3,-1.
300713-8
300716-2
30a7fi-o300723-5
300726-A
3AO732-4
300735-9
30a742-L
300743-0
3AO746-4
300748-O
300749-9
30a754-2300755-3
300761-8
300762-6
3AA7ffi-4300772-3
300773-1
30a774-0
300775-8
300776-6
3A0777-4
300779-0
300783-9
400001-3
400002-1
400003-0400004-8
400005-6400006-4
400aa7-2
Status
Duplicate
Rejected
Duplicate
Rejected
Rejected
Rejected
DuplicateRejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Duplicate
DuplicateDuplicate
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Duplicate
Rejected
Rejected
DOCUMENT 3728
Claim No.
400008-0
400009-9
400010-2
40001 2-9
4000L3-7
400014-5
400015-3
400016-1
400017-0
400018-8400020-0
400021-8
4AAO22-6
400023-4400024-2400025-0
400026-94AOA27-7
400028-5
400029-3
400030-7
400031-5
400032-3
400034-0
400035-8
400036-6
400037-4
400038-2
400039-0
4AO040-4
400041,-2
400042-o
400043-9
400044-7
400045-5
400046-3
404a47-L
400048-0400049-8
400050-1_
400051-0400052-8
4000s3-6
400054-4400055-2
400056-0
Status
Rejected
Rejected
Rejected
Duplicate
Duplicate
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Rejected
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Duplicate
Rejected
DuplicateDuplicate
Duplicate
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Pase 11 of 124
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
400057-9
400058-7
400059-5
400060-9
400061-7
400063-3
400064-1
400065-0
400066-8
400067-6400068-4
4A0069-2
400070-6400471-4
400072-2
400073-040a074-9
4AOO75-7
400076-5
400077^3
400078-1
400079-0400080-3
400081-1400082-0
400083-8
400084-6
400085-4400086-2400087-0
400088-9400090-0
400091-9
400092-7
400094-3
400095-1400096-0
400097-8
400098-6
400099-4
400100-L
400102-8400103-6
400104-4
400!05-2400106-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Duplicate
Rejected
Duplicate
Duplicate
Rejected
Duplicate
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Rejected
Duplicate
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DOCUMENT 3728
Claim No.
400t07-9400108-7
400110-94AO1t1,-7
404]12-5400113-3
4001,14-L
40011,6-8
4Aotfi-640a178-4
400119-2400120-6
4AO121-4
40a122-2
400123-a
400t24-9400125-7
4AAL27-3
400r28-t400t29-o400130-3
400131-1
400132-0
400135-4
400136-2
400137-A
400138-9
400139-7
400140-0400!41-9400L42-7
400143-5400144-3
400145-7
400146-0
400147-8
400148-64001.49-4
400150-8
400151-6400152-4
400153-2
400154-0
400155-9
400157-5400158-3
Status
Rejected
Duplicate
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejecied
DuplicateDuplicate
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
DuplicateDuplicate
Rejected
Duplicate
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 13 ot 724
DOCUMENT 3728
Claim No.
400160-5400161-3
40at62-t400165-6
4003,66-4
404167-2
400168-0
400169-9
400u4-2400171-o
4AOL72-9
40afi3-7440fi4-5400r.75-3
400176-L
400178-8
400180-0
400181-8
400L82-6
40aL83-4
400184-2
400185-0
4AOr87-7
400188-5
400189-3400190-7
400L91-5
400L92-3400194-0400195-8
400196-6
4003_97-4
4AO198-2
400199-0
400200-8400201-6404242-4
400203-2400204-0
400205-9
400206-7
400247-5
400208-3
400209-14AO2L0-s
4A021t-3
Status
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Rejected
Duplicate
Duplicate
Rejected
Rejected
Excluded
Duplicate
Duplicate
Rejected
Excluded
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Exhibit B-3 - Rejected Claims
Daoa 11I nf 1)11
DOCUMENT 3728
I
:
Claim No.
400772-t4002L3-0400215-6
4002t6-4400217-2
400218-0
4002L9-9
40a224-2400221-A
400222-9
40a223-7
40a225-3
400226-L400227-O
400228-8400229-6
400230-0
400231-840a232-6
40a233-4400235-0
400236-9404237-7
400238-5
40a239-3
400240-7
400241-5
400242-3
400243-1
404244-O
4AA245-8
400246-6
400247-4
400248-2400249-O
404250-4
400251-2
400252-A
400253-9
400254-7
400255-5400256-3
40a257-t400260-1
40a26L-O
400262-8
Status
Rejected
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
D>so 1\ nl 11A
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
4A0263-6
400264-4
400265-2
400266-0
400267-9
40a269-5
400271-7
4AO272-5
400273-3
4AA274-1.
400275-O
400276-8
400278-4
400279-2400281-4
404282-2
400283-0
400285-7
400286-5
400287-3400288-1
400290-34042v.-1"
400293-84A0294-6
400295-4
4AA296-2
400298-9
400299-7
400300-4
400301-2
400302-0
400303-9
400304-7
400305-5400306-3
400307-t400309^8
400310-1
400311-0
400312-8
400313-6
40031.4-4
40031_5-2
400316-0
400318-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Duplicate
Rejected
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
^^-^ 4a ^t4aA
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
400319-5
400320-9
400323-3
4Ac:24-3.
400325-0400326-84AO327-6
40a328-4
400330-6
400333-0
400334-9
400335-7
400336-5
400337-3
400338-1
400340-3
400341-1
400342-O
440344-6
400345-4
4Ac346-2
400347-O
400348-9400349-7
400350-0
400351-9
40a3s2-7400355-1
400357-8
400358-6
400359-4
400360-8
400361-6
4A0362-4
40a363-2400364-0
400365-940a366-7
400367-5
400368-3
400369-1
400370-5400372-7
400374-8
40037s-6400379-9
Status
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Rejected
Duplicate
Rejected
Duplicate
Rejected
Duplicate
Rejected
Rejected
Duplicate
Rejected
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Excluded
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
DOCUMENT 3728
Claim No.
400380-2400381-0
400382-9400384-5
400385-3
400388-8
400389-6400390-0
400391-8
40a392-6
400393-4
40a394-2
40039s-0
400396-9
400397-7
400398-5400400-0
400401-9
400403-5
400404-3
400405-1
40a407-8
400410-8400411-6
4004t2-44004I3-2400414-0400415-9
40a416-7
400418-3
4AA422-1.
400423-0
400424-8
40a425-6
400426-4
400427-24AO428-0
4A0429-9
4AO430-2
4AO433-7
4AA434-5
4AA436-r
400437-O
400438-840044L-8
400442-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
flrao 't Q a{ 11A
DOCUMENT 3728
:
i
Claim No.
40a444-240a445-A
4A0446-9
40a447-7
400448.5
4A0449-3
400450-7
400451-5
400452-3
400453-1
400454-0
400455-8
400457-4
4AO458-2
400460-4
40a461-2
400462-0
400463-9
4A0464-7
400465-5
400466-3
400467-L400469-8
400470-t400471-4
40a472-840a473-6
400476-0400477-9
400478-7
4AA479-5
400480-9
4A0481,-7
400482-5
400483-3
400484-1
400486-8400488-4
400489-24AA490-6
400492-2
400493-0
400495-7
400496-5400500-7400501-5
Status
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Excluded
Excluded
Excluded
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DuplicateDuplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Droa 10 n$ 1)A
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
400502-3
400503-L
400504-0
400505-8
400506-6
4A4507-4
400508-2
400509-0
4AOXt2400512-0
400513-9
4AO514-7
400515-s400516-3
400519-8
400520-1
400521-040a522-8
400523-6400524-4
400527-9
400530-9
400532-5
400s33-3400534-1
400537-6
400539-2400540-6
40a541-4400542-2
400543-0400546-5
400547-3
400552-0
400554-6
400555-4400556-2
400s57-0
400558-9
400561-9
400562-7
400563-5
400564-3
400565-1
400s68-6
400570-8
Status
Rejected
Rejected
Duplicate
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DOCUMENT 3728
Claim No.
400571-6
400572-4
400576-7
400577-5
400581-3
400582-1
4005s3-0
400s84-8
400585-6
400586-4
400588-0400590-2
400s91-0
400593-7
400594-5
400596-1
400601-1
400602-0
400603-8
400604-6400605-4
400606-2
400607-0
400608-9
400609-7400610-0
400511-9
400613-5
4006L4-3
400615-1
400616-0400677-B
400618-6
40061_9-4
400620-8
40a621-6
4A0622-4
400623-2400624-0
4A0626-7
400627-5400628-3
400630-5
400631-3
400632-t400633-0
Status
Rejected
Rejected
Rejected
Duplicate
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DuplicateDuplicate
Duplicate
Duplicate
DuplicateDuplicate
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Duplicate
Duplicate
Rejected
Exhibit B-3 - Rejected Claims
Daoe )1 af 1)L
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
400634-8
400635-6400636-4
400637-2
400638-0
400639-9
40064A-2
400641-0
400642-9
400643-7
400644-5
400645-3
400646-1
4A0647-O
400648-8
400651-8
400652-6
600001-0600002-9
600003-7
600004-5
600005-3
600006-1
600007-0
600009-6
600010-0
600011-8
600012-6
600013-4
600014-2
600015-0600015-9
600017-7
60001"9-3
600020-7
600022-3
600023-1'600024-0
600025-8600027-4
600028-2
600029-0600030-4
600031-2
600032-0600034-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejecied
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DOCUMENT 3728
Claim No.
600035-5
600036-3
600037-1
600038-0
600039-8
600040-1
600041-0600042-8
600043-6
604444-4
600045-2
600046-0
600047-9
600048-7
600049-5
6000s0-9
600051-7600052-5
600053-35000s4-1
600055-0600056-8
6000s7-6600058-4
600059-2
600060-6600061-4
6A0062-2
600063-0
600064-9
600065-7
600066-5600067-3
600068-1
600069-0600070-3
600071-1
600072-0
600073-8
600075-4600076-2
6AA077-O
600078-9
604079-7
600080-0
60008L-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Drna .)l nI 11A
DOCUMENT 3728
Claim No.
604082-7
600084-3
600085-1
600087-8
600088-6
600089-4
600091-6
600092-4
600093-2
600094.0600095-9
600096-7
600097-5600098-3
600099-1
600100-9
60010L-7
500102-s
600103-3
600104-1
600108-4
600r12-2600114 9
6001L5-7
600L19-0600120-3
604t22-o600123-86A0124-6
600Lzs-4600129-7
600130-0
600131-9
6A0t32-7
600133-5
500134-3600135-L
600136-06AU.43-2
600148-3
600149-1
600152-1600153-0
600160-2
600161-0600L62-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Daoc ?4 nf 1)A"
DOCUMENT 3728
Claim No.
600163-7600164-5
60016s-3
600166-1
600L67-0
600168-8
600169-6
60ant8600172-6
604L77-7
500178-5
600183-1
6001_88-2
600190-460079L-2600193-9
6AA194-7
600199-8
600200-5
604202-1.
500203-0
600204-8
600205-6
600207-2
600208-0
600209-9600211-0
60a212-9
6A0213-7
600216-1
60a2L7-A
600220-0600224-2
60a227-7
600239-0
600240-4
60024L-2600242-O
600243-9
600244-7
600245-5
60a246-3
600247-t500248-0600251-0500252-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Droo ?E n{ 1)L
DOCUMENT 3728
Claim No.
500253-6
600254-4
600255-2
600256-0
6002s7-9
600258-7
600259-5
6A0262-5
600263-3
60a264-t600265-0
600266-8
604267-6
600268-4
600269-2
600271-4
6A0272-2
600273-O
600274-9
604275-7
600276-5
600277-3
600278-t600279-O
600280-3
600282-0
600284-6
600285-4600286-2
600287-0
600288-9500289-7
600290-0
600295-1
600296-0600297-8
600300-l_
600301-0
600302-8
600303-6600305-2600307-9
600308-7
600309-5
600311-7600320-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Reiected Claims
rJaaa 1A al 1', A
DOCUMENT 3728
Claim No.
60032t-4600334-6
600339-7
600341-9
600343-5
600347-8
600348-6
600350-8600355-9
600356-7
600357-5
600358-3
600361-3
600362-1500365-6
600373-7
600374-5
600375-3
640376-L600377-O
600378-8
600379-6
600380-0
600381-8
600382-6600383-4
600384-2
600385-0
600386-9
600387-7
600388-5
600389-3
600390-7
600391-5
600392-3600393-1
600394-0
600395-8
600396-6
604397-4600398-2
600399-0
600400-8
600401-6
6A0402-4
600403-2
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Paee27 of 124
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
600404-0
600405-9
600406-7
600407-5
600408-3
600409-1
600410-5
6AA412-7
600413-0
600414-8
600415-6
600416-4600417-2
600419-9
600420-2
640422^9
600424-5
60a426-t6A0427-A
600431-8
600432-6
600434-2
600436-9
6A04'37-7
600439-3
500445-8
600449-0
600452-0
600455-5
600459-8
600461-0
604462-8
600465-2
600470-9
600475-A
600480-6
600482-2
600487-3
600488-1500489-0
600490-3
600491-1
600499-7
600503-9
6AA504-7
600506-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
t
DOCUMENT 3728
Claim No.
600s07-1
600510-1
600513-5
6005L5-2
6005L6-0
600517-9600519-5
600520-9
60052!-7600522-s
600s23-3
600524-1
600525-0
600528-4
600529-2
600530-6600531-4
600532-2
600533-0600534-9
600538-1
600541-1
600542-0
600543-8
600545-4
600547-0
600550-0
600552-7
600554-3
600s55-1600574-8
600s75-6
600576-4600577-2
600578-0
600579-9
600580-2
600581-0500582-9
600585-3
600586-1
600590-0
600591-8
600592-6
600593-4
600594-2
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 29 of L24
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
600595-0600596-9
600597-7
600598-5
600599-3
600600-0
600601-9
600602-7
600604-3
600606-0
500607-8
600608-6
600609-4
600610-8
600611-6
600612-4
600613-2
600614-0
600615-9
600616-7
600617-5
600618-3
600619-1
604622-1.
600623-0
600624-8
600626-4
600628-0
600629-9
600630-2
600631-0600632-9
600635-3
600636-1
500537-0
600639-6
600640-0
600541-8
600642-6600643-4
600645-0
600646-9
6A0647-7
600648-5
600649-3
500650-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
h -- ^^ -ae^t
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
500651-5
600652-3
600653-1
600654-0
600655-8
600656-6
600657-4
600658-2
600659-0
600661-2
600663-9
600667-1^
600669-8
600670-1
600671-0
600675-2
600679-5
600680-9
600681-7
600682-5
600683-3
600684-1
60068s-0
600686-8
600687-6
600688-4
600689-2
600690-6
600695-7
600696-5
600697-3
600699-0
60a700-7
600701-s
60a702-3
600703-1
600704-0
600705-8
6A0707-4
60a71I-26A071Z-O
600713-9
600714-7
600715-5
600717-t600718-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DOCUMENT 3728
Claim No.
6A0720-L
60a721-o
60a723-6
600725"2
600726-0
604727-9
600728-7
600729-5
600730-9
60a737-7
600732-5
600733-3
600735-0
600736-8
600737-6
600738-4
600739-2
600740-6
60a741.-4
604742-2
600743-06A0744-9
60474s-7
6A4747-3
600748-L604749-O
600750-3
600751-1500753-8
600754-6
600755-4600756-2
600759-7
600760-0
600761-9
600762-7
600763-5
600764-3
600765-1
600766-0
600767-8
600768-6
600769-4600770-8
60a77L-6600772-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Paee 32 of 124
DOCUMENT 3728
Claim No.
600773-26A0778-3
600779-r600780-5
600781-3
600783-0600784-8
600785-6600787-2
600788-0
600789-9
600790-2
60079i-0600792-9
600793-7
600794-5
500795-3
600796-l_
600797-0
600798-8
600801-1
600802-0600803-8500804-6
500805-4600807-0
600808-9600811-9
600813-5
600814-3
600815-1
600816-0
600817-8
6008L8-5
600820-8
600822-4
600823-2
600824-0600825-9
6A0826-7
600827-5
600828-3
600829-1
600830-5
600831-3
600832-1
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
D:oa ?? nl 11A
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
600833-0
600834-8
500835-6
600836-4
60a837-2
600838-0
600839-9
600842-9
600843-7
600844-5
600845-3
600848-8
600849-6600850-0
600851-8
600852-6600853-4
600854-2
600855-0
600856-9600857-7
600860-7
600861-5
600862-3
600863-1
600864-0
600865-8
600866-6
6A0867-4
60a871.-2
600873-9
600874-7
600877-1.
600878-0
600879-8600880-1
60088L-0600882-8
600883-6
600885-2
600886-0
600887-9
600888-7
600889-5
600890-9
600891-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
d^-^)n ^sa1A
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
600892-5
600894-1
600896-8
600897-6
60089B-4
600905-0
600906-9
600907-7
600908-5
600909-3600910-7
600911-5600912-3
600913-1500914-0
600916-6
600918-2600919-0600920-4
600921-2
600922-O
600924-7
600925-5
600926-3
60a927-t600929-8
600930-L
600931-0
600932-8
600933-6
600934-4
600935-2
600936-0600937-9
600939-s
600940-9
60094L-7
600942-5600943-3
600945-0600946-8
600947-6600956-5
600958-1
6009s9-0600960-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Duplicate
h--^ tr -44^,
DOCUMENT 3728
Claim No.
600962-0
600963-B
600965-4600966-2
600967-0
600968-9
500970-0
600971-9
600974-3
600978-660a979-4
600981-6
6A0997-2
600998-0
600999-9
601003-2601004-0
601007-5
601008-3
601009-1
601011-3
60totz-7601013-0
6010L6-4
6AlA27-O
601028-8
501 029-6
601030-0
601031-8601032-6
601033-4
60L034-2
601035-0
601a40-7
601042-3
601045-8
601046-6
607047-4601048-2
601049-0
601052-0
6010s5-5
60L057-1
601060-1
601062-8601066-0
Status
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 36 of 124
DOCUMENT 3728
Claim No.
601070-9
60to7t-7501073-3
601074-1.
601075-0
601076-8
60rc77-6601078-4
6ALA82-2
601083-0
601085-7
601086-5
601087-3
601088-1
601089-0
601090-3
601091-1
601092-060L093-8
601094-5
601095-4
601097-0
601098-9
6A7A99-7
601100-4
6AILOL-2
6011"02-0
601103-9
601110-1
601119-5
601120-9
6ALn2-56A7123-3
60Lt24-t601t26-860L729-2
6A1131-4
601132-2
601133-0
601137-3
601138-L50Lr74-8601181-0601184-5
601185-3501189-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
l-rana ?7 a$ 11 A
DOCUMENT 3728
Claim No.
601191-8
601200-0
601201-9
601208-6
601249-4
6At2t7-66012t3-26At2L4-A
601215-9
6412L6-7
501217-5
60122L-3
601226-4
601229-9
601234-5
60L239-6
601240-0
64L243-4
601245-0
601246-9
6A1247-7
641249-3
601256-6
601264-7
601274-4601277-9
601286-8
601289-2
601290-550129t-4601305-8
601309-0
6ABLL-2601312-060r.316-3
601317-L601318-0
60132A-1601321-0
601323-6
601326-0601327-9
601329-5601330-9
60133L-7
601332-s
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Duplicate
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 38 af 724
DOCUMENT 3728
I
Claim No.
601336-8
601337-6
601345-7
601345-5
601350-360135L-1
601352-0601360-0
607362-7
601372-4
6A1373-2
6AL374-O
601375-9
601396-1
601397-0
601398-8
60L404-6
60t446-26A1407-O
601408-9
6A14A9-7
60141,4-3
601416-06At4t7-8607421-6
6A1422-4
6A1,423-2
601426-7
60L437-2601438-0
501439-9
60144A-2
60144L-O
601442-9
6A3,443-7
601446-1,
601,447-A
601448-8601-449-6
601450-0
601451-8
607452-6
6A1454-2
601455-0
601.457-7
601458-5
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Droa ?Q a$ l)L
DOCUMENT 3728
Claim No.
60L464-7
601461-5
601.462-3
601463-1
601464-0
601465-8
601466-5
601467-46U"474-4
60t47L-2601473-9
601,474-7
601475-5
601477-1,
601478-0
601481-0
607487-9
601492-5
601493-3
601s00-0
601510-7
601511-5
601512-3
601513-1
601515-6
601519-0
60L520-4
6A]5U.-2
601522-A
601524-7
601527-L
601s30-1
601532-8
601533-6
601539-5
6AL54t-7
60L550-5
601555-7
601556-5
6A1572-7
601581-6
60rc42-2601606-5
601607-3
601610-3
601612-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 40 of 124
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
601613-8
601614-6
601615-4
6016t6-2601621,-9
607622-7
601623-5
601624-3607625-I60r.626-0
60t627-8601628-6
601630-8601631-6
601632-4
601633-2
601634-0
601635-9
601635-7
601637-5
601638-3
601639-1
601640-5
601543-0
60L644-8601645-6601648-0
601657-0
601659-6
601660-0
601662-6
60r.563-4
601664-2
601665-0
601666-9
601668-5
601670-7
601671-5
601672-3
601673-1
60L674-O
601675-8
60L676-6
601"677-4
601679-0
601680-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
^--, ^^ -ta^^
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
601681-2
601682-0
601683-9
60L684-7
601685-5
601686-3
601687-L601688-0
601689-8
601690-1
601691-0
601692-8
501693-6
6At694-4
601595-2
601696-0
601-697-9
601698-7
601699-5
607700-2
601701-0
601702-9
60!7A3-7
60L744-5
601705-3
601706-1
60fi47-o601708-8
501709-6
601710-0
60t7L1-8601712-6
60t713-46AL7t4-2
601715-0
601716-9
6Aflfl-7601718-5
60t 7!9-3601720-7
60172t-56A7722-3
601723-L
601724-0
601725-8
601726-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
^--^ ^- -ti^^
DOCUMENT 3728
Claim No.
601727-4
601728-2
60L729-O
60t730-460L731-2
607732-A
601733-9601734-7
601735-5
601736-3
607737-7
601738-0601739-8
6Afi40-760L741-A
60L742-8
60L743-6601744-4601745-2
601746-A
601747-9
601748-7
6AL749-5
601750-g
60!751-7601752-5601753-3
601754-t601755-0601756-8
6Afi57-660t758-460t759-264L760-6
60L761.-4
60L762-2
601763-0
641764-9
60L765-7
607766-5
601770-3
601771,-1
601772-O
607773-8
6A!774-660!775-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 43 of 124
DOCUMENT 3728
Claim No.
60L775-2601777-O
6Afi78-96A1779-7
601780-0
601781-9
60L782-7
601783-560L784-3
501785-1
601786-0
601787-8
601788-6607789-4
601790-8
60L791-6607792-4
64fi94-O601795-9
6A1796-7
60!797-5601798-3
6Afi99-t601800-9
601"801-7
601802-560L803-3
601804-1
601805-0601806-8
601807-6601808-4
601809-2
601810-6
601811-4
601.872-2
601813-0
601814.9601815-7601816-5
601817-3
601818-1
601819-0
601820-3
601821-1
601822-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 44 ot !24
DOCUMENT 3728
Claim No.
601823-8601"824-6
601825-4601826-2601827-O
601828-9
601829-7
601830-0601831-9
6A1832-7
601833-5
601834-3
601835-1
601836-0
601837-8
601838-6
601839-4
601840-8
601841-6
601842-4
601843-2
60r.844-0
601 845-9
60L846-7
501847-5601848-3
501849-1
601850-5
601851-3
601852-1
601853-0601854-8
601855-6601856-4
601857-2
601858-0601859-9
601860-2
601861-0
601862-9
60L863-7
601864-5
601865-3
501866-1
601867-0
60r.868-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3' Reiected Claims
Pase 45 of 124
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
601869-6
601870-06A187L-8
6A1872-6
601873-4
60t874-2601875-0
601876-9
607877-7
501878-5
601879-360L880-7
601881-s501882-3
601883-1601884-0
601885-8
601886-6601887-4
601888-2601889-0
601890-4
60t89L-2601892-0
601893-9
60L895-5
601896-3
601897-1
601898-0
501899-8
60r_900-5
601901-3
6019A2-t601903-0
601904-8
601905-6601906-4
601907-2
601908-0601909-9
6At9LO-Z6019L1-0
601912-9601913-7
601914-5
601915-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
n^^^ ^c
a€,11A
DOCUMENT 3728
Claim No.
601_916-1
6A19fi-0601918-8
601919-6
60192L-8
601922-6
601923-4
60L924-2601925-0
601926-9
6A!927-7
601928-5
601930-7
601931-5
601932-3
601935-8
601936-6
60r.938-2
601939-0
60L941-2
60L942-A
601943-9
60L944-7
60194s-5
601946-3
601947-L
601948-0
601950-1
60r_951-0
601953-6
601954-4
601957-9
601958-7
601959-5
601960-9
60L96L-7
601962-5
601963-3
601964.1
601965-0601966-8
601977-3
60L978-r601979-0
601980-3
601981-1
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Dtna A1 nf 11A
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
601983-8601985-2601988-9
601989-7601990-0
601991-9
601992-7
601995-1
601998-6602000-3
60200L-1602002-0
602003-8
602004-6
602005-4
642006-2
602007-0
602009-7
602011-9
602012-7
602022-4
602423-2642024-O
602026-7
642427-5
602428-3
602034-8602035-6
602036-4602037-2
602038-0
502039-9
602044-2
602041-0
602A42-9
602043-7
602044-5
602045-3602047-O
602048-8
602049-6
6020s0-0602052-6
602053-4602055-0
6A2A57-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
602058-5602059-3
602064-7
602061-56A2062-3
602063-1
602064-0
602065-8
602066-6
602068-2602074-7
602075-5
602076-3602077-1
602A78-0
6A2079-8
602080-1
502081-0
602082-8
602083-6
602084-4
602085-2
602086-0
602087-9
602088-7
602089-5
602093-3
6A2A94-7
502095-0
602096-8
602497-6
602098-4
602099-2.
602100-0
502101-8
602142,6
602to3-46A2704-2
602105-0602106-9
602107-7
602108-5
602109-3
6A2LLO-7
602111-5
6021"12-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
^--^ in ^I 4^A
DOCUMENT 3728
Claim No.
6021.14-A
602115-8
6021,L7-4
642118-2602119-0
602r2A-4602121-2
602122-A
602123-9642124-7
602L25-5
602126-3602\27-1.
602L28-O
602729-8602L30-1
602131-0
602132-8502133-6642t35-2602136-0
602t37-9602138-7
602139-5
602140-9
602142-5
602L43-3
602145-0
602146-8
602147-6
602748-4
6021.49-2
6021.52-2
602153-0
602754-9
6A2L55-7
602156-5
602157-3602158-1
6021s9-0
602160-3
602163-8
6021.64-6
6A2765-4
602166-2
602168-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 50 of 724
DOCUMENT 3728
Claim No.
6021,69-7
642770-O
60217L-9602L72-7
602173-s
6A2T4-35A2fi5-1602776-0
602L77-8
602779-4
602180-8
602181-6
602t82-4602183-2
602184-0
602185-9
602186-7
602L87-5
642L88-3
602189-1
602190-5
602191-3
602192-1.
602193-0602194-8
602195-6
642196-4
602198-0
602199-9
602200-6
602202-2
602203-0
6A7204-9
602205-7
602206-5
602207-3
602248-1602209-0
6A22rA-3
60221,1.-t
602212-O
6A2213-8
6A2214-6
6A2215-4
6A22t6-2
602217-O
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 51 af !24
DOCUMENT 3728
Claim No.
6022L8-9602219-7
6A222A-A
602221,-9
6A2222-7
6A2223-5
602224-3
6A2225-1
6A2226-A
6A2227-8
602228-6
6A2229-4
602230-8
602231.-6
602232-4
6A2233-2
602234-O
60223s-9
6A2236-7
602237-5602238-3
6A2239-!6A2240-5
602247-3
602242-t602243-A
6A2244-8
6A2245-6
6A2246-4
602247-2
602248-O
6A2249-9
602250-2602251-A
602252-9
6022s3-7
6A2254-s
602255-3
6A2256-1.
6A2257-A
502258-8
602259-6
602264-O
602261-8
602262-6
602263-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Droa (? nf 1)A
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
6A2264-2
602265-O
602266-9
602267-7
6A2268-5
6A2269-3
602270-7
6A227L-5
602272-3
602273-t602274-O
602275-8602276-6
602277-4
602278-2
602?79-06A2280-4
60228L-2602283-9
6A2284-7
602285-5
602286-3
602287-1
602288-0
602289-8
602290-t602291-O
6A2292-8
602294-4
602295-2
602296-0
602297-9
602298-7
602299-5
602300-260230L-0
602302-9
602303-7
602304,5
602305-3
602306-1
602347-O
602308-8
602309-6
602310-0
602311-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
RejettedRejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
h--^ ra ^t4ai
DOCUMENT 3728
Claim No.
6A2312-6
6A23]3-46023t4-260231s-0
6A23L6-9
602318-5
602320-7
60232L-5
602322-3
602323-1
602324-A
6An26-66A2327-4
602328-2
602329-0
602330-4
602337"2
602332-0
602333-9
602334^7
602335-5
602336-3
6A2337-t
602338-0602339-8
602340-1.
502341-0
6A7342-8
502346-0602347-9
6A2348-7
602349-5
60235!-7
602352-5
602353-3
602354-t602355-0
602356-8
602357-6
602358-4
602359-2
602360-6
602361-4602362-2602363-0
6A2364-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Duplicate
Duplicate
Duplicate
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Pase 54 of \24
DOCUMENT 3728
Claim No.
602365-7
602366-5
642367-3
602368-1
602369-0
642370-3
60237l-t602372-O
602373-8
642375-4
602376-2
602377-O
602378-9
602379-7
602380-0
602381-9
6A2382-7
602383-5
6A2384-3
502386-0502387-8
602389-4
602390-8
602397-6
602392-4
602393-2
602394-0
602395-9
602396-7
602397-5
602398-3
602399-1
602400-9
602407-7
6024A2-s
602403-3
602404-1.
60240s-0
602406-8
602407-6
6A24A8-4
602410-6
6A24tL-4
6A24L2-2
602413-0
6A2474-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 55 of \24
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
6024r5-7
602416-56A24L7-3
6024L8-r6A24rc-A
60247A-3
60242L-L
6A2422-O
602423-8
602424-6
602425-4
602426-2
602427-O
6A2428-9
602429-7
602430-0
602432-7
602433-5
602435-t6A2$6-0602437-8
602438-6602439-4
602440-8
602441-6
602442-4
602443-2
602444-O
602445-9
602446-7
602447-5
602448-3
602449-t602450-5
602451-3
602452j1,
602453-06A2454-8
602455-6
602456-4
6A2457-2
602458:0
602459-9
602464-2602467-O
602462-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
i^-^ fa ^llnA
DOCUMENT 3728
Claim No.
602463-7
602464-s
602465-3
602466-L602467-O
602468-8602469-6
602474-06A2471.-8
6A2472-6
642473-46A2474-2
602475-O
6A2476-9
602477-7
6A2478-5
6A2479-3
6A2480-7
60248L-5
6A2482-3
6A2484-0
602485-8
602486-6
6A2487-4602488-2
602489-O
602490-4
60249r-2642492-0
602493-9
602495-5
602496-3
642497-L
602501-3
602s02-1_
602503,0
602504-8602505-6
602546-4602509-9
602511-06025r2-96A25L3-7
602s74-5602515-3
602516-L
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Pase 57 of 124
DOCUMENT 3728
Exhiblt B-3 - Rejected Claims
li
,1
!iii.
t'
.:
il
ti
l:
!'
t.I
Claim No.
6A25L7-O
6025L9-6
602520-0
602522-6
6A2523-4
602524-2
60252s-0
6A2526-g
6A2s27-7
602528-s
602529-3
602530-7
602s31-5
6A2fi2-3602533-1
602534-0
602s3s-8
602536-6
602537-4
602538-2
602539-0
602s40-4
602541-2
602s42-A
602543-9
602s44-7
602545-s
602546-3602s47-1.
602548-0602549-8
602550-1602551-0
602552-8
602553-6
602554-4602555-2
602556-0
602557-9
602ss8-7
602559-5602560-9
60256L-7
602552-5
602563-3602564-',J"
Status
Rejected
Rejected
Rejected
ReJected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
n^-^ fo ^$ 41A
DOCUMENT 3728
Claim No.
60256s-0
602566-8602567-6
602568-4
602569-2
602570-6
6A2571-4502572:2
6A2573-0
602574-9
6A2575-7
602576-5602577-3
602579-0
602580-3
602581-1
602582-0
602583-8
602584-6
60258s-4
602586-2
602587-0
602s88-9
602589-7
602590-0
602591-9
602592-7
602s93-5602594-3
602595-1
602596-0602597-8
602598-6
602599-4602600-1
602601-0
602642-8602603-6
6A2644-4
602605-2
602606-0
602607-9
602608-7
602609-5602617-7
6A26t7-5
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 59 of 124
DOCUMENT 3728
Claim No.
502613-3
602615-0
602677-6
602619-2
602620-6
602627-4
602622-2
602623-0
602624-9
502625-7
602626-5
602627-3
602628-t602530-3
6A2637-1.
602ffi7-A602633-8
6A2634-6
602635-4
602636-2
602637-O
602638-9
602639-7
602640-06A264L-9
602642-7
602643-5602644-3
602645-1.
6A2646-O
6A2648-6
602649-4
602650-8
602651-6
602652-4602653-2
602654-0
6026s5-9602658-3
602659-1
602660-5
602651-3
602662-L
602663-0602664-8602665-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 60 of 124
DOCUMENT 3728
Claim No.
602666-4
602667-2
602668-0
502669-9
602670-2
6A267t-O
6A2672-9
6A2673-7
602674-5
6A2675-3
602676-t602678-8
6A2679-6
602680-0
602681-8
602682-6
602683-4
602684-2
602685-0
602686-9
602687-7
602688-5
602689-3
602690-7
60269L-5
602692-3
602693-1
602694-O
602695-8
602696-6
6A2697-4
602698-2
602699-0
502700-8
60270L-6
602702-4
602704-O
602705-9
6A2746-7
6A27A7-5
602708-3
602709-t6A27LA-'
6027L3.-3
607712-1
602713-O
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejecied
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 6L ot 124
DOCUMENT 3728
Claim No.
6A2774-8
602715-6502716-4
602717-26A27Lg-O
6A2779-9
6A2720-2
6A27zt-O
6A2722-9
6A2723-7
6A2724-5
6A2725-3
602726-t6Q2727-O
602728-8
602729-660273A-O
602731.-8
602732-66A2733-4
602734^2
602736-9
602738-5
602739-3
602740-7
602741-5
6A2742-3
6A2743-7
6A2744-0
6A2745-8
602746-6602747-4
6A2748-2
602749-O
602750-4
602751,-2
602752-A
602753-9602754-7
6027s5-5
642756-3
6A2757-7
602758-0
602759-8
602760-t60276r-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Reiected Claims
Page 62 of t24
DOCUMENT 3728
Claim No.
602762-8602764-4
6A2765-2
602765-0
6A2767-9
602768-7
602769-5
602770-9
602771,-7
602772-5
602774-1
602775-O
602776-8
6A2777-6
602778-4
602779-2
502780-6
60278L-4
602782-2
602783-0
64278s-7
602786-s
602787-3
642788-L
602790-3602791-1.
602792-0
602793-8602794-6
602795-4
602796-2602797-O
602798-9
642799-7
602800-4
602801-2
602802-0
602803-9
602805-5
602806-3
602807-1
602808-0
602809-B
602810-1
602811-0
602812-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
ReJected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 63 of 724
DOCUMENT 3728
Claim No.
602813-6
602814-4
6A28$-26028J.6-0
602818-7
6028J.9-5
602820-9
6A2821-7
602822-5
602823-3
602824-t602825-0
602826-8
602827-6
602828-4
642829-2
602830-6
6A2n1.-4
602832-2602833-0
602834-9
602835-7
602836-s6A2837-3
602838-1
502839-0
602840-3
602841.-7
602842-O
602843-8
602844-6
602845-4
602846-2
6A2847-0
602848-9
6A2849-7
602850-0
602851-9
602852-7
602853-5
602854-3
602855-1
602856-0
602857-8
602858-6502859-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Reiected Claims
n^d6 Cll aF '11 n
DOCUMENT 3728
Claim No.
602860-8
602861-6
602863-2
602854-0
602865-9
6A2866-7
6A286V-5
602868-3
502869-L
602870-5
60287L-3
6A2872-7
602874-8
6A2875-6
602876-4
6A2877-2
602878-0
6A2879-9
602880-2
602881-0
602883-7
602885-3
6A2894-2
602895-0
602896-9
602897-7
602898-5
602901-9
6A2904-3
602905-1
602906-0
602947-8
602908-6602909-4
602910-8
50291.1-6
6029L2-4
6029L3-26A2974-O
602918-3
602919-1
6A2920-5
60292L-3
602922-t6A29n-A602924-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejecied
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Dnaa A( nf 41A
DOCUMENT 3728
Claim No.
602925-6
602926-4
6A2927-2602928-O
602929^9
602930-2
602931 -0
602937-9
602933-7
6A2934-5
602935-3
6A2936-L
6A2937-A
602938-8
602939-6
602940-0
6A294L-8
602944-2
602945-0
6A2946-9
602947-7
602948-5
602949-3
602950-7
602951-5
602952-3
602953-1602955-8
602956-6
602957-4
602958-2
602959-0
6A2960-4
60296t-2602962-0
602953-9602965-5
602966-3
6A2967-L
602968-0
6A2970-1
64297L-O
602972-8602973-6
6A297s-2
602976-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
D^^^ CC ^t 41A
DOCUMENT 3728
Claim No.
602977-9
6A2978-7
602979-5602980-9
6A298t-7
602984-1
602985-0
602986-8
602988-4502990-6
60299L-4
602993-0
602994-9
602995-7
602996-5
602998-1
603000-9603002-5
603003-3
603004-1603005-0
603006-8
603007-6
603008-4603009-2
603010-6
603011-4
503013-0603014-9
603015-7
603018-L
603020-3
603021-1
603022-0
603023-8
603025-4603027-0
603028-9
603029-7
603030-0
603031-9
603032-7
603033-5
603034-3
603035-1
603036-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 67 of 124
DOCUMENT 3728
Claim No.
603037-8
503038-6603039-4603040-8
503041-6
6A3A42-4
603043-2603044-0
603045-9603046-7
603048-3
603049-1
603050-5
603051"-3
603052-1
603053-0603054-8
603057-2
603058-0603059-9
603063-7
603064-5
603065-3503067-0
603068-8
603069-6603070-0
603071-8603472-6
603073-4
643474-2603079-3
603081-5
603082-3
603083-1603084-0
603086-6
603087-4603088-2
603089-0
603090-4
503092-0
603093-9603095-5
603096-3
603098-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 68 of 124
DOCUMENT 3728
Exhibit B-3 - Rejected Claims
Claim No.
603099-8
603100-5
503102-1
603103-0
603106-4
6A3107-2
603108-0603109-9
6A31LO-2
603L11-0503112-9
603113-7
603114-5603115-3
6A3n7-O6031 18-8
603119-6603120-0
603121-B
603L22-6
603L23-4
603124-2
603126-9
6A3t27-7
603129-3
603131-5
603132-3
603133-L
603134-0
603135-8
603136-6603137-4
603138-2
603139-0603140-4
603t4t-2603L42-A
603143-9603151-0
603152-8
603153-6
603t54-4603155-2
603156-06031s7-9
603160-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
n--^ an ^14a^
DOCUMENT 3728
Claim No.
603161-7603162-5
603163-3
6031,64-1"
603166-8603168-4
603L69-2
603170-6
603L73,-4
603172-2
603173-0
603174-9
60317s-7
603!77-g
603180-3
603182-0603183-8
603185-4
603186-2
603187-0
603188-9
603189-7603190-0
603191-9603L92-7
603193-5
603194-3
503195-1
603197-8
603198-6
603201-0
6A3202-8
603205-2
603206-0603207-9
6$248-7603209-5
6A32L1,-7
6032t2-5603213-3
603214-L
603215-0
6032L6-8
643221-4
603222-2603224-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Reiected Claims
n-^^ ?n a( 41A
DOCUMENT 3728
Claim No,
603225-7
603227-3603230-3
603231-1
603232-0
603233-8603234-6
603235-4
603236-2
603237-0603238-9
603239-7
603240-06A3241-9
6A3242-7
603243-56A3244-3
6A3245-1.
603246-0
603247-8603248-6
6A3249-4603250-B
603251-6
6032s2-4
603253-2
603254-0
603255-9
603256-7
603257-5
603258-3
603259-1
603260-5
603261-3
603262-7
603263-0
603264-8
603265-6
603266-4
603267-2
603268-0
603269-9
60327A-2
6A327tA603272-9603273-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Paee7l of t24
DOCUMENT 3728
Claim No.
603274-56A3275-3
603276-7603277-O
603278-8603279-6
603280-0
603281-8
603282-6
603283-4
6A3284-Z
60328s-0
603286-9603287-7
603288-5
603289-3
603290-7
603291-5603292-3
603293-1
603295-8603296-5643297-4
603299-0
603300-8
603301-6
603302-4603304-0
603305-9
603306-7
603315-6
603316-4603317-2
603318-0
603319-9
603320-2
603321-0
603322-9603323-7
603324-5
50332s-3
603326-1
6A$27-O
603330-0603331-8
603332-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 72 of 124
DOCUMENT 3728
Claim No.
603333-4603334-2
603335-0603336-9
6A3337-7
603338-s603339-3
603340-7
603341-5
603342-3
603343-1
603344-0
603345-8
603346-6
603347-4
603348-2
603349-0603350-4
603351-2
603352-0
603353-9603354-7
603355-5
603356-3
603357-1
6033s8-0
603359-8
603360-L
603361-0
603362-8
603363-6
603364-4
603365-2
603366-0
603367-9
603368-7
603369-s
603370-9
603371-7
6A3372-5
603373-3
603374-3.
603375-0
603376-8
603377-6
603378-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Pace 7? of 12 4
DOCUMENT 3728
Claim No.
603379-2
603380-6
603381-4
603382-2
603383-0
603384-9
603385-7603386-s
603387-3
603388-1
603389-0
603390-3
603391-1
603392-0
603393-8
603394-6
603395-4
603396-2
603397-0603398-9
603399-7603400-4
6034A1-2
603402-0
603403-9
6c34A4-7
603405-5603406-3
603407-1.
603408-0603409-8603410-1
503411-0
603412-8
603413-6
60341.4-4
603415-2603416-0
603417-9643418-7
603419-5
603420-9
603423.-7
603422-5603423-3
603424-1.
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Daop 74 of 1) A
DOCUMENT 3728
Claim No.603425-O
603426-8603427-6
603428-4
6A3429-2
503430-6
603431-4
603432-2
603433-0
603434-9
603435-7
603436-5
603437-3
603438-1
603439-0
603440-3
603447-1
603442-O
603443-8
6A3444-6
603445-4
6A3446-26A3447-O
603448-96A3449-7
603450-0603451-9
603452-7
603453-5
603454-3603455-1
603456-0
603457-8
6034s8-6
603459-4
603450-8
603461-6
603462-4
6A3463-2
503464-0
603474-8
6A3475-6
603476-4
603477-2603478-A
603479-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhiblt B-3 - Rejected Claims
Daoo 7( n* 11A
DOCUMENT 3728
Claim No.
603480-2603481-0
603482-9603483-7603488-8
603490-0
603491-8
603492-6
603493-4
603500-0
603501-9
603s02-7
603504-3
603s06-0
603507-8
603508-6
603509-4
6A3512-4
603514-0603515-9
603517-5603518-3
603519-1603520-5603521-3
603522-t603523-0
503524-8
503525:6
603526^4
603529-9
603530-2503531-0
603532-9
603s33-7
603534-5
603537-0
603s39-6
603540-0603541-8
603544-2603545-0603546-9
603547-7
603548-5
603549-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Dnso 76 af 1)tr
DOCUMENT 3728
Claim No.
503550-7
603551-s
603552-3
6035s3-1
6035s5-8
603556-6
603557-4
603558-2
6035s9-0
603s60-4
603561-2
603562-0
603565-5
603566.3
603567-1
603569-8
603570-1"
603571-0
603572-8603s73-6
60357s-2603576-0
603577-9603578-7
603579-5603580-9603581-7
603582-5
603s83-3
603584-1
603585-0
603586-8
603587-6
603588-4
603589-2
603590-6
603591-4
6A3s92-2
603593-0
603594-9
603595-7
603s96-5603597-3
603598-1
603599-0
603600-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page77 of124
DOCUMENT 3728
Claim No.
603601-5
603602-3
603603-1
603604-0
603605-8
603606-6
603507-4
603608-2603609-0
603610-4
60361"1-2
603612-0
603613-96036L4-7
603615-5603616-3
6036L7-t603618-0603619-8
603620-L603621.-0
6A3622-8603623-5
603624-4603625-2
603626-0603627-96A3628-7
603629-5
603630-9603631-7
603632-5
603633-3
603634-1
603635-0
603636-8
603637-6603638-4
603639-2
603640-6
603541.-4
6A3642-2
603643-0
603644-9603645-7603645-5
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
nejeitedRejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Daoa 79 a{ 1}tr
DOCUMENT 3728
Claim No.
603647-3
603648-1
603649-0
6036s0-3
603651-1
603652-0
603653-8
6036s4-6
603655-4
603656-2
603657-0
603658-9
603659-7603660-0
603661-9
603662-7
503663-5
603654-360366s-1
603666-0
603667-8603668-6
603669-4
603670-8603671-6
603672-4
603673-2
603674-O
603675-9
643676-7
603677-5
603678-3
603679-1
603680-5
603681-3603682-1
603683-0
603684-8603685-5
603686-4
6A3687-2
603688-0
603689-9
603690-2
603691-0603692-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Daco 70 af 11A
DOCUMENT 3728
Claim No.
603693-7
603694-5
60369s-3
603696-1
603697-0
603698-8
603699-6
603700-3
6037Ab1.
503702-0
603703-8
603704-6
603705-4
603706-2
603708-9
603710-0
6A37tL-g
603713-5
603716-0
6A37fi-8603718-6
6A3719-4
603722-4
603723-2603724-A
603725-9603726-7
6A3727-5
603728-3
603729-t603730-5
603731-3
6A3732-1.
603733-0603735-6
6A3736-4
6A3737-2
503738-06c3744-Z
603743.-0
603742-9
6A3743-7
6A3744-5
603745-3
6A3746-1.
6A3747-O
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
trage RO af 1)L
DOCUMENT 3728
Claim No.
603749-6
603750-0
603753-4
6A3754-2
603755-0
603756-9
6A3757-7
603758-5
603759-3
603760-7
603761-5
603762-3
6A3763-1.
603764-0
603755-8
603168-2
603769-0
6A3770-4
603771,-2
603772-O
603773-9
6A3774-7
6A3775-5
603777-1-
603778-A
603779-8
603780-L
603781-0
603782-8
603783-5
603784-4
603785-2
603786-0
603787-9
603789-5
603790-9
603791-7
603792-5
603794-L603795-0
603796-8
603797-6
603800-0
503801-8
603802-6
603803-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Reiected Claims
n^d^ Q.t ^( 11n
DOCUMENT 3728
Claim No.
603804-2
603805-0
603812-3
603813-1
603814-0
603815-8
603816-6
603817-4
60381"8-2
603819-0
603821-2
603822-0
603823-9
603824-7
603826-3
6A3827-t
603828-0
603829-8
603830-1
603831-0
603833-6
503834-4603839-5
603840-9
603841,-7
603842-5
603843-3
603844-l-603845-0
603846-8
603847-6
603848-4603849-2
603850-6
603851-4
603852-2
603853-0
603854-9
603855-7
603856-5
603857-3
603858-1
603859-0
603860-3
603861-L
603862-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Paee 82 af t24
DOCUMENT 3728
Claim No.
603863-8603864-6603865-4
603866-2
603867-0
503868-9
603869-7603870-0
503871-9
603872-7
603873-5
603874-3
60387s-1603876-0
603877-8
603878-6
603879-4
603880-8
603881-6
603882-4
603883-2
603884-0603885-9
603886-7
603888-3
603889-1
603890-5
603891-3
603892-1
603893-0603894-8
603895-6
603896-4
603897-2603898-0
603899-9
603900-6
603901-4643902-2
603903-0
503904-9
603905-7
603905-5
603907-3
603908-1
603909-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 83 of I24
DOCUMENT 3728
I
Claim No.
603910-3
603911-1
603912-0
603913-8
503914-6
603915-4
6A3916-2
603917-0
603918-9
6039L9-7
603920-0
603921-9
603922-7
603923-5
603924-3
603925-1
603926-0
603927-8
603928-6
603929-4
603930-8
603931-6
503932-4603933-2
603934-0
603935-9
603936-7
603937-5
603938-3
603939-1
503940.5
603941-3
6A3942-r
503943-0
603944-8
60394s-6
603946-4
603947-2
603948-0
603949-9
603950-2
603951-0
503952-9
603953-7
603954-5
603955-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Daaa 9A af 1?8.
DOCUMENT 3728
Claim No.
603956-L
603957-0
603958-8
603959-6
603960-0
603961-8
603962-6
603963-4
603964-2603965-0
603966-9
603967-7
603968-5
603969-3
603970-7
603971-5
603972-3
603973-1
603974-0
603975-8
603979-0
603981-2
603987-1
603989-8
603990-1
603991-0
603992-8
603997-9
603999-5
604000-4
604001-2
604002-0
604003-9
604004-7
604005-5
604006-3
604007-L
604008-0
604009-8
604010-1"
604011-0
604012-8
60401.3-6
604At4-4
604015-2
604016-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 85 of L24
DOCUMENT 3728
Claim No.
604017-9
604018-7
6040L9-s
604020-9
604A2L-7
6A4022-s
604023-3
604024-1_
604025-0504025-8
604027-6
604028-4
604A29-2
604030-6
604031-4
6A482-2604033-0
604034-9
604035-7504036-s
604037-3604038-1
604039-0
604040-3
6A4A4L-t
604042-O
604043-8
604044-6
604045-4
6A4046-2
604047-0
604048-9
6A4049-7
604050-0
604051-9
6A4052-7
604053-5
6A4054-3
604055-1
604056-0604057-8
604058-6
6040s9-4
604060-8
504061-6
6A4062-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 86 of 124
DOCUMENT 3728
I
Claim No.
604063-2
604064-0
604065-9
604066-7
604067-5
604068-3
604069-1
604075-6
644076-4
604077-2
604078-0
604079-9
604080-2
604081-0
504082-9
604083-7
604084-5
604085-3
604086-1
604087-0
604088-8
604089-6
604090-0
604091-8
604092-6
6A4093-4
604A94-2
604095-0
604098-s
604099-3
604100-0
604101-9
604102-7
604103-5
604104-3
604105-1
604106-0
6A4107-8
604108-6
604109-4
604110-8
604111-6
604112-4604118-3
6A4121-3
6041.22-t
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Daac R'7 of 11y'
DOCUMENT 3728
€laim No.
604\23-A604!24-86A4L25-6
604126-4604127-2
604128-O
604129-96A4L30-2
604131-0
604132-9
604L33-7
6A4134-5
604135-3
604136-1
604137-0
604138-8
604139-6
604140-06041.41-8
6A4l.42-66041.43-4
604144-2604147-7
504148-5
604149-3604150-7
604151-5
604152-3
604153-1
604154-0
60415s-8
604156-66A47s7-4
604158-2
604159-0
604160-4604161.-2
6041.62-0
604163-9
6A4164-7
604165-5
604168-0
604169-8604fi4-t6A4fitA604172-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3' Rejected Claims
Page 88 of I24
DOCUMENT 3728
Claim No.
604173-6604174-4
644175-2
604176-0
604177-9
604L78-7
604179-5
6041 80-9
6A478L-7
6041.82-5
604183-3
604L84-t604186-8604187-5
604188-4644189-2
604190-6
60419L-4604192-2
604L93-06A4194-9
604L95-7
604196-s
604197-3
604198-1
604199-0
604240-7
604201-5
6A4202-3
604203-1
604204-O
604205-8604206-6
604247-4644208-2
604209-0
6A4210-4
6A42fl-2604212-O
644213-9604214-7
604215-5
644216-3
6A42fi-3.604218-0604219-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 89 of I24
DOCUMENT 3728
Claim No.
604220-1.
6A422t-O
604222-8
6A4223-6
604224-460422s-2
604226-O
6A4227-9
604228-7
504229-5604234-9
604231-7
604232-5
604233-3
604234-7
604235-0
604236-86A4237-6
604238-4604239-2
604244-6
6A424r-46A4244-9
6A4245-7
604246-5604247-3
604248-1.
604249-O
604250-3
6042st-t6A4252-A
604253-8604254-6
604255-4
604260-0
60426L-9604262-7
6A4264-3
604265-t604266-0
604267-8
604268-6
604269-4604274-8
604271.-6
604272-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 90 of L24
DOCUMENT 3728
Claim No.
6A4273-2604274-O
604275-9
604276-7
6A4277-5
604278-3
6A4279-t
604280-5
604281.-3
604282-L
604283-0604284-8
604285-6
6A4286-4
604287-2
604288-0
6A4289-9
60429A-2
604291-0
604293-7
604294-5
604295-3
644296-1.
604297-O
604298-8
604299-6604300-3
60$ar-L644302-O
604303-8
604304-6604305-4
604306-2
604309-7
604310-0
604311-9
604312-7
604313-5
60+:31.4-3
6043L5-1
604316-06A4377-8
604318-6
604319-4604320-8
604321,-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 91 of !24
DOCUMENT 3728
Claim No.
644322-4
604324-0
604325-9
604326-7
6A4327-S
604328-3
604329-1,
604330-5
604331-3
6A4332-t604333-0
604334-8
604335-6
604336-4
604337-2
604338-0
604339-9
6A4340-2
604341-0
604342-9
604343-7
604344-s604345-3
604346-1.
604347-A
604348-8
604349-6
604350-0504351-8
604352-6604353-4
604354-2
604355-0
604356-9
6A$57-7604358-5
604359-3
6A4364-7
604361-5
604362-3
604363-1
6A4364-A
604365-8
604369-0
604370-460437t-2
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 92 of t24
DOCUMENT 3728
Claim No.
604372-O
6A4J73-9
6A4374-7
604375-5604376-3
6A4377-l6A4378-A
604379-8
604380-1
604381-0
604382-8
604383-6604384-4
604385-2604386-05A4387-9
604388-7
604389-5
604390-9
6A439r-7
604394-L
604395-0
604396-8
604397-6504398-4
604399-2
604400-0
604401-8
6A4402-6
604403-4
604404-2
60440s-0
604406-9
604407-7
504408-5
6A441.A-7
604472-3
604413-L
604414-0604415-8
604416-6
604417-46A4418-Z
6A44t9-O
6A4420-4
60;4421-2
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 93 of I24
DOCUMENT 3728
Claim No.
6A4427-0
6A4423-9
604424-7
604425-s
604426-3
6A4427-t
604428-O
604429-8
604430-L
504431-0
604432-8
504433-6
604434-46A4$5-2604436-0
604437-9
604438-7
604439-5
604440-9
64444r-7
6A4442-5
604443-3
604444-t604445-0
604446-8
604449-2
604450-6
604451-4
604452-2
604453-0
604454-9
604455-7
604456-5
604457^3
604458-1
604459-0
604460-3
6A446t-1,
604462-A
604463-8
604464-6604465-4
604466-26A4467-A
604468-9
604469-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Papp 94 af 174
DOCUMENT 3728
Claim No.
604470-O
604477-9
6A4472-7
604473-s
604474-3
604476-A
604477-8
604478-6504480-8
604481-6
604482-4
604483-2
604484-0
604485-9
604486-7
604487-5
604488-3
604489-t604490-5
604491-3
604492-1.
604494-8604495-6
604496-46A4497-2
604498'0
504499-9
604500-5
604501-4
6A4502-2
604503-0
604504-9
604505-7
604506-5
604507-3
604508-1
604509-0
604510-3
604511-1
604512-0
604513-8
604514-6
604515-4
604576-2
604517-0
604518-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 95 of 124
DOCUMENT 3728
Claim No.
604st9-7604520-0
6A4571.-9
604522-7
604523-5
604524-3604525-1
604526-0
604527-8
604528-6
604529-4604530-8604531-6
604532-4
604533-2
604534-0604535-9604536-7
604537-5
604538-3
604539-1
604540-5
604541-3
604542-1.
604543-0
644s44-8
604545-66A4546-4
604547-2604548-0
604549-9
604550-2
604551-0
604552-9
604553-7
604s54-5
604555-3
604556-1
604557-0
604558-8
604559-6
604560-0
604561-8
604s62-6604563-4
604564-2
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 96 of 124
DOCUMENT 3728
Claim No,
604565-0
604566-9
6A4567-7
604568-5
604569-3
6A457A-7
604571-5
604572-3
604573-1.
6A4574-0
60457s-B
6A4576-6
644577-4
6A4578-2
604579-0
604580-4
604581-2
604582-0
604583-9
604584-7
604585-5
604586-3
604587-t604s88-0
604589-8
604s90-1
604591-0
604592-8
604s93-6604594-4
604595-2
604596-0
604597-9
604598-7
604599-5
604600-2
604601-0
604602-9
6A4603-7
604604-5
604605-3
604606-1
6A4607-A
604608-8
504609-6
604610-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 97 of 124
DOCUMENT 3728
Claim No.
604611-8604612-6
604613-46046t4-260461s-0604616-9
6446fl-7604618-5
604619-3
604620-7
604621-5
604622.-3
604623-7604624-0
604625-8
604626-6644627-4
6A4628-2
604629-O
604630-4
604631-2
604632-0
604633-9
604634-7
604635-5
604636-3
6A4637-1.
604638-0
604639-8
604640-L
604641-0
604642-8
604643-6644644-4
604645-2
604646-0
604647-9604648-7
604649-5
604650-9
6A465L-l
604652-5
6046s3-3
604654-1.
6046s5-0604656,8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 98 of 124
DOCUMENT 3728
Claim No.
604657-6
604658-4
604659-2
604660-6604662-2
604663-06A4664-9
604665-7
604666-5
604668-L
604670-3
6A467r-t604672-0
604673-8
6A4674-6
6A4675-4
604676-2
604677-A
604678-9604679-7
604680-0604681-9
604682-7
604683-5604684-3
504685-1604686-0
604687-8
604688-6
604689-4
604690-8604697-6
604692-4
6A4693-2
604694-0
604695-9604696-7
6A4697-5
604698-3
604699-1
604700-9604741-7
604702-5
604703-3
604704-1604705-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Paee 99 of L24
DOCUMENT 3728
Claim No.
604706-8604707-6604708-4
604709-2
604710-6604711-4
6047t2-26A4713-O
6A47]5-7
60471.6-5
604777-3
6047L8-1"
604719-O
6A4720-3604721-1
604722-O
5A4723-8
6A4725-4604726-2
604727-O
604728-9
644729-7
604730-0
604731-9
604732-7
604733-5
6A4734-3
604735-1
604n6-A604737-8604738-6
604739-4
604744-8
60474t-6604742-46A4743-2
6A4744-0
604745-9604746-7
6A4747-5
604748-3
604749-1
604750-5
60475r-36047s2-1.
604753-0
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B'3 - Rejected Claims
Page 100 af 124
DOCUMENT 3728
Claim No.
604754-8
604755-6
504756-46047s7-2
504758-0
6A4759-9
644760-2
60476t-O
604762-9
6A4763-7
604764-5
604765-3604766-1_
6A4767-0
604768-8
604769-6
60477A-O
604777-8
644772-6604773-4
604774-2
604775-O
604776-9
604777-7
644778-5
604779-3
604784-7
644781^s
604782-3
604783-3.
604784-O
604785-8
604786-6604787-4
644788-2
604789-0604790-4
604791-2
604792-A
604793-9
6A4794-7
644795-5
604796-3604797-t604798-0
604799-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 101 of 124
DOCUMENT 3728
Claim No.
604800-5604801-3
6A4802-t
604803-0604804-8
604805-6604806-4
604807-2604808-0
604809-9
6048LA-z604811-0
604812-9
604813-7604814-5
604815-3604816-1
6048fi-A604818-8604819-6
604820-0
60482!-86A4822-6
6A4823-4
6A4824-2
604825-0
604826-9
604827-7
604828-5
604829-3
604830-7
604831-5
604832-3
604833-1
604834-0
604835-8
604836-6
6A4837-4
504838-2
604839-0
604840-46A4841-2
6A4842-A
504843-9
6A4844-7
604845-5
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 102 oft24
DOCUMENT 3728
Claim No.
644846-3604847-1.
604848-0
604849-8604850-1
604851-0604852-8
604853-6
604854-4604855-2
604856-0
6A4857-9
604858-7
604859-5
604860-9
604867-7
604862-s
604863-3
604864-1604865-0
604866-8
604867-6
604868-4604869-2
604870-6
644871-4
604872-2604873-0
6A4874-9
604875-7
604877-3
604878-1.
604879-A
604880-3
604881.1
604882-0604883-8
604884-6
604885-4
604886-2
604887-0
604888-9
604889-7
604890-0604891-9
604892-7
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
ReJected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 103 of I24
DOCUMENT 3728
Claim No.
604893-5
604894-3
604895-1
604896-0
604897-8
604898-6
6}4899-4604900-1
604901-0
604902-8
604903-6
604944-4
604905-2
504906-0
604907-9
604908-7
604909-5
604910-9
604911.-7
604912-5
604913-3
6A4914-t60491s-0
604916-8
604917-6
6049X.8-4
644919-2
604924-6
604921.^4
644922-2
604923-A
604924-9
604925-7
644926-5
604927-3
604928-1
604929-O
604930-3
604931-1
604932-0
604933-8
604934-6604935-4
604936-Z
604937-0604938-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 104 of 124
DOCUMENT 3728
Claim No.
604939-7
604940-0
644941-9
604942-7
604943-5
6A4944-3
604945-1
604946-0
604947-B
604948-6
6A4949-4
604950-8
604951-6
604952-4
604953-2
604954-0
604955-9
504956-7
604957-5
604958-3
604959-1
604960-5
604961-3
604962-1
604953-0
604964-8
604965-6
604966-4
604967^2
604968-0
604969-9
604970-2
60497L-O
644972-9
604973-7
644974-5
604975-3
604976-1
604977-O
604978-8
604979-6
604980-0
604981-8
604982-6
604983-4604984-2
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 105 af t24
DOCUMENT 3728
Claim No,
60498s-0
604986-9
604987-7
604988-5
604989-3
604990-7
604991-s
604992-3
604993-1
604994-0
604995-8
604996-6
604997-4
504998-2
604999-0
605000-0
605001-B
605002-5
60s004-2605005-0
605006-9
605007-7
605008-5
605009-3
505011 -5
605012-3
60s013-1
605014-0
60501s-8
605016-6
605017-4
605018-2
605019-0
605020-4
60s021,-2
605022-0
605023-9
605024-7
605025-5
605026-3
605027-t605028-0
605029-8
605030-1
50s031-0
605032-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 1"06 of t24
DOCUMENT 3728
Claim No.
605033-6
605034-4
505037-9
605038-7
605039-5
605040-9
605041-7
605442-5
605043-3
605044-1
605045-0
605046-8
605047-6
605048-4605A49-2
60s0s0-6
60505L-4
605452-2
605053-0
605054-9
605055-7
605056-5
605057-3
60s058-1
605059-0
605060-3
60506L-1
605062-0
60s063-8
605064-6
605065-4
60s066-2
605067-0
60s068-9505069-7
605070-0
60s071-9
605472-7
605073-5
605074-3
605075-1
605076-0
605077-8
605078-5
605079-4
605080-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 107 of I24
DOCUMENT 3728
Claim No.
605081-66AsO82-4
605083-2605084-0
605085-9
505086-7
605087-5
605088-3
605089-1
605090-s
605091-3
60s092-1
505093-0
605094-8505095-6
605096-4
605097-2605098-0
60s099-9
605100-6
605101-4
605102-2
605103-0
605104-960510s-7
60s106-5
605107-3605108-1
605109-0605110-3
605111-1
605112-0
605113-8
605114-6
605115-4
605116-2
60511 8-9
605119-7
605120-060s123,-9
605L22-7
605123-s
605724-3
605125-1
605126-060s127-8
StatusRejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B'3 - Rejected Claims
Page 1O8 of 124
DOCUMENT 3728
Claim No.
605128-66A5729-4
6053"30-8
605131-6
60s132-4
605133-2
605134-0
605135-9
605136-7
605137-5
605138-3
60s139-15051"40-5
60514r.-3
6051,42-L
605143-0
605144-8
605L45-6
605L46-4
6Ast47-2605148-0
605149-9
605150-2
605151-0605152-9
60s153-7
605154-5
605155-3
605156-1
605157-0
605158-8
6051s9-6
605160-0
605161-8605162-6
605163-4605164-2
605165-0
605166-9
605167-7
605168-5
605169-3
605fi4-7605171-5
605172-3
605173-3.
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
ReJected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 109 of 124
DOCUMENT 3728
Claim No.
605L74-0605175-8
605176-6605177-4
605178-2
605179-0
605180-4
605181-2
605182-0
605183-960s185-5
605186-3
605r"87-1
605188-0
605189-8
605190-t505L91-0
605192-8
605193-6605L94-4
605L95-2
605196-0
605197-9605r.99-s
605200-2
605201-0
605202-9
605203-7
605205-3
605206-1
605207-0605208-8
605209-660s212-6
605213-4
6A52U-260521_5-0
605216-9605277-7
605218-5
605219-3
605220-7
605223-r60s224-A
645225-8
60s226-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 110 of 1.24
DOCUMENT 3728
Claim No.
6As227-4
605228-2
605229-0
505230-4
605231-2
605232-060s233-9
6A5234-7
605235-5
605236-3
605239-86A5240-1.
605241-0
605242-8
605243.6
605244-460524s-2
605246-0605247'9
605248-7
60s249-s
605250-9
605251-7
605252-5
60s253-3
605254-r605255-0605256-8
605257-6605258-4
6A5259-2
605260-6
605261-4
605262-2
605263-0
6As264-9
6As265-7
60s266-5605267-3
605268-1
605269-0
605270-3
6A5277-1.
645272-O
605273-8
605274-6
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page L11 of 124
DOCUMENT 3728
Claim No.
60s275-4
6A5276-2
605277-O
605278-9
605279-7
605280-0605281-9
605282-7
605283-5605284-3
605285-1
605286-0
605287-8
60s288-6
605289-4
605290-8
605291-6
645292-4
64s293-2
605294-0605295-9
605296-7
6A5297-5
605298-3
605299-1
605300-9
605301-7
605302-5
605303-3
605304-1
605305-0
605306-8605307-6
605308-4
505309-2
605310-6
605311-4
645312-2
60s313-0605314-9
605315-7
605316-5
605317-3
605318-1605319-0605320-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 112 of L24
DOCUMENT 3728
Claim No.
605321-1.
605322-0605323-860s324-6
605325-4
605326-2
605327-O
605328-9
605329-7
605330-0
605331-9
605332-7605333-5
60s334-3
605335-1605336-0
60s337-8605338-6605339-4
605340-8
605341-6
6A5342"4
605343-2
605344-0
605345-9
605346-7
60s347-5
605348-3
605349-1
605350-5
605351-3
6053s2-1
605353-0
605354-8
5053s5-6
605356-4
60s357-2
605358-0
605359-9
605360-2
605361-0
605362-9
60s363-7605364-5
605365-3
605366-1
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 113 of 124
DOCUMENT 3728
Claim No.
605367-0
605368-8
605369-6
605370-0
605371-8
605372-6
605373-4
605374-2
60s375-0605376-9
605377-7
605378-5
605379-3
60s380-7
605381-5
605383-1
605384-0
605386-6
605387-4
605388-2
605389-0
605391-2
605392-0
605393-9605394-7
605395-5
605396-3
60s397-1
605398-0605399-8
605400-560s401-3
605402-L
605403-0
605404-8
60540s-6
605406-4
6A54A7-2
60s408-0
605409-9
605410-2
605411-0
6054L2-9
6054L3-7
60s4L4-5
60541s-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Reiected Claims
Page 114 of 124
DOCUMENT 3728
Claim No.
605417-0
6054L8-8
605420-0605421-8
6A5422-6
605423-4605424-2
605425-0
605426-9
605427-7
60s428-5
605429-3
605430-7
605431-s
6A5432-3
605433-1605434-0
60543s-8
605436-6
605437-4
60s438-2605439-0
645440-4
645441-2
605442-O
605446-3
605447-L
605448-0605449-8
605450-1
60545L,0
605452-8
605453-6
605454-4
605455-2
605456-0
605457-96054s8-7
605459-5
605460-9
605467-7
605462-5
605463-3
60s464-160s46s-0
60s466-8
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 115 of I24
DOCUMENT 3728
Claim No.
60s467-6605468-4
605469-2
60s474-6
645471,-4
605472-2605473-0
6A5474-9
605475-7
605476-5
605477-3
605478-1
605479-O
605480-3
605481-3.
605482-0
605483-8
605484-6
605485-4
60s486-2605487-0
605488-9
605489-7
605490-0
605491-9
605492-7
605493-5
605494-3
505495-1
605496-0
605497-8
605498-6
605499-4
605500-1
60s501-0
605502-8
605s03-6
605504-4505505-2
605506-0
60s507-9
605508-7
605509-5
605510-9
605511-7
605512-5
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhlbit B-3 - Rejected Claims
Page 116 of 124
DOCUMENT 3728
Claim No.
605513-3
605514-1_
60ss15-0
60551"6-8
505517-6
605518-4
605519-2
605520-6
605521-4
6A5s22-2
605523-0
605524-9
60s525-7
605525-5
60s527-360s528-1
605529-060ss30-3
605s31-1
605532-0605533-8
605534-6
605535-4
605536-2
605537-0
605538-9
605539-7
605540-0
605541-9
605542-7
605543-5
605544-3
60ss48-660s549-4
605550-8
605551-6
605552-4
60ss53-2
6055s4-0605555-9
605556-7
605557-5
6055s8-3
60s559-1
60s560-5
605561-3
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 117 of I24
DOCUMENT 3728
Claim No.
605562-1
605563-0
605s64-8
60s565-6
605565-4
605567-2
605568-0605569-9
605570-2
505571-0
605s72-9605573-7
605574-5
605575-3
605576-1
605s77-0605578-8
605579-6
605580-0
605581-8
605582-6
605583-4
605584-2
605585-0
605586-9
605587-7
605588-5
605589-3
60s590-7
605591-5
605592-3
60s593-1
605594-0
605595-8
60s596-6
605597-450ss98-2
605599-0
605600-8
605601-6
605602-4
605603-2
605604-0
605605-9
605606-7
605607-5
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
RejectedRejectdd
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 118 of t24
DOCUMENT 3728
Claim No.
605608-3
605609-1
60s610-5
605611-3
605612-1
505613-0605614-8
605615-6
605616-4605617-2
605518-0
605619-9605620-2
605621-0
605622-950s623-7
605624-s605625-3
605626-1
6A5627-O
605628-8
605629-6
605630-0
605631-8
605632-6
505633-4
605634-2605535-0
605635-9
605637-7
60s638-5
605639-3
605640-7
505641-5
605642-3
605643-1
605644-0
605645-8
605646-6
605647-4
605648-2
605649-0
605650-4
605651-2
605652-0
605653-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 1L9 of 124
DOCUMENT 3728
Claim No.
605655-5
605656-3
605657-1
605658-0
605659-860s660-1
605661-0
605662-8
605663-6
605664-4
605665-2
605666-0
60s667-9
605668-7
605669-5
505673-3
605674-L
605675-0
60s676-8
605677-660s678-4
605679-2
605680-6505681-4
605682-2
605683-0605684-9
605685-7
605586-5
605687-3
605688-1
505689-0
605690-3
605691-1
605692-0
605693-8
605695-2
6057L9-5
605720-9
64s721-7
605722-5605725:O
605731-4
645732-2605733-0
645734-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 12a of 124
DOCUMENT 3728
Claim No.
60s735-7
605738-160s740-3
605741-1
6A5743-8545752-7
605753-560s768-3
605769-1
605770-560s772-1.
605780-26A5782-9
605784-5605785-3
605786-1
605787-0
605789-6605790-0
6A5792-6
60s793-4
605795-0
60s796-9605798-5
605799-3
605800-0
60580L-9
605802-7
605803-5
605805-L505806-0
605807-8605808-6
605809-4
605813-2
605814-0605815-9
605816-7
605817-5
605818-3
605820-5
605821-3
605822-1605823-0
60s824-8605825-5
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 121 of 124
DOCUMENT 3728
Claim No.
605826-4
605830-2
605831-0605834-5
605835-3
605836-1605840-0
605841-860s842-6
605843-4605845-0
605849-3
605850-7
605852-3
605858-2605859-0
605860-4
605861-2605863-9
60s86s-s
605866-3605867-1
605868-060s859-8
605871-0
605874-460s877-9
605878-7
605879-5
605880-9
605881-7
605882-5
605883-3605884-1
60s88s-0
605887-6605888-4
605889-2
605890-6
605897-3
605901-5
605904-0
505905-8
605906-6
6A5924-4
605925-2
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page I22 af 124
DOCUMENT 3728
Claim No.
60s927-9605928-7
605932-5
605937-6605938-4
605948-1
605949-0605953-8
605955-4
605959-7
605962-7
605981-3
605982-L
605983-0
605984-8
60s985-6
605986-4
60599s-3
60s998-8
606003-0
606004-8606005-6
606006-4606A07-2
606008-0
606009:9
606012-9
606013-7
506016-t
605017-0
606018-8
606019-6
606020-0606021-8
606022-6
606023-4606024-2
606025-0
605026-9606029-3
606030-7
606031-5606032-3
606035-8
606038-2
606040-4
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 123 of t24
DOCUMENT 3728
Claim No.
606041-2606442-O
605045-5606048-0
606049-8
606050-1
605051-0606052-8
606053-6605054-4
6060s9-s
606061-7
606062-5
606063-3
606064-1
60606s-0
606066-8606067-6
606068-4
506069-2646072-2
606A74-9
Status
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Duplicate
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Exhibit B-3 - Rejected Claims
Page 124 ol 124
DOCUMENT 3728
EXHIBIT C
(filed under se sl)
DOCUMENT 3728
EXHIBIT D
DOCUMENT 3728
o(Kclalm Recognized Tnnsactioncount sharespurchasedNo. Los
Name
300772-S 0.00 0
0
603158-7 15
300773-1
60315G10.00
239,377,80
0L7
GENERAL MOTOhS UNSECURED CREDITORS COMMITTFE
175OOO GENERAL MOTORS CORP SALARIED - IAMG - LG CAP 6ROWTH
603149-8
0.0t}
75,255.63
0
12
GENERAL MOTORS UNs€CURED CREDITORS COMMITTEE
2OO,OOO GENERAT MOTORS CORP SATARIED . IAMG . INTTRMEDIATE GROWTH
300776-66012X0-8
603x52-8
0.00.
1,0x0,625.001.010,625.00
0
x1
GSNEBAL MOTORS UNSECI,,RED CREDITORS COMMINEE
tlO,OOO .GMAM INVESTMENT FUNDS TRUST
110.000 GENERAL MOTORS CORP SATARIED -Jp MORGAN CONVERTIBLE
3A077746012124603155-0
LJnmatched
601213-2
603151-0
603153-6
603154-4603155-2
603157-9
0,005,912,535.70
1893,689.70
0.00
0.000.000.00
0.00
0.00
06
6
8
3
18
6
2
2
GgNERAL MOTORS UNSECURED CREDITORS
710,1OO GMAM INVESTMENT FUNDS TRUST
71O,IOO 6ENERA! MOTORS COfiPSAIARIED. GENERAL MOTORS CORP - IAMG.CONVERTIBLE
O GENERAL MOTORS
125,000 6E$ERAL MOTO8s CORP SA|ARIED - SALOMON ASSEr MGT
170,700 GENERAI MOTORS CORP SALARIED - CHANCELLOR EQ - tG CAP
5d3OO GENERAI MOTORS CORP SAIARIED - BRINSON PARTNERS- EQUITY
47,700 GENEML MOTORS CORP SAIARIED - UNCOLN CAP - EQUITY
696 GENERAI MOTORS CORP 5ATARIED . UBS ASSET M6T
Hlghllghted cldtms rcpresent untiled MedPdttners cldlms
Alt Edota cldtms flled by dither lNY Metton or stdte stteet - stdtus of dtt matehed ddims ls 'valid" ond dll unmdtched cloims ts 'Relected'
6M Unsecuted Creditors Claims - Form A qerences inEP Clotms W tD dnd dmount
MEP Totrl CAli i 7,5L4p29,94
Q((TotalcAL: $ 7,510025.21
o(-MEPA I (4,90S.7n1
DOCUMENT 3728
EXHIBIT E
(filed under se al)
DOCUMENT 3728
EXHIBIT F
DOCUMENT 3728
Exhibit F - lnPhyNet Principals
lnPhyNet Shares Claim No.3O0OB7-7 Claim No.300376-0 Claim No.300550-0 Claim No.400498-1
Shares Held Directly in lndividual's Name L51",7L0 33,7tt 120,1,49 644,071
Shares Held I ndirectly through S-Corporations+ 3s1,333 44,870 44,870 191,703
Shares in Escrow 60,000 40,000 40,000 60,000
Total Shares as of 6197 563,043 118,581 205,019 895,774
Shares 664,390 r39,925 24L,922 1,057,013
Recognized Loss $ 7,29L,680.25 5 390,4e1,88 S 1,s09,908.95 2,578,308,68
Shares 593,591 92,726 L94,722 986,213
Recognized Loss S asn,sts:o GAIN s 992,862.s6 5 7,806,209.74
Shares 179,018 39,779 L4L,776 760,004
Recognized Loss S 1,96s,606.65 GAIN S 411,s04.s0 GAIN
ACS lnc. 341",1,24 40,310 40,310 177,818
Acute Management rc,249 4,560 4,560 13,885
Total 351,333 44,870 44,870 19L,703
lndividuallv Held Shares asloof Total Shares Claimed 26s4% 28.43% s8.60% 7190%
Escrow Shares as % of Total Shares Claimed 10.66% 33.73% 1951% 6.70%
** share/loss comparison reflects post-merger 7:7.78 rotio
DOCUMENT 3728
EXHIBIT G
DOCUMENT 3728
AIG-Caremark Class Actlon
Clalms Admlnlstratorc/o Gllardl& Co. ILC
P.O. Box 8040San Rafael, cA 94912-8040
To whom lt maY concern:
IhaveenclosedbyproofofClalmandRelease{Form"8"}. PleasebeadvlsedthatIamprotestlng
attorney's fees ln thls matter as I feel they are excesslve.
Mldlothlan, VA 23113
DOCUMENT 3728
Fa cts:
Dr. Jacqulred 215,017 shares of MedPartners common stock ln Aprll of 1996 through the sale of
hls lnterest ln Retlna & Vltreous Assoclates of Alabama, P.C. (RVAA), Despite the bansactlon date of
December, L995, the stock had restrlctlons ln place so that nr.Jdld not have llqulddtlon rlghts to
hls MedPartners stock at that tlme'
Durlng the 2 year perlod followlng the transactlon, whlch lncludes the dates lnvolved ln the
class actlon sult, the stock prlce decllned slgnlflcantly, and or,f was left ownlng shares of
Medpartners stock valued slgnlflcantly lower than when they were orlglnally recelved' We have
uploaded what we belleve to be relevant documentatlon regardlng or. Jclalm that hls
ownershlp of MedPaftners stock durlng the period ln questlon resulted ln flnanclal Joss'
Regardlng the fees, I sffongly object to the extraordlnarily hlgh fees awarded the plalntlffs
attorneys, to be deducted from the funds awarded to shareholders, Especlally because these
are the sarne attorneys pald ln the flrst lltlgatlon. The attorney's fees awarded are more than
twlce usual and customary for such cases, and I questlon a posslble confllct of lnterest on the
part of the awardlng Judge,
lncluded ln the upload, you wlllfindl
r Common Stock Reglstratlon Rlghts Agreement for between MedPattners and Or.I
DOCUMENT 3728
EXHIBIT H
DOCUMENT 3728
•
LLC
Administration Services Invoice Detail Johnson v. Caremark Rx, LLC
June 16, 2018
Daniel Burke; Danlel.Burke@gilardi coin; 415 458.3069
NOTICE PROCEDURES Date and Forms Sot-up
- Format Document(s) - Staff - Manager
- Process and Standardize Bank and Broker Flies - Staff - Manager
Sub-total of Data and Forms Set-up
RESPONSE RATE
Print/Mall Notice Packet to Known Class Members - Handing of Returned Undeliverable Mali
- Staff Sub-total of PrInUMall Notice Packet to Known Class Members
QUANTITY
1 00 hrs 12 00 hrs
38,00 hrs 73.00 hrs
2 00 hrs
Websffe Set-up & Maintenance - Update Webslte & Set up Online Claim Ming Module
- Manager 1.25 hrs - Server Space rental 15 mos
Sub-total of Webaite Set-up & Maintenance
Case Management and Affidavits - Project Management and Reports
- Staff 9 75 hrs - Manager 623.00 hrs - Senior Manager 158 25 hrs - Director 745 hrs
- Principal 10 50 hrs - Correspondence Processing Staff Hours m: Brokers and Other Class Members
- Staff - Manager - Director
- Declarations - Manager - Senior Manager
Sub-total of Case Management and Affidavits
SUB-TOTAL OF NOTICE PROCEDURES
TELEPHONE SUPPORT Automated Call Support
- Script Updating and Management - Manager
- Projected S of Punchthroughe to Live Operator (% of Calls) - Average Call Duration (minutes) - IVR Transfer Line Charges - Live Operator Line Charges
SUB-TOTAL OF TELEPHONE SUPPORT
RESPONSE RATE
18.00 hrs 78.50 hrs 10.35 hrs
11 OD his t 50 hrs
QUANTITY
250 hrs
132 mins 2,370 mins
RATE PER UNIT COST TOTAL
$16,015.00
$170.00
$950.00
6153,140.60
$171,176.50
RATE PER UNIT COST TOTAI
$3,369.86
014500 Page 1 of 2
qi}uJi Admlnlstratlon Services lnvolco DetailJohnson v. Caremark Rx, LLC
June 16, 2018
Daniol Burke; Danlsl.BuIke(Ooiladi.mm: 415.458.3069
Dal,a and- Fomat Documenl(s)
- Statf- Manager
- Process 8nd slandardizo Bank and Broker Fllss
- Statf- Manager
Sub'lotal of Data and Forms Sst uP
PdnUMall Notlce Prck€t to KnoM Class Members
- StaffSub.lotal of PrinuMall Notlcs Pack€tto Known claes Members
W€brlt6 Set-up & MalntenancE- Updato W€bsito & S€t up Onllne Clsim filing Module
- Mansoer- SeN€rspace renlsl
Sub-tolal ofWebsite Set"up & Malntenanca
case Management and Aflldavlts- PpJBct l\4anagsmenl snd RePorts
- Staff- Manag8r
- Senlor Menager
- Dir€ctor- PrinciPtl
- Corsspondonce Procsssing Slaff Hours re: Broker6 and Oth€rClass Members
- Statf- Manager
' Dlr€ctor- Declarallons
- Manager
- SenlorManagersub-lotal of caEe Managemsnt and Afridavlls
SUB-TOTAL OF NOTICE PROCEDURES
hrg
hr$
1.00
12,00
38.00 hrs73.00 hrs
2.00 hrs
916,81 6,00
sl70'00
ss60.00
$153,140,50
*liTiriE"od'
1.25 hrs15 mos
9.75 hrs
623.00 hrs
158.25 hrs
7.45 hrs'10.50 hrs
18.00 hrs
78.50 hrs
10.35 h.s
.00 hr6
.50 hrs
- Scdpt Updallno snd Mqnagomsnt- Mansgor
- ProjectBd # of Punchlhrough8 to Live OpeEtor (% ot Cells)
- Av€cgo Call Duratlon (mlnut€s)
- IVR Transfsr Line Chars8s- Llve OperslorLlne Charg8s
SUB'TOTAL OF TELEPHONE SUPPORT
2.50 hrs
132 mlns
2,370 mlns
--3Jsr^s5
#14590 Page 1 ol 2
DOCUMENT 3728
Administration Services Invoice Detail Johnson v. Caremark Rx, LLC
June 16, 2018
Daniel Burke: Daniel [email protected]; 415.458.3089
CLAIMS ADMINISTRATION of GlaIror.
Process Claims Filed Online
Process Claims Filed Electronically - # of Electronic Flies
Process Claims Flied by Postal Mall - Open/image/Data Enter Forms
- Opennmage Forms Process Claims
- Staff Hours Processing Claims - Staff - Staff - Manager - Senior Manager - Director
Audit Flied Claims (Paper Claims) - Staff Hours Completing Audits
- Staff - Manager - Senior Manager - Principal
Deficient Claims Processing - Print/Mall Deficiency Letters - Staff Hours Processing Deficiencies
- Staff - Manager
Calculation of Recognized Loss - Manager - Senior Manager - Director
SUB-TOTAL OF CLAIMS ADMINISTRATION
DISBURSEMENT'!; Y. I AX REPORTING Funds 1(Inodhoowni, Obtain Tax ID
- Staff - Supervisor - Manager - Manager - Principal
Distribution Calculations 8 Prep - Staff - Manager
Settlement Fund Tax Returns (annual)
SUB-TOTAL OF DISBURSEMENTS 8 TAX REPORTING
RESPONSE RATE
JADDITIONAL CHARGES Oilier C0515
- CPA Tax Advice - Courier
SUB-TOTAL OF ADDITIONAL CHARGES
SUB-TOTAL ADMINISTRATION COSTS
Plus Postage' TOTAL COST (through May31, 2018)"
OTHER SERVICES AND 0111 01 POCKET EXPENSES Other Services and Ad Hoc Reporting, ea n nedinl or requested Other Charges and Out-of-Pocket Costs"'
oLIAN l ITy 8,515 claims
HAIL PER UNIT COST TOTAL
1116SPONS1 RATE
RESPONSE RATE
RESPONSE RATE
1,328 claims
7,405 claims 44 files
784 claims
5 claims
12.11 hrs 1,898.98 hrs
581.60 hrs 22 00 hrs
3.50 hrs
20.00 hrs 39.75 hrs 59.00 hrs 7.00 hrs
127 units
13.25 hrs 71.50 hrs
19 00 hrs 20.75 hrs
1.00 hrs
3.82 hrs 7.25 hrs 6 DO hrs
15 50 hrs 6.50 hrs
0 25 hrs 1.00 hrs
1 yr
QUANTITY
OUAN1ITY
• Postage and Handling " Does not Include applicable taxes.
'" Includes, bulls not limited lo long distance calls, overnight shipping, photocopies, storage, PO Box rentals. broker lees, etc
RATE, PER ESTIMATED UNIT cosi
$300,952.90
TOTAL_
$7,677
RATE PER UNIT COST FOTAI
RAM PER UNIT
$1,050 00 $43.35
COS I (standard hourly rates)
(actual)
$1,093.36
$404,268.80
$66.60 $484,335.40
#14590 Page 2 of 2
Q;#riAdministration Ssrvices lnvoice Detail
Johnson v. Caremark Rx' LLCJun€ 14 2018
Danlsl Bur*s: Danlal.Burk€@gllardl.com; 41 5.458.3069
RESPONSERATE
HAT[ PERUNII cos fQUAN I II'YLAlllS AlllillNlSf RA IION lOTAL
Onllne
Procoss clalms Flled Eleclronlcally- f ot Elelronic Fllss
Process clalms Flled by Postal Mall- Opon/lnags/Data Ent€r Foms
- Openllmago FormsProce6s Clalms
- Slaff HouE Pmcesslng Claims
- stat{- Staff- Mansgor
- SeniotManager- Dlrdctor
Audlt Flled clalms (Paper clalmsl- StaffHouF ComPlellng Audils
- Sl8ff.- Msnager- SenlorManager- PdnciPal
Detlclent clalm6 Processlng
' PrinuMsll Deliclency Letter6
- Statf HouE Processlng Deflclencies
- Stafi- ManagBr
Cslculation of Rocognlzed LosE
- Managor
- sonlofManagsr- Dlmclor
12.11 hm
1,898.98 hr6581.60 hrs22.00 hrs3-50 hrs
20.00 hrs
39.75 hrs
59.00 hrs
7.00 hrs
'127 unlts
13.25 hrs
71.50 hrs
19.00 hrs
20.75 hrs
1.00 hrs
SUB-TOTAL OF CLAIMS ADMINISTRATION
1.326 claims
7.405 clalms
44 files
784 clalms
5 clalms
$300,952,90
RIlSPONSI;lrAl t
I{A IE T'LRUIIIT
E S TI fu1ATE I]cos'tDISBURSLI/LI.11 S A I AX IlEPORI II']C rol Ar_OUAtlt I l','
Funds- Staff- Superuisor
- Manag8r
- Managor
- PdnclPal
Dlstrlbutlon calculallons & Prep- Statl- Manager
Sotllenent Fund T8x Retutns {annual)
3,82 hrs
7.25 hts6.00 hrs
15.50 hG
6.50 hts
0.25 hrs'1.00 hrs
1yl
SUB-TOTAL OF DISBURSEMENTS & TAX REPORTING 97,67f
RFSPONSERAIE
IIAIT PERtJutT COS'IloNAl cilARCt-s ro tAtOIJANTITY
- CPATaxAdvl6- Couder
SUB-TOTAL OF ADDITIONAL CHARGES
SUB.TOTAL ADMINISTRATION COSTS
Plus Post3gs'TOTAL COST (through May3t, 2018)'^
61,050.00s43.35
__--!1999!t
--T4m',16s"oo
$88.60
$484,336.40
srRVt(:ts Auu otJl.o[ PocKEl t-xPFNSFSRESPOl.lSl:
IiA TE
llAIll: Pf R(,NIT cos IQUANI IlY
Olhsr Serulcos snd aa or r€qu€BGd hourly
Other charges and Out{f-Pocket costs"'
' Postage 8nd Hsndllng.
" Doos not include applicable laxes.... lncludss, but is not limited to long dislance calls, ovenight shlpping, photomples, stor€go, PO Box tenlals, brcker ress, elc.
(aclual)
#14590 Page 2 ol 2
DOCUMENT 3728